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Abstract 
The Histone Acetyltransferase Dmel\TIP60 Is Essential for Multicellular 
Development in Drosophila 
Xianmin Zhu 
Felice Elefant, Ph.D. 
 
Combinatorial histone modifications control chromatin packaging which in turn, 
contributes to the precise patterning of gene expression during development. Histone 
acetyltransferases (HATs) are a key class of chromatin regulatory proteins that 
mediate such developmental chromatin control; however their specific roles during 
multicellular development remain unclear. Here, we report the first isolation and 
developmental characterization of a Drosophila HAT gene (Dmel\TIP60) that is the 
homolog of the human HAT gene TIP60. We show that Dmel\TIP60 is differentially 
expressed during Drosophila development, with transcript levels significantly 
peaking during embryogenesis. We further demonstrate that reducing endogenous 
Dmel\TIP60 expression in Drosophila embryonic cells by RNAi results in cellular 
defects and lethality. Finally, we use our Drosophila GAL4 inducible Dmel\TIP60 
knockdown/overexpression system to explore the role of Dmel\TIP60 in a wide 
variety of specific tissues during Drosophila development. We show that ubiquitous 
and cell/tissue specific reduction of Dmel\TIP60 expression results in lethality and/or 
cell/tissue specific phenotypes during fly development. Loss of Dmel\TIP60 in the 
wing leads to a range of wing abnormalities, including the formation of wing blisters 
 xiii
in the most severe cases. Wing surface area and cell count/hair density assays reveal 
that although the number of cells that compose the wing remain unaffected, their size 
is significantly smaller than normal and there are defects in wing cell planer polarity. 
Additionally, we find that loss of Dmel\TIP60 in the CNS leads to lethality and a 
substantial loss of differentiated neurons in the larval brain, while cyclin E levels and 
apoptosis remain unaffected. Finally, we show that loss of Dmel\TIP60 in the 
mesoderm leads to lethality, and malformation or absence of the muscle fibers in the 
developing embryo. Overexpression of Dmel\TIP60 in each of these tissues has no 
affect on their development. Taken together, our results support an essential role for 
Dmel\TIP60 in the differentiation and formation of a variety of specific cell and tissue 
types. Significantly, our inducible and targeted HAT knockdown system in 
Drosophila now provides a powerful tool to effectively study the roles of these 
chromatin mediators in specific tissues and cell types during development. 
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Chapter 1: Background 
 
Chromatin packaging and epigenetic regulation 
 
Metazoans consist of different cell-types that carry out specialized functions 
essential for proper development. The differentiation of such specialized cell-lineages 
is achieved through the establishment and maintenance of tightly regulated gene 
expression profiles distinct for each cell type (Orphanides and Reinberg 2002). In 
eukaryotes, the differential packaging of genes into chromatin significantly 
contributes to this regulation. 
Chromatin, the genetic material in eukaryotic cells, is constructed by 
nucleosomes. Each nucleosome consists of 146 bp of DNA wrapped around a histone 
octamer core, containing two copies each of histone proteins H2A, H2B, H3, and H4 
(Luger 2006). There are two different types of eukaryotic chromatin: euchromatin and 
heterochromatin. Euchomatin has a diffuse appearance during interphase, and 
undergoes condense and decondense in the cell cycle. Euchromatin is found outside 
centromere and telomere regions. It contains most of the single-copy genes and lacks 
meiotic recombination (Dimitri et al. 2005). Acetylation of histone H3 and H4 tails 
and methylation of lysine 4 residue on H3 (H3K4) are characteristic for euchromatin 
(Strahl and Allis 2000). In contrast to euchromatin, heterochromatin is condensed 
throughout the cell cycle. About 30% of D. melanogaster genome and 20% of human 
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genome are packaged into heterochromatin (Dimitri et al. 2005). With very few 
meiotic recombinations, heterochromatin replicates late in S phase, and is associated 
with repressive transcription (Westphal and Reuter 2002). Heterochromatin always 
resides in centromere and telomere. It has high volume of repetitive DNA copy 
number but very low single-gene copy number (Dimitri et al. 2005) (Weiler and 
Wakimoto 1995). For example, only approximately 300 genes in D. melanogaster are 
predicted inside heterochromatin (Lu et al. 2000a; Schulze et al. 2005). The 
heterochromatin structure is required for the proper expression of heterochromatic 
genes, because these genes in heterochromatin are found to be repressed when placed 
into euchromatin by chromosomal rearrangement (Wakimoto and Hearn 1990; Eberl 
et al. 1993). Taken together, these studies support the premise that chromatin 
packaging plays an essential role in the regulation of gene expression. 
As stated above, epigenetic regulation, i.e., packaging of DNA into chromatin, 
directly controls gene expression (Felsenfeld and Groudine 2003; Dillon 2006). 
Epigenetic regulation is achieved by controlling DNA accessibility for cellular 
processes such as replication, transcription and DNA repair (Woodcock 2006). In 
general, there are three types of biochemical mechanisms in epigenetic regulation, 
which are DNA methylation, binding of non-histone proteins (e.g., HP1, Polycomb 
(PcG) and trithorax (trxG) group complexes), and histone modifications (Bock and 
Lengauer 2007). 
DNA methylation directly replaces a hydrogen atom of the cytosine base by a 
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methyl group. Although the modified cytosine can still be transcribed into mRNA, 
DNA methylation leads to inhibition of transcriptional activation because it promotes 
a highly condensed chromatin structure so that to prevent the binding of 
transcriptional factors (Bird 2002; Weber and Schubeler 2007). The details of how 
DNA methylation involves in gene regulation during development will be discussed 
later. 
Epigenetic regulation via non-histone proteins can be categorized into two 
mechanisms (Bock and Lengauer 2007). One is relied on ATP-dependent chromatin 
remodeling complexes, which directly move or displace nucleosomes along the DNA 
(Gangaraju and Bartholomew 2007). The other mechanism is to recruit proteins such 
as HP1, PcG and trxG complexes, which recognize the epigenetic marks on the 
chromatin and further modify these marks (e.g., histone modifications and/or DNA 
methylation) by recruiting other protein complexes (Ringrose and Paro 2004; Schulze 
and Wallrath 2007). The detailed discussions on PcG and trxG functions during 
development will be in the section “Epigenetic Regulation during Development”. 
Covalent modification of the core histones is another way to remodel 
chromatin (Berger 2002; Kouzarides 2007). Such modifications include acetylation (L 
residue), methylation (K and R), phosphorylation (S and T), ubiquitination (K), 
sumyolation (K), ADP ribosylation, glycosylation, biotinylation, and carbonylation 
(Margueron et al. 2005). As known, the histone N-terminal tails is unstructured and 
protrude out of the nucleosome, which can interact with the other neighboring 
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nucleosomes. The modifications on histone N-terminal tails can physically modulate 
the affinity between histones and DNA so that to influence the nucleosomal assembly 
and chromatin structure. For example, histone acetyltransferases (HATs) can transfer 
an acetyl group to the histone lysine residues, which facilitate gene expression by 
promoting chromatin decondensation and allowing the transcriptional factors to bind 
onto DNA (Brownell and Allis 1996). Histone modification has proved to be as 
important as the genetic code, and as such is called “histone code” (Jenuwein and 
Allis 2001; Turner 2007). Furthermore, the combinatorial and coordinated histone 
modifications can determine the chromatin status at different levels (Fischle et al. 
2003) and regulate many biological processes including development (Margueron et 
al. 2005). 
In conclusion, epigenetic regulation, which precisely controls chromatin 
packaging, plays an essential role in regulating gene expression for normal growth 
and development of multicellular organisms. 
 
Epigenetic regulation during development 
 
The development of multicellular organisms requires the specialization and 
maintenance of cell lineages, which is achieved by precise regulation of differential 
gene expression profiles at different developmental stages. As stated above, 
epigenetic regulation plays an essential role in controlling gene expression. Below are 
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the detailed mechanisms of epigenetic regulation during development. 
 
Dosage compensation 
 
In both mammals and Drosophila, females have two X chromosomes (XX), 
whereas males have only one (XY), so that X-linked genes have a twofold difference 
between females and males. Dosage compensation is the precise regulation that 
equalizes the amount of X chromosomal gene expression between two sexes. 
However, the mechanisms of dosage compensation in these two species are different. 
Dosage compensation is achieved by X chromosome inactivation (XCI) in 
mammalian females, whereas it is achieved by specifically activating transcriptions in 
Drosophila males. 
 
X inactivation in mammalian systems 
 
During mammalian development in the mouse model system, the 
preimplantation mouse embryonic cells initially undergo imprinted inactivation of the 
paternal X chromosome (Xp). In the late blastocyst, Xp in the inner cell mass cells is 
activated, except that in the extraembryonic cells (trophoectoderm, primitive 
endoderm). Afterwards, the embryo carries out random X inactivation (Allegrucci et 
al. 2005). 
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Random X inactivation is initiated by the transient interchromosomal 
interactions between X inactivation center (Xic) loci on the X chromosomes, which 
allows for an estimation of the number of X chromosomes and initiates which X 
chromosome will be inactivated in female cells. Within Xic loci, there are three genes 
that encode distinctive noncoding RNAs (ncRNAs): Xist, Tsix, and Xite. 
Accumulation of Xist is required for inactivation of one of the X chromosomes. Tsix 
is antisense to Xist which leads to Xist silencing. Xite can positively regulate Tsix 
transcription. On the inactivated X chromosome (Xi), transcription of Tsix is 
down-regulated, while that of Xist is up-regulated and accumulates to recruit 
additional histone modifiers. On the active X chromosome (Xa), Tsix represses Xist 
by introducing H3K4me2 (Sado et al. 2005; Sun et al. 2006). Epigenetic regulations 
are widely involved in promoting heterochromatization of Xi. In support of this 
phenomenon, Xi was found to be located within hypermethylated CpG islands 
(Kratzer et al. 1983). Additionally, the Eed-Ezh2 Polycomb group (PcG) complex 
associates with Xi and contributes to H3K27me3 (Plath et al. 2003). Furthermore, the 
histone modifications of H3K9me2 and H3K4me2 are also found in Xi (Valley et al. 
2006). Compared to Xa and autosomes that contain the activating histone variants, 
such as H2ABbd and H2A.Z, Xi contains the most extreme repressive histone variant 
macroH2A (Chadwick and Willard 2001; Chadwick and Willard 2003). 
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Dosage compensation in Drosophila 
 
In Drosophila, a dosage compensation complex (DCC) is the regulating center 
for activating gene transcription on the X chromosome in males. This complex 
consists of several protein factors and RNAs. The protein factors are male specific 
lethal (MSL), the RNA-DNA helicase maleless (MLE), male specific lethal1, 2 and 3 
(MSL1, 2 and 3), the acetyltransferase males absent on first (MOF), the histone H3 
kinase JIL-1. Two ncRNAs are RNA on the X 1 and 2 (roX1 and roX2). 
Within the DCC complex, MSL2 can limit and guide the formation of the 
functional DCC complex only in males, since all of the MSL proteins, except MSL2, 
were found to be expressed in females. (Kelley et al. 1995; Zhou et al. 1995). MSL2 
further recruits MSL1 and MSL3 and other members. As described below, an 
epigenetic regulation is essential for DCC mediated dosage compensation when 
dissecting the functions of each member in this complex. MOF is most likely to be 
involved in activation of the male X chromosome by acetylating histone H4 on lysine 
16 (H4Ac16), a modification associated with transcriptional activation (Akhtar and 
Becker 2000; Smith et al. 2000) and usually found in the male X chromosome 
(Turner et al. 1992; Bone et al. 1994). This elevation of gene expression is likely due 
to the regulation of the rate of elongation, rather than promoter activation as the DCC 
complex and H4Ac16 are more enriched in the coding regions of compensated genes 
than on their promoters (Smith et al. 2001; Alekseyenko et al. 2006; Gilfillan et al. 
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2006). Another histone modification in the male X chromosome is H3 phosphorylated 
on serine 10 (H3pS10), which is attributed by the JIL-1 (Wang et al. 2001). JIL-1 may 
antagonize the spread of heterochromatin and promote active euchromatin, most 
likely because H3pS10 can somewhat block H3K9me2 and thus prohibits HP1 
binding on the chromosome region (Zhang et al. 2006). Additional factors that play a 
role in X activation in males are the noncoding RNAs, roX1 and roX2. These RNAs 
are found to coat the X chromosome in males and be regulated by one or more 
members of the MSL complex (Bai et al. 2004; Lee et al. 2004a; Rattner and Meller 
2004). For example, MSL3 and MOF have RNA binding activity in vitro. As 
demonstrated by experiments, MLE and MOF are removed from the X chromosome 
by RNase A digestion (Richter et al. 1996; Akhtar et al. 2000; Buscaino et al. 2003). 
Additionally, the MSL proteins can be co-immunoprecipitated with the roX RNAs 
and JIL-1 (Copps et al. 1998; Jin et al. 2000; Smith et al. 2000). Furthermore, 
knockout both roX1 and roX2 will significantly reduce the survival rate in males 
(Meller and Rattner 2002). Thus, the ncRNAs (roX1 and roX2) must play a central 
role in the interactions among the members within the DCC complex. 
Interestingly, the proteins in Drosophila DCC also have human homologs; 
however, their human counterparts may not have the same functions as described. For 
example, human MOF (hMOF), which also has histone acetyltransferase activity, has 
nothing to do with dosage compensation in human but is required for normal function 
of human ATM and DNA repair (Gupta et al. 2005). 
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Position effect variegation (PEV) 
 
Position effect variegation is defined as differential gene expression in 
individual cells when such gene is positioned within heterochromatin. This 
phenomenon was first described when H Muller explored the effect of X ray radiation 
on Drosophila development in 1920s and 1930s (Schulze and Wallrath 2007). The 
mutated flies had mosaic red and white eyes due to the position of the white gene into 
the heterochromatin region. Multiple screens have been performed to identify the 
genes that either enhance or suppress PEV (Reuter and Wolff 1981; Sinclair et al. 
1989; Wustmann et al. 1989; Dorn et al. 1993). As a result, a series of genes have 
been identified, ranging from 50 to 150 thus far (Weiler and Wakimoto 1995). Some 
of them show dosage-dependent effects on variegation, which proves genetically that 
the amount of protein factors is important for the formation of heterochromatin 
(Schotta et al. 2003). Such genes fall into 2 categories: enhancer of position 
variegation effect E(var) and suppressor of position variegation effect Su(var). The 
majority of these genes encode the proteins associated with chromosome structure. In 
general, Su(var) represses transcription by forming heterochromatin, whereas E(var) 
enhances gene expression by opening chromatin structure, (Schulze and Wallrath 
2007). For example, Su(var)3-9 encodes a protein containing histone 
methyltransferase activity that can methylate H3K9 (Rea et al. 2000; Lachner et al. 
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2001). Methylated H3K9 in the centric heterochromatin regions is always observed to 
be bound with heterochromatin protein 1 (HP1) encoded by the Su(var)2-5 gene 
(James and Elgin 1986; Eissenberg et al. 1990). Su(var)3-1 encodes JIL-1 as 
mentioned in dosage compensation, which phosphorylates serine 10 of histone H3 
(H3S10) and controls the heterochromatin spreading upstream of the control of HP1 
(Ebert et al. 2004; Schulze and Wallrath 2007). In contrast, E(var)62/trithorax-like 
(trl) encodes the GAGA factor which can bind the (GA)n motif and open the 
chromatin structure for transcriptional activation (Granok et al. 1995).  
 
Genomic impriting 
 
Imprinting is the process of monoallelic expression of certain genes from 
either paternal or maternal allele. In mammals, the epigenetic regulation of imprinting 
is somewhat similar to XCI (Reik and Lewis 2005). More than one hundred of 
imprinted genes have been found, most of which function in regulation of late 
placental and fetal growth (Kiefer 2007). Disruption of genomic imprinting always 
leads to many human developmental disorders and cancers (Feinberg et al. 2002). 
Imprinted genes are differentially expressed from one parental chromatin due 
to the epigenetic marks (e.g. DNA methylation) established on that particular 
chromatin (Wood and Oakey 2006; Edwards and Ferguson-Smith 2007). Such genes 
are usually present in cluster of 3-11 genes and are controlled by an imprint control 
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region (ICR) located within the cluster. Before oogenesis and spermatogenesis, 
pre-existing DNA methylation at the ICR is erased in the primordial germ cells by 
unknown mechanisms (Delaval and Feil 2004). During oogenesis and 
spermatogenesis, DNA in the ICR is differentially methylated by DNA 
methyltransferase Dnmt3a and Dnmt3l between two homologous chromosomes in 
germ-line cells. After a genome-wide reprogramming that erases DNA methylation 
immediately from the paternal pronucleus and progressively from maternal 
chromosomes following fertilization (Edwards and Ferguson-Smith 2007), the de 
novo allelic DNA methylation is established and maintained in the somatic cells 
throughout the development (Wood and Oakey 2006; Edwards and Ferguson-Smith 
2007). 
Genomic imprinting is achieved by several epigenetic mechanisms such as 
DNA methylation and histone modifications, serving as a good example of epigenetic 
gene regulation during development (Delaval and Feil 2004; Kiefer 2007). For 
instance, the insulin-like growth factor 2 receptor (Igf2r) cluster that encodes a fetal 
growth regulator and potassium voltage-gated channel, subfamily Q, member 1 
(Kcnq1) cluster that encodes cardiac potassium channel are both expressed on the 
maternal chromosome and their expression is regulated by the ncRNA antisense Igf2r 
RNA (Air) and Kcnq1 overlapping transcript 1 (Kcnq1ot1), respectively (Delaval and 
Feil 2004). On the maternal chromosome, DNA methylation inhibits the ncRNA 
transcription of Air and Kcnq1ot1, so that the Igf2r and Kcnq1 clusters can be 
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expressed (Stoger et al. 1993; Engemann et al. 2000). Although the mechanisms 
underlying how Air and Kcnq1ot1 can silence Igf2r and Kcnq1 on the paternal 
chromosome are not clear to date, one recent study found that Kcnq1ot1 induced 
silence is associated with H3K9 and H3K27 methylation and concordant with the 
recruitment of the Eed-Ezh2 PcG complex on the paternal chromosome (Umlauf et al. 
2004). The imprinting mechanisms are diverse among different clusters and may be 
even different within the same cluster. For instance, insulin-like growth factor 2 (Igf2) 
and H19 are in the same cluster, however, Igf2 is only expressed on paternal 
chromosome and H19 is expressed on maternal chromosome. On the maternal 
chromosome, the ICR in this cluster is unmethylated, thus blocks Igf2 expression by 
recruitment of an insulator CCCTC binding factor (CTCF) and blocking interaction 
between the promoter and enhancer of Igf2. Conversely, the unmethylated ICR 
directly allows the maternal expression of H19. On the paternal chromosome, the 
opposite events happen allowing Igf2 expression and blocking H19 expression (Hark 
et al. 2000; Engel et al. 2004). 
 
Polycomb group / Trithorax group 
 
Embryonic patterning in Drosophila is established by the transient presence of 
maternal and zygotic transcription factors, which are regulated by the Polycomb 
group (PcG) and trithorax group (trxG) genes. To date, there are 18 PcG genes and 
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17 trxG genes (Ringrose and Paro 2004). PcG maintains the spatial pattern of 
homeobox-containing (Hox) genes, a group of conserved genes that lead to 
anterior/posterior patterning. The name Polycomb comes from the finding in the early 
1940s that a fly mutant for the gene that encodes for PcG exhibits sex combs on all 
the legs of males instead of the normal pattern where sex combs are present only on 
the first leg (Lewis 1978), which (known as homeosis) is caused by the loss of 
repression of a Hox gene through PcG. (Ringrose and Paro 2004). Mutation of 
Trithorax (trx) was initially found to be able to transform body segment into anterior 
ones (Ingham 1985). It was not until the late 1980s that several other suppressors of 
PcG mutant phenotypes were identified that belonged to the trxG. genes (Kennison 
and Tamkun 1988). PcG and trxG proteins are well conserved between Drosophila 
and vertebrates. Although Drosophila shares a number of vertebrate homologs such 
as enhancer of Zeste [E(Z)], extra sex combs (ESC), and suppressor of Zeste 12 
[SU(Z)12], some Drosophila proteins are missing in vertebrates, which include three 
sequence-specific DNA-binding proteins GAF, Pipsqueak (PSQ), Zeste (Ringrose and 
Paro 2004). 
PcG represses Hox genes in regions where they are not normally expressed by 
marking those regions with the silencing epigenetic marks, H3K27me3 and 
H3K9me2. Flies and mice mutant for PcG genes exhibit ectopic Hox expression, 
sometimes eliciting homeotic transformations (Jürgens 1985; van der Lugt et al. 
1994). The PcG gene Bmi1 mutation mice have been shown to have numerous defects 
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in the self-renewal of hematopoietic and neural stem cells, and in the proliferation of 
primary fibroblasts (Jacobs et al. 1999) (Lessard and Sauvageau 2003; Molofsky et al. 
2003; Park et al. 2003). As mentioned previously, trimethylation of H3K27 by PcG 
also promotes silencing on Xi and imprinted genes. PcG binds to Polycomb group 
response elements (PREs) in regulatory regions of target genes. In Drosophila, PREs 
are comprised of different combinations of specific binding sites. PcG targets several 
developmental genes, including the transcription factors Fox, Sox, and Pax and the 
signaling molecules Wnts, Shh, and BMPs (Bracken et al. 2006; Negre et al. 2006). 
Additionally, PcG target profiles differ in undifferentiated and differentiated cells. 
Taken together, these studies support the premise that the PcG complex comprises an 
important group of epigenetic regulators that are involved in various developmental 
processes. 
There are two PcG complexes derived from the Drosophila embryo, 
Polycomb repressive complex (PRC) 1 and 2 (Kiefer 2007). Another complex, named 
chromatin associated silencing complex for homeotics (CHRASCH) was purified 
from Drosophila Schneider cells (Huang et al. 2002; Huang and Chang 2004). 
Drosophila PRC1 is composed of Polycomb (PC), Polyhomeotic (PH), Posterior sex 
combs (PSC), RING, Sex combs on midleg (SCM), Zeste, and some other 
transcriptional factors (Saurin et al. 2001). The core complex of PC, PH, PSC and 
RING has no preference for DNA sequences that contain PRE, but will bind to Zeste 
sites when reconstituted with Zeste protein (Mulholland et al. 2003). GAF and PHO 
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are also found inside the PRC1 complex as demonstrated by coimmunoprecipitation 
(Poux et al. 2001). PRC1 can repress transcription by inhibiting chromatin 
remodeling by SWI/SNF (Francis et al. 2001) and/or preventing transcription 
initiation by RNA polymerase (Dellino et al. 2004). Recently, it was demonstrated 
that the mammalian PRC1 complex promotes Hox silencing through ubiquitination of 
H2A (Cao et al. 2005). Drosophila PRC2 contains the core proteins extra sex combs 
(ESC), suppressor of Zeste 12 [SU(Z)12], enhancer of Zeste [E(Z)] and some 
additional proteins (Ringrose and Paro 2004). PRC2 complex can methylate lysines 9 
and 27 on histone H3 , the mark for gene silencing that serves as a binding site for 
chromodomain of PC (Czermin et al. 2002). It is important to note that PcG 
regulatory regions do not seem to overlap with those of HP1, suggesting that PcG 
function during development is different from the general HP1-related 
heterochromatic silencing during early embryogenesis (Schulze and Wallrath 2007). 
Although it is related to PRC1 complex, CHRASCH has a unique protein PSQ, which 
ensures the complex binding to PREs that specifically contain the (GA)n motif. In 
addition, the complex contains HADC1 that is associated with repression of gene 
expression (Huang and Chang 2004). 
Similar to PcG, trxG functions are also carried out in distinct trxG complexes. 
There are four trxG complexes that have been found in Drosophila so far: BRM 
complex, small or absent, small or homeotic discs 1 (ASH1) complex, ASH2 complex, 
and trithorax acetylation complex 1 (TAC1) complex. The BRM complex is 
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composed of the trxG proteins Brahma (BRM), Moira (MOR), and OSA, as well as 
additional accessory proteins (Papoulas et al. 1998; Collins et al. 1999). In the BRM 
complex (the homolog in yeast is the SWI2/SNF2 complex), BRM acts as ATPase for 
the ATPase-dependent chromatin remodeling (Papoulas et al. 1998). The ASH1 and 
ASH2 complexes are composed of the trxG proteins ASH1 and ASH2, respetively 
(Papoulas et al. 1998). The TAC1 complex contains the trxG protein TRX, the histone 
acetyltransferase CBP and the antiphosphatase sbf1 (Petruk et al. 2001). Of note, 
TAC1 complex can also repress Hox gene Ultrabithorax (Ubx) by facilitating 
transcriptional elongation of bxd ncRNA transcripts (Petruk et al. 2006). trxG binds 
the same chromosomal element as PcG. However, this element is called trithorax 
response element (TRE) and not PRE when trxG binds to it. 
The histone modification H3K4me3, which is a well characterized epigenetic 
mark related to transcriptionally active genes (Strahl and Allis 2000; Cheung and Lau 
2005), plays a key role in the trxG-mediated gene activation (Sims and Reinberg 2006; 
Schuettengruber et al. 2007). For example, both TRX and ASH1 have SET domain 
that is a catalytic domain responsible for methylating histones, and thus function as 
histone methyltransferases that specifically methylate lysine 4 on histone H3 (H3K4) 
(Beisel et al. 2002). Noncoding TRE transcripts, which are required for activation of 
PRE/TRE, recruit Drosophila ASH1 to make the active euchromatin mark H3K4me3 
(Sanchez-Elsner et al. 2006). Furthermore, bromodomain PHD finger transcription 
factor (BPTF), a subunit of nucleosome remodeling factor (NURF) complex, 
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specifically targets the chromatin remodeling trxG. NURF complex to H3K4me3 on 
the promoter region and promotes active chromatin by repositioning nucleosomes 
along DNA (Wysocka et al. 2006). These data highly suggest that trxG activates gene 
expression (e.g. Hox genes) by facilitating euchromatin. 
 
Lineage restriction 
 
During embryogenesis, specific gene programs in multipotent cells are 
activated thus triggering differentiation of these cells into specialized lineages. 
Equally important, a cell must also silence expression of genes specific to other cell 
lineages to secure its fate. Because there gene expression profiles must be maintained 
throughout the life of the animal, epigenetic mechanisms are ideal for mediating such 
events. 
 
Nervous systerm 
 
During neuron differentiation in vertebrate systems, a vast array of 
transcriptional activators and repressors are involved in neuronal and glial fate 
specification (Bertrand et al. 2002; Ross et al. 2003). Epigenetic regulation provides a 
modulating center for either recruiting or displacing such different transcription 
factors, thus allowing for gene activation or repression in a temporal and special 
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manner. In epigenetic repression, the repressor element 1 (RE-1) silencing 
transcription factor/neuron restrictive silencing factor (REST/NRSF), a zinc finger 
protein, plays a central role for epigenetic silencing of neuronal genes (Ballas and 
Mandel 2005). In support of this, mice lacking REST/NRSF die at E11.5 and show 
the neural-specific gene βIIItubulin expression in some non-neural tissues (Chen et al. 
1998). In non-neuronal cells, REST/NRSF binds a 21 to 23 bp motif RE1 site (also 
known as neuron-restrictive silencing element, NRSE) in the regulatory regions of 
target genes and represses their transcription. These genes are essential for 
neurogenesis, and include ion channels, neurotransmitter receptors, axonal guidance 
molecules, and the neurogenic gene NeuroD (Bruce et al. 2004). REST/NRSF 
imposes dynamic, non-permanent repression through its association with several 
cofactors and complexes. The corepressors that interact with REST/NRSF include 
CTD phosphatase, which inhibits RNA polymerase II (Yeo et al. 2005), N-CoR 
(Jepsen et al. 2000), mSin3A/B complex (Naruse et al. 1999), and CoREST/HDAC2 
complex (Ballas et al. 2001). The corepressor CoREST coordinates stable, epigenetic 
repression by directly binding the H3K9 HMT G9a (Roopra et al. 2004) and the 
H3K4 demethylase LSD1 (Shi et al. 2004). CoREST also recruits additional 
epigenetic silencing factors, such as the methyl DNA binding protein MeCP2, the 
H3K9 HMT SUV39H1, and HP1 which binds the regions marked with methylated 
H3K9 (Lunyak et al. 2002). 
Upon neuronal differentiation, the repression of REST/NRSF complexes 
 19
would be removed from RE1 site. However, this is not sufficient to activate all neural 
cell type. Thus, distinct derepression mechanisms are required for different neuronal 
genes and cell types. For example, in the transformation from pluripotent embryonic 
stem cells to differentiated neurons, REST/NRSF can be removed from RE1 site, 
which is sufficient to activate the neuronal genes previously repressed by the complex. 
For some genes (e.g. brain-derived neurotrophic factor, BDGF and Calbindin), the 
disassociation of REST/NRSF from RE1 is not enough to trigger the activation of the 
genes. Additional CoREST/MeCP2 complexes must also be removed from the 
adjacent methylated DNA CpG regions to accomplish this depression process (Ballas 
et al. 2005). In neuronal progenitors of the adult hippocampus, a small noncoding 
double-strand RNA (dsRNA) was found to be associated with NRSF and capable of 
converting REST/NRSF from a repressor to an activator, most likely due to 
preventing the interaction of REST/NRSF with other factors by changing 
conformation of REST/NRSF and not by RNAi mechanisms (Kuwabara et al. 2004). 
The ATPase Brahma-related gene 1 (Brg1), the catalytic subunit of SWI/SNF 
has shown to be required for neuronal differentiation through its association with 
Neurogenin 1 and NeuroD (Seo et al. 2005). Neurogenins and NeuroD are important 
neural basic helix-loop-helix (bHLH) transcription factors required for neuronal 
commitment and cell fate determination respectively. Recent research also showed 
that Geminin can block gene expression and maintain the undifferentiated state of 
the cell by disrupting the interactions between brg1 and neural bHLH proteins (Seo 
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et al. 2005). 
Epigenetic regulations also control neural plasticity, memory and behavior. 
For example, upon stimuli in Aplysia (sea hare) neurons, CBP and HDAC5 are 
found to antagonize each other in the acetylation of histones at the promoter of the 
early gene C/EBP (Guan et al. 2002). Additionally， polyADP-ribose polymerase 1 
is activated supporting the notion that transient chromatin remodeling is required for 
long-term memory (Cohen-Armon et al. 2004). In mouse Rubinstein-Taybi 
syndrome (RTS) model, the HAT activity of CBP is also essential for neuronal 
plasticity, and learning. Remarkably, increasing histone acetylation by HDAC 
inhibitor suberoylanilide hydroxamic acid or Trichostatin A rescues the RTS 
phenotypes in CBP mutant mice (Alarcon et al. 2004; Korzus et al. 2004). 
Additional studies show that behaviors influencing the maternal care in rats can be 
inherited and is influenced by levels of DNA methylation and histone acetylation at 
the promoter of glucocorticoid receptor (GR) gene (Weaver et al. 2004). Finally, 
retrotransposition of the human long interspersed nuclear element-1 (LINE-1) is 
regulated by epigenetic control mechanisms. Such retrotransposition is thought to 
influence neuronal differentiation but not glial differentiation (Muotri et al. 2005). 
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Muscle 
 
During muscle development, lineage commitment is achieved by coordinated 
activation and repression of specific genes so that appropriate myogenic identity is 
acquired (Pomerantz and Blau 2004). The undifferentiated muscle precursors will 
then proliferate, enter the differentiation program, and finally turn into terminally 
differentiated cells. As shown below, epigenetic mechanisms are of great importance 
in regulating these complicated events during muscle development. 
Myogenesis is generally controlled by several transcriptional factors that 
include the muscle specific basic helix-loop-helix (bHLH) transcription factors 
(muscle regulatory factors, MRFs), and the myocyte enhancer factor 2 (MEF2). The 
four members of MRFs are myogenic factor 5 (Myf5), myogenic differentiation 
antigen (MyoD), myogenin, and MRF4. These factors bind E-box DNA elements in 
the muscle specific promoters in a temporal manner and initiate the nuclear 
reprogramming for myogenic lineage commitment. The homeobox protein Msx-1 
was found to inhibit the differentiation of skeletal muscle during embryogenesis 
(Bendall et al. 1999; Bendall and Abate-Shen 2000). Furthermore, there was evidence 
that Msx-1 binds to the linker histone H1b and guides H1b to the regulatory region of 
MyoD, which represses the expression of MyoD and inhibits myogenesis (Lee et al. 
2004b). In accordance to this finding, H1b expression in undifferentiated cells, 
including muscle precursors, decreases as differentiation proceeds (Wang et al. 1997). 
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In proliferating myoblasts, histone hypoacetylation and hypermethylation 
within chromatin inhibits premature muscle-gene expression and is achieved by 
several histone modifiers, including histone deacetylases (HDACs), YY1 and 
Polycomb proteins. Upon induction of differentiation, As to histone acetylation, the 
association of class I HDACs with MyoD in undifferentiated myoblasts is disrupted 
thus allowing for acetylation of genes and concomitant expression (Mal et al. 2001); 
(Puri et al. 2001). The interactions between class I HDACs and MyoD is regulated by 
the pRb signaling pathway (Puri et al. 2001) described more in the next section. Class 
II HDACs bind and repress the MEF2 protein (Lu et al. 2000b; Lu et al. 2000c; 
McKinsey et al. 2000a; McKinsey et al. 2000b; McKinsey et al. 2002; Zhang et al. 
2002), and this repression is facilitated by histone methylation. The 
NAD(+)-dependent histone deacetylase Sir2 also regulates skeletal muscle 
differentiation most likely by sensing the redox state of the cell in response to 
exercise, food intake, or starvation (Fulco et al. 2003). Histone methylation also plays 
a very important role in maintenance of the myogenic lineage. HDAC4, HDAC5 
(class II HDACs) and the MEF2 repressor MITR each associate with HP1. Upon 
induction of differentiation, H3K9 methylation surrounding the MEF2 binding sites 
of target genes is decreased with concomitant disruption of the HP1-HDAC and 
HP1-MITR interactions (Zhang et al. 2002). These data suggest that class II HDACs 
bind to MEF2 target genes, not only creating a hypoacetylation environment but also 
promoting H3K9 methylation. The histone methyltransferases Ezh belongs to 
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Polycomb group (PcG), which also regulates muscle specific gene transcription. Ezh1 
and 2 can methylate H3K27 via a conserved SET domain (Cao et al. 2002; Cao and 
Zhang 2004). Recently, it was shown that Ezh2 is down-regulated in the 
dermomyotome of the somites during embryonic development, coincident with the 
activation of the myogenic lineage. During myoblasts differentiation in culture, 
decreased Ezh2 expression correlates with hypomethylation of H3K9 at muscle 
regulatory regions while increased Ezh expression inhibits muscle differentiation due 
to hypermethylation of muscle-specific regulatory regions and the recruitment of the 
corepressor YY1 (Caretti et al. 2004). 
Upon induction of differentiation, the HDACs and their associated 
co-repressors dissociate from the MRFs and MEF2 factors, allowing for the 
recruitment of chromatin modifying complexes to the chromatin surrounding the 
regulatory elements of muscle specific genes. These complexes include HATs 
CBP/p300, PCAF, p/CIP, SRC1 and glucocorticoid receptor interacting protein 
(GRIP), the co-activator-associated arginine methyltransferase 1 (CARM-1) and the 
ATP-dependent switching/sucrose non-fermenting (SWI/SNF) chromatin remodelling 
complexes (Eckner et al. 1996; Yuan et al. 1996; Puri et al. 1997a; Puri et al. 1997b; 
Sartorelli et al. 1997; Chen et al. 2000; de la Serna et al. 2001; Chen et al. 2002; Wu 
et al. 2005). Acetylation of the histone tails by p300 and PCAF results in a relaxed 
chromatin structure permissive for transcription, while acetylation of MyoD by the 
same acetyltransferases increases the affinity for its recognition site in the DNA (Puri 
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et al. 1997b; Sartorelli et al. 1999; Polesskaya et al. 2000; Polesskaya and 
Harel-Bellan 2001; Polesskaya et al. 2001a; Polesskaya et al. 2001b; Dilworth et al. 
2004). Interestingly, p300 is shown to acetylate histones, whereas PCAF 
preferentially acetylate MyoD on its three conserved lysine residues (K99, K102 and 
K104) (Dilworth et al. 2004). Similarly, p300-mediated acetylation of multiple 
lysines is essential for MEF2 function (Ma et al. 2005). Subsequently, it was found 
that the conserved MADS box of MEF2 binds both p300/CBP and GRIP (Chen et al. 
2000). CARM1 then forms the ternary complex with MEF2 and GRIP, leading to 
decondensed chromatin and cooperative activation of MEF2 target genes (Chen et al. 
2002). In support of the importance of histone acetylation in muscle differentiation, 
inactivation of p300 or PCAF is sufficient to block skeletal myogenesis in cultured 
cells and in mouse embryos (Puri et al. 1997b; Polesskaya et al. 2001b; Roth et al. 
2003). 
Along with the expression of muscle-specific genes, terminal differentiation 
requires an exit from the cell cycle, which is achieved by the induction of cyclin 
dependent kinase (CDKs) inhibitors such as p21/CIP or p27, and the inhibition of 
pro-mitogenic genes (Kitzmann and Fernandez 2001). MyoD promotes the 
transcription of both p21/CIP (Guo et al. 1995; Halevy et al. 1995) and the tumor 
suppressor pRb (Martelli et al. 1994; Magenta et al. 2003). High levels of p21 allows 
the cells to exit the cell cycle by targeting and inactivating the CDKs, leading to pRb 
dephosphorylation (Kitzmann and Fernandez 2001). Hypophosphorylated pRb 
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represses the transcription of E2F dependent genes that are necessary for cell cycle 
progression. Involved in these pathways are chromatin modifying enzymes such as 
the catalytic subunits of the SWI/SNF complex (Brg-1 and Brahma (Brm)), class I 
HDACs, histone methyltransferases (e.g. Suv39h1) and some members of the 
Polycomb family of transcriptional repressors (Dunaief et al. 1994; Strober et al. 1996; 
Trouche et al. 1997; Zhang et al. 1999; Strobeck et al. 2000; Nielsen et al. 2001; 
Ogawa et al. 2002; Ait-Si-Ali et al. 2004). In quiescent and terminal differentiated 
cells, these protein complexes and their interaction with the pRb-associated 
repression of certain genes are necessary for cell cycle progression. Acute pRb 
deletion in either cultured myotubes or myofibers of adult mice does not cause 
reactivation of DNA synthesis, despite the re-activation of E2F-dependent 
transcription of genes leading to G1-S phase progression. (Camarda et al. 2004; Huh 
et al. 2004). Since pRb-interaction with HDACs and lysine methyltransferases is 
essential for the establishment of the post-mitotic state in myotubes, it is likely that 
pRb promotes epigenetic modifications at particular loci (e.g., cell cycle genes), such 
as histone hypoacetylation and methylation, leading to chromatin condensation and 
formation of heterochromatin, which eventually persist in the absence of pRb. 
DNA methylation is also involved in muscle differentiation. DNA methylation 
is observed in about 70% of the CpGs in the mammalian genome. DNA 
methylatransferases (Dnmts) add a methyl group into cytosines within the context of 
CpG dinucleotides. This will inhibit gene expression by recruiting the methyl binding 
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domain proteins (MBDs) that specifically recognize methylated CpGs (Bird 1992; 
Hendrich and Bird 1998). A muscle specific Dnmt-1 was found to be only expressed 
in differentiated myotubes but not myoblasts (Aguirre-Arteta et al. 2000). The 
association between MBDs, Dnmts and members of the SWI/SNF chromatin 
remodellers suggests that DNA methylation may induce transcriptional silencing 
through local ATP-dependent chromatin remodeling (Geiman et al. 2004; 
Harikrishnan et al. 2005). The treatment with a methyltransferase inhibitor, 
5-azacytidine, can convert embryonic fibroblasts to muscle, leading to the cloning of 
MyoD gene (Taylor and Jones 1982). Additionally, the transfection of fibroblasts with 
antisense RNA against DNA methylatransferase (Dnmt-1) leads to the same 
myoblastic conversion (Szyf et al. 1992). CpG islands in general, and the MyoD 
promoter in particular (Jones et al. 1990), are constitutively free of methylation in all 
the tissues of the organism (Bird 1986). The distal control element in MyoD enhancer 
plays a pivotal role in first activating the expression of human and mouse MyoD 
during embryonic development (Goldhamer et al. 1995; Kablar et al. 1999). The 
regulatory region in MyoD, the distal control element, is specifically demethylated 
prior gene activation during somitogenesis in mice (Brunk et al. 1996). However, 
mutation of the CpGs found to be methylated in vivo did not lead to precocious 
activation of MyoD regulatory regions in transgenic mice (Brunk et al. 1996). Taken 
together, these studies support the notion that DNA demethylation is not sufficient for 
MyoD-dependent gene activation, but may play an important role in controlling 
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which genes will be activated during myogenic differentiation. In support of this idea, 
demethylation of Myogenin promoter is found at the onset of C2C12 muscle cells 
differentiation (Lucarelli et al. 2001). Furthermore, a genome-wide demethylation has 
been observed during mouse myoblast differentiation (Jost et al. 2001). 
 
Histone acetylation and histone acetyltransferases 
 
Histone acetylation carried out by histone acetyltransferases (HATs) is one of 
the most well-studied of the histone modifications. HATs enzymatically transfer an 
acetyl group from acetyl-coenzyme A (acetyl-CoA) to the ε-terminal group of specific 
and highly conserved lysine residues within the histone N-terminal tail (Sterner and 
Berger 2000; Roth et al. 2001). Numerous HATs have been found and categorized 
into super families, as shown in Table 1 (Adapted from (Sterner and Berger 2000; 
Yang 2004)). 
The distribution patterns of histone acetylation within the eukaryotic genome 
have been shown to be associated with specific gene expression profiles. For example, 
transcriptional coactivators that display HAT activity, such as general control of 
amino-acid synthesis 5 (GCN5)/p300/CBP-associated factor (PCAF), 
p300/CREB-binding protein (CBP), steroid receptor coactivators 1 (SRC1), and 
TATA box binding protein (TBP)-associated factor, 250kDa (TAFII250), are recruited 
to specific promoters through their interaction with DNA-bound transcriptional 
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activators. This interaction provides a mechanism for promoter-specific histone 
acetylation and subsequent gene activation (Bannister and Kouzarides 1996; Mizzen 
et al. 1996; Shiama 1997; Brown et al. 2000; Deckert and Struhl 2001; Nagy and Tora 
2007). 
HAT function during development is strongly supported by studies 
demonstrating that histone acetylation plays critical roles in chromatin control and 
gene expression (Roth et al. 2001). To assess HAT function during development, 
researchers have utilized gene targeting experiments to create null HAT alleles (p300, 
CBP, PCAF and GCN5) in mice. The results indicate that specific HATs carry out 
specialized functions required for proper multicellular development (Xu et al. 2000; 
Roth et al. 2001). To date, extensive developmental analysis of HAT expression 
profiles is limited. Such studies have reported cell-type specific CBP distribution 
patterns that co-localize with CBP target gene expression. Additionally, GCN5 and 
PCAF, which carry out distinct roles during development, are expressed in 
complementary amounts during development and in adult mouse tissues (Xu et al. 
1998; Xu et al. 2000). These studies suggest that HAT function is controlled, at least 
in part, through the regulation of HAT expression patterns. 
Not surprisingly, misregulation of HATs often leads to disorders and diseases. 
For example, loss of either CBP, p300 or PCAF HAT function has been implicated in 
the pathogenesis of Huntington’s disease and many other polyglutamine 
neurodegenerative diseases (Steffan et al. 2001). Particularly, TIP60 and its 
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relationships to certain diseases will be discussed in the next section. Taken together, 
these studies demonstrate that deciphering the regulation of HAT (e.g., TIP60) 
function will not only unveil the mystery of epigenetic regulation during development, 
but also provide some possible ways to cure different human disorders and diseases. 
 
TIP60 and its function 
 
Tat-interactive protein, 60 KDa (TIP60) belongs to the MYST histone 
acetyltransferase super family (Sterner and Berger 2000). TIP60 was first identified 
through its interact with the human immunodeficiency virus, type 1-encoded 
transactivator protein Tat (Kamine et al. 1996). The human TIP60 (hTIP60) gene is 
located at 11q13.1 and has 14 exons. There are three variants: TIP60 isoform 1, TIP60 
isoform 2 (TIP60α) and TIP60 isoform 3 (TIP60β, PLA2 interacting protein, PLIP) 
each resulting from alternative RNA splicing (Sapountzi et al. 2006). Isoform 1 is a 
novel protein with translation of intron 1 (Legube and Trouche 2003). Isoform 3 
(TIP60β) is generated from the gene translated without the proline-rich exon 5 (Ran 
and Pereira-Smith 2000) and may be similar to TIP60α (Sheridan et al. 2001). TIP60 
isoforms are expressed at relatively low levels in a broad variety of tissues and cells 
and exhibit cell type specific functions (Hlubek et al., 2001). TIP60α is the best 
characterized and thus has been referred to as “TIP60” in most of the published data 
and in the context below. TIP60 has homologs in different organisms and is 
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evolutionally conserved (McAllister et al. 2002; Zhu et al. 2007). 
hTIP60 (TIP60α) encodes a 513 amino acid protein (58 kDa). It contains an N 
terminal chromodomain and a C-terminal MYST domain as shown in Figure 1. 
Chromodomains are present in many chromatin regulatory proteins (e.g. PcG, HP1) 
which are required for interactions between the protein and methylated histone 
lysines or RNA molecules (Akhtar et al. 2000). The function of the chromodomain in 
TIP60 still remains unclear, however, it may carry out the protein-protein interaction 
function as TIP60 consistently found to interact with different protein complexes. 
Additionally the chromodomain may offer TIP60 a unique characteristic, allowing it 
to act as repressor for transcription, similar to HP1. Within the MYST domain, there 
is a conserved catalytic HAT domain (residues 335–404), which has the HAT activity. 
A Cys-Cys-His-Cys zinc finger is also present in the MYST domain, which is shown 
to be essential for its HAT activity and is required for protein–protein interactions 
(Hlubek et al. 2001) (Nordentoft and Jorgensen 2003); (Xiao et al. 2003). 
As shown in Table 2, TIP60 has been found in a highly conserved 
multi-protein complex which will be further discussed below. Although recombinant 
TIP60 protein is found to directly acetylate free histone substrates H2A (Lys5), H3 
(Lys14) and H4 (Lys5, Lys8, Lys12 and Lys16) in vitro via its C-terminal MYST 
domain (Yamamoto and Horikoshi 1997; Kimura and Horikoshi 1998), the TIP60 
complex can acetylate nucleosomal histones H2A and H4 even when linker histones 
are present (Ikura et al. 2000). Additionally, Drosophila Dmel\TIP60 can acetylate the 
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histone variant phospho-H2Av at Lys5 (Kusch et al. 2004). Cellular TIP60 can also 
acetylate additional transcription factors, such as the androgen receptor (AR) 
(Gaughan et al. 2002), upstream binding transcription factor (UBF) (Halkidou et al. 
2004), myelocytomatosis oncogene c (c-Myc) (Patel et al. 2004), and the kinase 
Ataxia Telangiectasia mutated (ATM) (Sun et al. 2005). 
 
HAT catalysis 
 
Structure information of the chatalytic HAT domain has been obtained from 
yHat1, Gcn5/PCAF, and yeast TIP60 orthologue in Saccharomyces cerevisiae, 
essential Sas family acetyltransferase 1 (yEsa1) (Marmorstein 2001). The central core 
domain, which includes A-D motif and the loop-β-strand region, mediates acetyl-CoA 
binding and catalysis. Inside this central core, Glu122 in Tetraymena Gcn5 (tGcn5) 
(Glu173 in yGcn5) plays the role as a general base for catalysis. Leu126 functions to 
polarize the carbonyl group of thioestyer prior to nucleophilic attack of the amino 
group and stabilize the negative charge that develops on the oxygen atom in the 
tetrahedral transition state. Additionally, there is a water molecule that may shuttle a 
proton from the reactive Lys of the histone to Glu122 of the enzyme. In the crystal 
structure, Glu338 in yEsa1 and Glu255 in yHat1 are thought to have the same 
function. However, little is known how the acetylated lysine product is released from 
the catalytic core. Several studies indicate how HATs bind to the histone substrate. By 
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studying tGcn5, it was found that loop-α2 at the N-terminus and loop-α4 at the 
C-terminus mediate histone substrate binding. For tGcn5, a small G-K-X-P 
recognition sequence on the histone H3 N-terminal tail is thought to promote 
HAT–histone interaction. Finally, it is thought that binding of acetyl-CoA by HATs 
facilitates a HAT-histone interaction. Unfortunately, neither yHat1/acetyl-CoA nor 
yEsa1/CoA crystal structure has been co-crystallized with an associated histone. So it 
is unclear if they apply the same histone binding strategy (Marmorstein 2001). Unlike 
the GNAT family, MYST proteins (e.g. TIP60) may transfer the acetyl group to the 
substrate Lys via a “ping-pong” mechanism. A Cys residue of the MYST enzyme 
(Cys369 in H. sapiens) forms an intermediate with acetyl-CoA. The deprotonated 
substrate Lys residue will carry out direct nucleophilic attack of acetyl-CoA to form 
the acetylated Lys (Yan et al. 2002). As shown in Figure 2, the recent study of yeast 
piccolo NuA4 (picNuA4) supports the direct-attack (sequential) mechanism in which 
Glu338 facilitates the nucleophilic attack on acetyl-CoA by deprotonating histone 
N-ε-lysine residues while the conserved Cys304 is not required for the catalysis as 
previously proposed (Berndsen et al. 2007). 
 
TIP60 complex 
 
TIP60 forms distinct complexes with different protein partners allowing it to 
carry out specific functions in a variety of regulatory events (Sapountzi et al. 2006). 
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As shown in Table 2, TIP60 co-purifies with a number of additional proteins that 
form a stable nuclear TIP60 HAT complex. Central to this complex is the 
transformation/transcription domain-associated protein (TRRAP), thought to act as a 
scaffold protein (Ikura et al. 2000). p400/Domino is an ATPase that is involved in 
ATPase-dependent chromatin remodeling (Ikura et al. 2000). BAF53 (BRG-1/human 
BRM-associated factor, 53 KDa) may have histone chaperone activity via an 
actin-related domain. Yeast BAF53 is responsible for recruiting chromatin modifying 
complexes to damaged DNA. RuvBL1 and RuvBL2 are putative helicases, which is 
related to the bacterial DNA repair RuvB protein. Inhibitor of growth 3 (ING3) has a 
plant homeodomain (PHD), which is also present in other chromatin modifying 
complexes (Cai et al. 2003; Doyon and Cote 2004). Mortality factor 4 related gene 15 
(Mrg15) and mortality factor 4 related gene X (MrgX), as well as glioma amplified 
sequence 41 (Gas41) are involved in a variety of cellular processes, such as cell 
proliferation, viability and senescence. The complex also contains additional protein 
factors: Mrg binding protein (MrgBP) and bromo-protein bromodomain containing 
protein 8/thyroid receptor coactivator protein 120 kDa (Brd8/TRCp120), DNA 
methyltransferase associated protein 1 (DMAP1), enhancer of polycomb 1 (EPC1) 
and EPC1-like, histone variants H2Av and H2B (Doyon and Cote 2004; Kusch et al. 
2004). 
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TIP60 localization 
 
TIP60 resides in both nucleus and cytoplasm where it plays distinct roles in 
different cellular processes. As a histone modifier, TIP60 has been shown to primarily 
reside inside the nucleus where it carries out a variety of functions (Yamamoto and 
Horikoshi 1997; Gavaravarapu and Kamine 2000; Ran and Pereira-Smith 2000; Cao 
and Sudhof 2001; Sheridan et al. 2001). However, the cellular localization of TIP60 is 
dynamic. In certain instances, TIP60 can also be found in the cytoplasm. For example, 
when prostate cancer (CaP) progresses to the hormone resistant state, a shift in TIP60 
cellular distribution from a predominantly cytoplasmic to nuclear localization is 
observed. This occurs together with an elevated TIP60 mRNA and protein expression 
level, which facilitates its involvement in the transcription of target genes (Halkidou 
et al. 2003). In other instances, TIP60 is observed in cytoplasm, instead of nucleus. 
This is found in the interleukin-9 (IL-9) signaling pathway, in which TIP60 interacts 
with IL-9 receptor (IL-9R) and represses the downstream transcription factor signal 
transducer and activator of transcription 3 (STAT3) in the cytoplasm by recruiting 
HDAC7 (Sliva et al. 1999; Xiao et al. 2003). Furthermore, TIP60 and HDAC7 were 
shown to translocate from the nucleus to the cytoplasm when interacting with the 
C-terminus of endothelin receptor A (ETA) in response to endothelin 1 (ET-1) (Lee et 
al. 2001). 
The mechanisms of TIP60 translocation remained unclear. The transport of 
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TIP60 into and out of the nuclear pore complex (NPC) may be mediated by the 
conserved karyopherin-β family (Pemberton and Paschal 2005). As TIP60 is found to 
be associated with many different complexes, perhaps certain protein partners in these 
complexes may also contribute to the shift of its physical distribution inside the cell. 
 
TIP60 cellular function 
 
TIP60 has been reported to play many essential roles in a wide variety of 
cellular processes based upon the different protein complexes it involves in. With the 
presence of ATPase and DNA helicase activity through the association with other 
proteins in different complexes, TIP60 has been shown to be involved in DNA repair 
and apoptosis (Ikura et al. 2000). 
TIP60 can activate gene expressions through several transcriptional activators. 
For instance, TIP60 was characterized as a nuclear hormone receptor coactivator 
(Brady et al. 1999), which enhances the transactivation of the androgen receptor (AR) 
in a ligand-dependent manner and other steroid receptors such as estrogen and 
progesterone receptors. Moreover, TIP60 was found to up-regulate class I nuclear 
hormone receptors through the interaction of its LXXLL motif with AR (Gaughan et 
al. 2001). 
TIP60 has also been characterized as a negative regulator of gene expressions. 
Studies have demonstrated that overexpression of TIP60 completely blocks activation 
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of cAMP-response element-binding protein (CREB), a transcriptional activator that 
mediates hormone and growth factor induction of gene expression, by cyclic 
AMP-dependent protein kinase A (PKA) (Gavaravarapu and Kamine 2000). In-vitro 
and in-vivo experiments show that TIP60 is associated with CREB through a 55 
amino acid C-terminal half of the praline-rich region. Inhibition of CREB activation 
by TIP60 is found to be independent on its HAT activity. TIP60 also acts as 
corepressor of the transcriptional repressor zinc finger E box-binding protein (ZEB) 
and additively inhibits the CD4 enhancer/promoter activity in Jurkat cells (Hlubek et 
al. 2001). Interestingly, TIP60 function in these examples is cell-specific and the 
TIP60 HAT domain is not required for carrying out these functions (Hlubek et al. 
2001). 
TIP60 itself was found to be regulated by Mdm2-mediated ubiquitination and 
proteasome-dependent degradation (Legube et al. 2002). Moreover, additional studies 
showed that HAT activity of TIP60 is controlled by phosphorylation of Ser-86 and 
Ser-90 amino acid residues in vivo, and that cyclin B/Cdc2 is responsible for the 
phosphorylation on Ser-90 (Lemercier et al. 2003). Consistent with these studies, 
phosphorylation has also been shown to stimulate HAT activity of the other HATs, 
such as transcription factor ATF-2 (Kawasaki et al. 2000), and CREB-binding protein 
(CBP) at the G1/S boundary (Ait-Si-Ali et al. 1998). 
It is worthy to note that the yeast TIP60 homolog Esa1 was found to be 
essential for viability (Clarke et al. 1999), in accordance with my findings in the 
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Drosophila model setting (Zhu et al. 2007). Below is a summary of TIP60 function in 
different pathways, as highlighted by its interactions with other molecules and the 
diseases that it is associated with. 
 
Nuclear hormone receptor and prostate cancer 
 
Prostate cancer (CaP) is a deadly disease, causing one in every four men 
diagnosed to eventually die. CaP is initially androgen sensitive and responsive to 
hormone ablation therapy. Despite the high rate of response to hormone treatment, the 
median duration of response is less than three years. Consequently, nearly all 
hormone dependent CaPs eventually relapse into fatal hormone independent diseases 
(hormone refractory, HR). 
TIP60 preferentially interacts with and up-regulates the class I nuclear 
hormone receptor. TIP60 has a single nuclear receptor box at its C terminus and it 
interacts with the androgen receptor (AR) in a LXXLL motif-dependent manner. 
(Gaughan et al. 2001). TIP60 can directly acetylate the AR by its factor acetylation 
(FAT) activity. AR may be regulated by both acetylation via TIP60 and deacetylation 
via HDAC1, since chromatin immunoprecipitaion (ChIP) demonstrated that AR, 
TIP60 and HDAC1 are found in a complex on the endogenous AR-responsive PSA 
promoter (Gaughan et al. 2002). As the disease progresses to hormone resistance, 
there is an upregulation of TIP60 mRNA and protein expression combined with a 
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shift in TIP60 cellular distribution from a predominantly cytoplasmic to nuclear 
localization. This upregulation and redistribution of TIP60 is believed to be involved 
in the misregulation of downstream target genes (Halkidou et al. 2003). 
 
Amyloid-β precursor protein and Alzheimer’s disease 
 
Amyloid-β precursor protein (APP) is a protein ubiquitously expressed on the 
cell surface. When APP is cleaved by β- and γ-secretase, the amyloid β-peptide (Aβ) 
is generated which is found to be accumulated in the amyloid plaques in the brains of 
Alzheimer’s disease (AD) patients (Selkoe 2001; Steiner and Haass 2001). Similar to 
the proteolytic processing of Notch, an intracellular domain of APP (AICD) is 
generated and is believe to have nuclear signaling function, which also may 
contribute to the pathogenesis of AD (Suh and Checler 2002). Yeast two-hybrid 
assays and coimmunoprecipitation experiments demonstrate that a ternary complex of 
AICD, TIP60 and adaptor protein Fe65 stimulates transcription in a cell culture model 
(Cao and Sudhof 2001). Stimulation of transcription by this complex is found to 
require the interaction of Fe65 with both AICD and TIP60 through the following 
conserved domains and sequences: the WW domain and PTB domains in Fe65 and 
the NKSY sequence in TIP60 (Cao and Sudhof 2001). AICD may bind to Janus 
kinase interacting protein-1 (JIP-1) and activate gene expression independent of 
TIP60 (Scheinfeld et al. 2003). In addition to AICD, TIP60 is also shown to form 
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complexes with other proteins processed by proteolytic cleavage, such as the 
lipoprotein receptor related protein (LRP) (Kinoshita et al. 2003) and APP-like 
proteins (APLP) (Li and Sudhof 2004). 
To date, it remains unclear about the molecular mechanisms including 
APP/TIP60 mediated transcriptional regulation of target genes and their relationships 
to the pathogenesis of AD. A variety of pathways have been studied to elucidate the 
role of TIP60 in its association with APP and transcriptional activation. One study 
demonstrated that Fe65 is only recruited and activated by a membrane-tethered AICD 
(but not a free AICD). This complex then translocates from the cytoplasm to the 
nucleus where it binds to TIP60 and other transcriptional factors to turn on gene 
expression (Cao and Sudhof 2004). Additionally, AICD has been suggested to cause 
neurotoxicity via misregulation of the downstream transcription events associated 
with histone acetylation. In support of this premise, introduction of the histone 
deacetylase (HDAC) inhibitor, sodium butyrate, in neuronal cells enhances the 
cytotoxicity induced by AICD (Kim et al. 2004). Additional studies support the 
existence of an AICD/Fe65/TIP60 complex in nucleus. This complex was found to be 
at the promoter region of the KAI1 gene, a putative target of APP-mediated 
transcription (Baek et al. 2002). Subsequently, it was shown that activation of 
transcription of the KAI1 gene requires both the AICD/Fe65/TIP60 complex and the 
nucleosome assembly protein SET (Telese et al. 2005). Confocal microscopy and 
co-immunoprecipitaion experiments suggested that the AICD ternary complex 
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localizes to the nucleus with different morphology depending on the APP adapter 
proteins (i.e., Fe65 and Jun-interacting protein Jip1γ) and could upregulate several 
APP-effectors genes, such as APP, BACE, TIP60, GSK3β, and KAI1, but not the 
Notch-effector gene Hes1 (von Rotz et al. 2004). Alternatively, other studies show 
that TIP60 associated signal transduction occurs without γ-secretase cleavage of APP 
and thus full length APP recruits TIP60 via cyclin dependent kinase 
(CDK)-dependent phosphorylation (Hass and Yankner 2005). In yet another 
conflicting study using GAL4DB-luciferase reporter system, Fe65 is found to be the 
key molecule for transcriptional transactivation, whereas TIP60 acted as repressor 
(Yang et al. 2006). APP/TIP60 mediated transcriptional regulation of the target genes 
may lead to different effects in the pathogenesis of AD. In support of this, at least in 
part, TIP60 and its HAT activity are found to be required for AICD-mediated 
apoptosis (Kinoshita et al. 2002). However, the function of TIP60 in AICD-mediated 
apoptosis seems to be redundant, since the other ternary complex of AICD, Fe65 and 
CP2/LSf/LBP1 could upregulate glycogen synthase kinase-3 beta (GSK3β) and also 
lead to apoptosis in neurons (Kim et al. 2003). 
In summary, TIP60 forms the ternary complex with AICD and FE65 and may 
play an important role in the pathogenesis of AD. However, the targets genes of this 
complex and their contributions to the pathogenesis of AD need to be further 
investigated in the future. 
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DNA damage 
 
ATM 
 
DNA double stand breaks (DSBs) initiate activation of cell cycle checkpoints 
that arrest the cell cycle to allow additional time for DNA repair (Abraham 2001). 
The key component in the signaling pathway that responds to DSBs is a 370 KDa 
protein kinase termed ataxia telangiectasia mutant (ATM) (Bakkenist and Kastan 
2003; Bakkenist and Kastan 2004). ATM resides in the cell as an inactive dimmer. 
Upon autophosphorylation at amino acid residue serine-1981, ATM disassociates to 
become an active monomer ATM-S1981(P) (Bakkenist and Kastan 2003). 
ATM-S1981(P) then phosphorylates other proteins, such as nbs1, p53, chk2, SMC1, 
and histone variant H2AX, to activate cell cycle arrest and DNA repair (Kim et al. 
2002; Bakkenist and Kastan 2004). 
TIP60 has been shown to be essential for initiating such cellular responses to 
DSBs, as well as shutting them down by the removal of phosphor-H2Av after DNA 
damage. Activation of ATM requires both autophosphorylation and acetylation. Sun et 
al found that TIP60 can directly acetylate ATM before its activation in response to 
DSBs and forms ATM-TIP60 complex through the C-terminal FATC domain of ATM 
(Sun et al. 2005). The same research group further demonstrated that lysine 3016 
(K3016) in the FATC domain of ATM is the acetylation site (Sun et al. 2007). 
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Additionally, recent studies show that HAT activity of TIP60 is required for 
ATM/ATR/CHK2 pathway induced by the tumor suppressor p14ARF in G2 cell cycle 
arrest (Eymin et al. 2006). To end the damage signal, the ATPase subunit 
p400/Domino of the Drosophila Tip60 (Dmel\TIP60) complex catalyzes exchange of 
the acetylated and phosphorylated histone variant H2Av (Drosophila homolog of 
H2AX) for an unmodified form (Kusch et al. 2004). 
Although it remains unclear how TIP60 recognizes and targets the DSBs, the 
modified histone variants in the DSBs may serve as marks for TIP60 recruitment. 
One of these marks is phosphorylated histone H2AX. In support of this, the NuA4 
complex (yeast homologous TIP60 complex) is recruited to DNA lesions where H2A 
is phosphorylated by ATM homologue telomere maintenance 1/mitosis entry 
checkpoint 1 (Tel1/Mec1). The NuA4 complex further recruits other chromatin 
remodeling complexes INO80 and SWR1 to facilitate the DNA repair (Downs et al. 
2004). It is postulated that methylated histones in DSBs may be recognized by TIP60 
through its chromodomain (Sun et al. 2005), since 53BP1 (protein 53 binding protein 
1) was shown to be recruited to the methylated histones at the DNA damage site 
(Huyen et al. 2004). Furthermore, the association of TIP60 with DNA damage may be 
mediated by histone H4 acetylation. For example, the TIP60-TRRAP complex in 
mammalian cells is required for the DNA damage-induced H4 hyperacetylation (Murr 
et al. 2006). Similarly, the yeast NuA4 complex is recruited to the vicinity of DNA 
damage and induces the transient histone H4 hyperacetylation (Tamburini and Tyler 
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2005). 
 
p53 
 
p53 is the key molecule in controlling DNA damage so that to maintain the 
genome integrity (Fuster et al. 2007). Without the appropriate DNA damage signaling, 
murine double minute 2 (MDM2) inactivates p53 by binding directly to its 
transactivation domain (Momand et al. 1998), as well as ubiquitylation of p53 for 
proteasome-dependent degradation (Honda et al. 1997). MDM2 itself is a 
transcriptional target of p53, thus generating a negative feedback to downregulate the 
increased p53 activity due to the DNA damage signals (Barak et al. 1993; Wu et al. 
1993). This feedback regulation is so important that aberrant accumulation of MDM2 
is always associated with many human tumors (Momand et al. 1998). Additionally, 
this feedback loop is regulated by other protein factors. For example, p53 activation 
by the oncogenic signals is dependent on the induction of p19ARF (acute renal failure, 
ARF). p19ARF is the production of an alternative transcript of the tumor suppressor 
gene INK4A (inhibitor of cyclin-dependent kinase 4A) which also encodes p16INK4. 
p19ARF blocks the ubiquitin ligase activity of MDM2, thus preventing 
MDM2-mediated p53 proteolytic degradation (Kamijo et al. 1997; Pomerantz et al. 
1998; Zhang et al. 1998). 
Numerous evidences have been found that TIP60 is involved in p53-mediated 
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apoptosis and cell cycle arrest by its association with different proteins inside the 
pathway. The tumor repressor Yng2 in the yeast NuA4/TIP60 complex is required for 
p53 function as transcriptional activator (Nourani et al. 2001). By a large RNA 
interference (RNAi) screening, TIP60 has been identified to be required for 
p19ARF/p53-mediated proliferation arrest and plays a critical role in genotoxic 
signaling networks (Berns et al. 2004). Furthermore, studies on Tip60+/- mice 
showed that TIP60 is a haplo-insufficient tumor suppressor, whose expression level is 
critical for the DNA-damage induced p19ARF/p53 pathway (Gorrini et al. 2007).  
The mechanisms of TIP60 function in p53 pathway have not been clear until 
the recent study showed that the lysine 120 (K120) on DNA binding domain of p53 
can be acetylated by TIP60 and this posttranscriptional modification is crucial for 
p53-dependent apoptosis but not cell growth arrest (Sykes et al. 2006; Tang et al. 
2006). As Tip60 dependant acetylation does not appear to influence p53 DNA binding 
affinity in vitro, it is proposed that the K120 acetylation mark serves to recruit an 
unidentified p53 co-factor required for apoptotic induction (Sykes et al. 2006; Tang et 
al. 2006). It should be noted that further investigation of the binding affinity of 
acetylated vs. non-acetylated p53 is necessary, as Tip60 has been shown in some 
instances in vivo, to enhance p53 binding to some pro-apoptotic target promoters 
while non-acetylated p53 binds with greater affinity to the cell cycle control p21 gene 
promoter. Taken together, these finding support a model by which TIP60 plays a 
central role in p53 mediated cell fate control by first sensing the level of DNA 
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damage resulting from cellular stress. When DNA damage levels are too high to be 
repaired, Tip60 acts to acetylate p53 on residue K120. Acetylation of p53 decreases 
its binding affinity for cell cycle arrest genes and promotes activation of pro-apoptotic 
genes, thus tipping the balance of p53 target gene activation in favor of apoptosis. 
In summary, TIP60 plays an important role in p53-mediated apoptosis and cell 
cycle arrest, and is suggested as a tumor suppressor (Squatrito et al. 2006). However, 
some questions on the detailed mechanisms still remain to be answered by further 
study. For example, MDM2 is responsible for ubiquitination and degradation of both 
TIP60 and p53 in vitro (Legube et al. 2002). However, acetylation of p53 is found to 
prevent its degradation by MDM2-dependent ubiquitination (Ito et al. 
2002).Furthermore, TIP60 HAT activity can antagonize the repressive effect of 
MDM2 on AR and HDAC1 (Gaughan et al. 2005). It seems that MDM2 and TIP60 
antagonize each other, though this may be the different phenomena observed in 
different model systems (i.e. cell types). 
 
Cell progression and cancer 
 
RB 
 
Retinoblastoma (RB), a nuclear phosphoprotein, can repress genes required 
for DNA synthesis and arrest cells during the G1 phase of the cycle. RB is inactivated 
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when it is phosphorylated by cyclin dependent kinases (CDKs) and their cyclin 
partners. Phosphorylation of RB allows cell progression through G1 to S phase (Sherr 
and Roberts 1999). RB regulates cell death by inhibiting apoptosis (Tan and Wang 
1998; Chau and Wang 2003). RB is also involved in the differentiation of many 
tissues and cell types, including skeletal myogenesis, neuronal and epithelial 
differentiation (Lipinski and Jacks 1999). Besides regulation by phosphorylation, RB 
function can also be controlled by acetylation. It was demonstrated that RB 
acetylation by p300/CBP and P/CAF is required for the establishment of permanent 
cell cycle withdrawal and expression of the late myogenic gene (Nguyen et al. 2004). 
TIP60 interacts with RB in a different way compared to its interaction with 
p53. Acetylation of RB by TIP60 results in the degradation of RB. In support of this, 
the tumor suppressor p14ARF (mouse homolog of p19ARF) can prevent RB degradation 
by inhibiting TIP60-dependent acetylation of RB C-terminus (Leduc et al. 2006). It is 
not surprising because several proteins are subject to degradation by acetylation 
(Caron et al. 2005). Additionally, the acetylation of RB is reported to increase MDM2 
binding (Nguyen et al. 2004) and MDM2 can promote ubiquitin-dependent RB 
degradation (Uchida et al. 2005). In summary, TIP60 can acetylate RB, and further 
initiate the MDM2-dependent ubiquitination of RB, which leads to the degradation of 
RB. 
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MYC 
 
The oncoprotein myelomonocytic leukemia (MYC) is a key regulator of 
numerous genes that affect growth, proliferation, differentiation and apoptosis. In 
mammals, there are five MYC genes identified so far, including MYC (formerly 
c-MYC), MYCN, MYCL, MYCS, and a poorly-known MYCB encoding only the N 
terminus protein (Adhikary and Eilers 2005) (Vervoorts et al. 2006). Genetic 
alteration of three of these MYC genes (i.e., MYC, MYCN, and MYCL) by either 
translocations or amplifications always leads to many different types of tumors 
(Nesbit et al. 1999; Boxer and Dang 2001). MYC promoter is targeted by multiple 
signal transduction cascades. These cascades, such as WNT, RAS/RAF/MAPK, 
JAK/STAT, transforming growth factor β, and NF-κB pathways, are misregulated in 
cancers and cause an elevated MYC expression (Clevers 2004; Liu and Levens 2006). 
MYC protein is within the MYC/MAX/MAD complex of basic 
region/helix-loop-helix/leucine zipper (bHLHZ) domain transcriptional regulators 
(Vervoorts et al. 2006). By recruiting and interacting with additional cofactors, MYC 
can either activate or repress gene expression (Adhikary and Eilers 2005; Oskarsson 
and Trumpp 2005; Cole and Nikiforov 2006). The amount of MYC proteins is 
precisely regulated in part by several posttranslational modifications, such as 
phosphorylation, acetylation, and ubiquitinylation (Vervoorts et al. 2006). 
To enhance MYC transactivation efficiency, TIP60 is recruited to 
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MYC-dependent promoters, as well as directly acetylates MYC. In support of this, 
TIP60, as well as p300/CBP, and mammalian mGCN5, is recruited by MYC when 
MYC is targeted to certain promoters (McMahon et al. 2000; Frank et al. 2001; Frank 
et al. 2003; Adhikary and Eilers 2005). It had been proposed that these HATs regulate 
MYC targeted gene activation by their ability to acetylate nucleosomal histones 
within the promoter regions of these genes. Additionally, TIP60 can also acetylate 
certain lysine residues on MYC (Patel et al. 2004). It is worthy to note that MYC can 
also be acetylated by p300/CBP (Vervoorts et al. 2003; Faiola et al. 2005; Zhang et al. 
2005), and hGCN5/PCAF (Patel et al. 2004). MYC associated protein MAX can also 
be acetylated by p300/CBP (Faiola et al. 2007). It is postulated that acetylation of 
MYC may enhance its stability by antagonizing the degredation of MYC by 
ubiquitination (Vervoorts et al. 2003; Patel et al. 2004; Faiola et al. 2005; Zhang et al. 
2005). MYC protein is believed to be stored in two cell compartments: an unstable S1 
pool and a stable S2 pool. Acetylation of MYC may switch MYC from the unstable 
S1 pool to the more stable S2 pool (Patel et al. 2004). Interestingly, TIP60 was found 
to acetylate MYC in vivo (Patel et al. 2004) but not in vitro (Faiola et al. 2005). This 
finding is most likely due to the fact that acetylation of MYC by TIP60 requires 
additional TIP60 associated proteins (Faiola et al. 2005), emphasizing the importance 
of TIP60 associating proteins in regulating TIP60 HAT function. One possible 
mediator that links MYC and TIP60 is TIP60 associated 
transactivation-transformation domain-associated protein (TRRAP; also called 
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PAF400). TRRAP binds MYC (McMahon et al. 1998; McMahon et al. 2000) and is 
recruited to MYC-binding sites within chromatin (Bouchard et al. 2001; Frank et al. 
2001). 
In summary, TIP60 enhances MYC-mediated transactivation by acetylating 
MYC itself and/or acetylating the histones on the promoter regions of the MYC target 
genes. However, the detailed mechanisms are still needed to be investigated in the 
future. 
 
NF-κB 
 
Nuclear factor kappa light chain gene enhancer in B cells (NF-κB) consists of 
five members of the Rel family, including Rel-A/p65, Rel-B, c-Rel, p50/p105 
(NF-κB1) and p52/p100 (NF-κB2). Different NF-κB complexes are composed of 
their homo- and heterodimers. NF-κB can both enhance and repress the expression of 
genes that are involved in many distinct pathways, such as immunity, inflammation, 
proliferation and apoptosis (Perkins 2007). In general, NF-κB complexes are 
restrained in the cytoplasm by inhibitors of NF-κB (IκBs). After induction by outside 
signals, IκBs are phosphorylated by the IκB kinase (IKK) complex. The 
phosphorylation of IκBs leads to their degradation, which releases NF-κB and allows 
it to translocate to nucleus. 
TIP60 is involved in NF-κB signaling pathway and functions as a coactivator 
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of the NF-κB regulated genes, though the mechanisms are studied in only one gene: 
the metastasis suppressor gene KAI1. Before stimulation, KAI1 promoter is repressed 
by N-CoR (nuclear receptor corepressor)/TAB2 (TAK1 binding protein 2)/HDAC3 
complex. In response to IL-1β signaling, phosphorylation of TAB2 results in the 
exportation of N-CoR/TAB2/HDAC3 complex so that p50-dependent KAI1 
expression is derepressed. In this process, the AICD/Fe65/TIP60 complex binds to the 
IκB family protein B-cell leukemia/lymphoma 3 (Bcl3) and displaces 
N-CoR/TAB2/HDAC3 complex, thus enhancing Bcl3/p50-activated transcription of 
KAI1 gene (Dechend et al. 1999; Baek et al. 2002). Additionally, overexpression of 
TIP60, Fe65 and AICD can directly displace N-CoR and activate transcription of 
KAI1 without extracellular stimuli (Kim et al. 2005). 
 
E2F 
 
In eukaryotic cells, E2F family transcription factors regulate cell cycle 
progression (G1/S transition) (Stevaux and Dyson 2002; Trimarchi and Lees 2002; 
Blais and Dynlacht 2007). E2F is inactive when bound by the RB family of “pocket 
proteins” (RB, p107, and p130). This inactive complex binds to DNA and represses 
transcription of E2F target genes during G1. When RB is hyperphosphorylation by 
CDKs and thus inactivated, E2F is then released from the former complex and 
activate genes required for DNA synthesis and entry into S. E2F1/3, which generally 
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act as transactivators, were discovered to bind to activated E2F target gene promoters 
with the presence of acetylation on histone H3 and H4 (Takahashi et al. 2000). In 
addition, E2F itself is likely to be acetylated by PCAF/GCN5 and p300/CBP 
(Ait-Si-Ali et al. 2000) (Martinez-Balbas et al. 2000; Marzio et al. 2000; Lang et al. 
2001; Pediconi et al. 2003). 
TIP60 is involved in the E2F-associated cell cycle control, though the detailed 
mechanisms are unclear. The first evidence is that E2F interacts with TRAPP in the 
TIP60 complex (McMahon et al. 1998; Lang et al. 2001). E2F, binding to the 
transcriptional factors Sp1 (specific protein 1) and Sp3, can recruit TIP60 to the 
promoter region of MYCN gene (Kramps et al. 2004). Furthermore, E2F is found to 
recruit TIP60 complex to the target gene regions in late G1 stage despite that the 
essential role of TIP60 during E2F-dependent transactivation was not successfully 
addressed by RNAi or DN mutant (Taubert et al. 2004). This is most likely due to the 
redundant HAT activity associated with PCAF/GCN5 and p300/CBP as stated above. 
It is worthy to note that Dmel\E2F is necessary for viability. Its mutation caused 
lethality at the late larval/pupal stage in Drosohila (Royzman et al. 1997). Similarly, 
our data showed that knockout Dmel\TIP60 by RNAi leads to lethality also in the 
same stages (Zhu et al. 2007). Perhaps this coincidence suggests that TIP60 and E2F 
are related at least in some degree during Drosophila development. 
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TRRAP 
 
TRRAP has been found in many HAT complexes that have important cellular 
regulatory functions. These HAT complexes can be categorized into two families: 
Spt/Ada/Gcn5 acetyltransferase (SAGA)-like HAT complexes and nucleosome 
acetyltransferase of H4 (NuA4)-like HAT complexes that is associated with TIP60. 
The TRRAP associated SAGA-like complexes include S.c. SAGA complex (Grant et 
al. 1997; Grant et al. 1998a; Grant et al. 1998b), mammalian SPT3-TAF(II)31-Gcn5L 
acetyltransferase (STAGA) complex (Martinez et al. 1998; Martinez et al. 2001), 
PCAF complex (Ogryzko et al. 1998), and TATA-binding protein-free TAF(II) 
complex (TFTC) complex (Wieczorek et al. 1998; Brand et al. 2001; Cavusoglu et al. 
2003). The TRRAP associated NuA4-like complexes include S.c. NuA4 complex 
(Allard et al. 1999; Galarneau et al. 2000; Brown et al. 2001; Nourani et al. 2001; 
Boudreault et al. 2003) and mammalian TIP60 complex (Ikura et al. 2000; McMahon 
et al. 2000). Studies have shown that TRRAP is essential for cell viability in both 
yeast and mouse (Saleh et al. 1998; Herceg et al. 2001). TRRAP regulates gene 
expression by acetylation of histone H3 or H4 (Herceg et al. 2003), which is 
correlated with its association with the different HAT complexes: the GCN5 
associated SAGA complexes preferentially acetylate histone H3 while the TIP60 
associated NuA4 complexes acetylates histone H4 (Carrozza et al. 2003; Robert et al. 
2006). 
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TIP60 is associated with TRAPP and involved in double-strand break (DSB) 
repair and cell progression control. In support of this, TIP60 and TRRAP are together 
recruited to the chromatin sites that have DSBs in vivo. The HAT activity of TIP60 
opens the chromatin structure to allow repair complex recruitment (Murr et al. 2006). 
However, this role of TIP60 in DSB repair may be redundant due to the association of 
TRRAP with MRE11, RAD50, NBS1 complex (MRN complex) in absence of HAT 
activity (Robert et al. 2006). In addition, the TIP60 complex has been found to 
colocalize with TRRAP at the Mad1 and Mad2 promoters which corresponds to 
histone H4 acetylation, which suggests that TIP60 may play an important role in 
mitotic checkpoint (Li et al. 2004). This idea is supported by the recent finding that 
the cyclin E-Cdk2 substrate NPAT (nuclear protein, ataxia-telangiectasia locus) 
recruits TRAPP-TIP60 complex to the promoter regions of histone genes for their 
transcriptional activation at the G1/S phase transition (Deran et al. 2007). As shown 
in my unpublished data in Chapter 3, TIP60 is required for the appropriate wing 
development in Drosophila. This function of TIP60 may be associated with TRAPP. 
In support of this, Nipped-A (Drosophila TRRAP) is found to be involved in the wing 
development by screening the genes that regulate cut and Notch pathways, (Rollins et 
al. 1999). Furthermore, Nipped-A and Domino (another subunit of TIP60) was found 
to be required for wing development by regulating mastermind and Notch signaling 
pathway (Gause et al. 2006). 
In summary, TIP60 complex with TRAPP is involved in DNA repair and cell 
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cycle progression. Further investigation of the mechanisms should be carried out to 
identify the interaction between these two molecules during the wing development in 
Drosophila. 
 
VHL 
 
The 30 KDa VHL (von Hippel-Lindau), which is encoded by the renal cancer 
gene VHL, binds and stabilizes the protein Jade-1. Jade-1 is expressed in kidney and 
renal proximal tubule cells and related to renal tubular epithelial cell growth, 
differentiation, apoptosis (Zhou et al. 2002; Zhou et al. 2004). In addition, Jade-1 is 
involved in anteroposterior axis development during mouse embryogenesis 
(Tzouanacou et al. 2003). The recent studies support a role for TIP60 in the 
recruitment by Jade-1 to Jade1 target genes. TIP60 associates with Jade-1 via Jade-1’s 
plant homeodomain (PHD) and acetylates histone H4 lysine residues on the Jade 1 
associated target promoters to active gene expression (Panchenko et al. 2004). 
Although further studies are needed to investigate the detailed mechanisms, this 
research suggests that TIP60 may be involved in gene regulation in renal caner and/or 
embryogenesis by its association with Jade 1. 
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Conclusion 
 
As stated above, TIP60 has been reported to play many essential roles in a 
wide variety of cellular processes and is a potential specific regulator during 
multicellular development. To investigate its mechanisms, I have carried out the 
functional characterization of a Drosophila Dmel\TIP60 that is the homolog of the 
human TIP60. I present evidence that Dmel\TIP60 is differentially expressed 
throughout Drosophila development, with expression levels significantly peaking 
during embryogenesis. Using RNAi, I show that reducing endogenous Dmel\TIP60 
expression in a Drosophila embryonic cell line results in cellular defects and lethality. 
Finally, I confirm this detrimental in vitro effect in vivo by using an inducible GAL4 
targeted RNAi system in Drosophila, and demonstrating that early ubiquitous 
reduction of Dmel\TIP60 expression results in total lethality of the developing flies. 
Furthermore, the data from cell/tissue specific knockdown of Dmel\TIP60 suggest 
that Dmel\TIP60 is a specific regulator which is required for the development of 
certain tissue/cell type, such as wing, central nervous system (CNS), and muscle. The 
roles Dmel\TIP60 plays in the development of different tissues are diverse. 
Dmel\TIP60 is required for the wing development through its essential roles in cell 
growth and differentiation. In CNS, Dmel\TIP60 is required for the maintenance of 
differentiated neurons, but not for cell differentiation, progression, or apoptosis. 
Dmel\TIP60 is essential for the appropriate formation of muscle fibers during 
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embryogenesis. Taken together, TIP60 plays diverse roles in different pathways and is 
essential for the multicellular development in Drosophila. 
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Chapter2: The cloning and characterization of the histone acetyltransferase 
human homolog Dmel\TIP60 in Drosophila melanogaster: Dmel\TIP60 is 
essential for multicellular development 
 
Abstract 
 
Chromatin packaging directly influences gene programming as it permits only 
certain portions of the genome to be activated in any given developmental stage, cell, 
and tissue-type. Histone acetyltransferases (HATs) are a key class of chromatin 
regulatory proteins that mediate such developmental chromatin control, however their 
specific roles during multicellular development remain unclear. Here, we report the 
first isolation and developmental characterization of a Drosophila HAT gene 
(Dmel\TIP60) that is the homolog of the human HAT gene TIP60. We show that 
Dmel\TIP60 is differentially expressed during Drosophila development, with 
transcript levels significantly peaking during embryogenesis. We further demonstrate 
that reducing endogenous Dmel\TIP60 expression in Drosophila embryonic cells by 
RNAi results in cellular defects and lethality. Finally, using a GAL4 targeted RNAi 
system in Drosophila, we show that ubiquitous or mesoderm/muscle specific 
reduction of Dmel\TIP60 expression results in lethality during fly development. Our 
results suggest a mechanism for HAT regulation involving developmental control of 
HAT expression profiles, and show that Dmel\TIP60 is essential for multicellular 
development. Significantly, our inducible and targeted HAT knockdown system in 
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Drosophila now provides a powerful tool to effectively study the roles of these 
chromatin mediators in specific tissues and cell types during development. 
 
Introduction 
 
Metazoans consist of numerous cell types, each carrying out distinct and 
essential roles that contribute to the growth and survival of an organism (Wolffe and 
Dimitrov 1993; Vermaak and Wolffe 1998; Orphanides and Reinberg 2002). 
Differentiation of such specialized cell-lineages is achieved through the establishment 
and maintenance of tightly controlled gene expression profiles distinct for each cell 
type (Wolffe and Dimitrov 1993; Orphanides and Reinberg 2002). Such regulation in 
eukaryotic cells is determined in large part by the differential packaging of genes into 
chromatin (Wolffe and Dimitrov 1993; Vermaak and Wolffe 1998). The majority of 
DNA in the eukaryotic nucleus is packaged into nucleosomes, consisting of 146 base 
pairs of DNA wrapped around a histone octomer core, containing two subunits each 
of histones H2A, H2B, H3 and H4. Nucleosomes are in turn, further packaged into a 
highly organized and compact chromatin structure through their association with 
nucleosomal-linking histone H1 and additional non-histone proteins (Brand and 
Perrimon 1993; Wolffe and Dimitrov 1993; Fischle et al. 2003). Chromatin 
compaction generally makes the DNA of genes and their regulatory regions 
inaccessible to the transcriptional machinery and co-factor protein binding required 
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for gene activation (Li et al. 2005). As the genome is largely maintained in this 
repressive chromatin state, chromatin packaging must be disrupted to accommodate 
protein factor binding and allow for gene activation (Wolffe and Dimitrov 1993; Roth 
et al. 2001; Orphanides and Reinberg 2002). 
Histone modifying enzymes termed histone acetyltransferases (HATs) are 
directly involved in promoting chromatin decondensation, generally resulting in 
positive effects on gene activation (Sterner and Berger 2000; Bottomley 2004). HATs 
enymatically act to catalyze the transfer of an acetyl group from acetyl-CoA to the 
ε-amino group of specific and conserved positively charged lysine residues within the 
N-terminal tails of nucleosomal histones. This modification weakens histone–DNA 
and neighboring nucleosomal contacts to promote chromatin disruption that in turn, 
facilitates factor binding and transcriptional activation (Sterner and Berger 2000; Roth 
et al. 2001). A second way that HATs regulate gene activity is through their distinct 
substrate preference for specific histone, lysine and gene targets, allowing HATs to 
generate different acetylation patterns within the genome (Strahl and Allis 2000; 
Berger 2001; Berger 2002; Fischle et al. 2003; Hake et al. 2004). Such distinct 
HAT-generated histone and lysine acetylation patterns, as well as additional histone 
modifications, have been postulated by the “histone code hypothesis” to serve as 
epigenetic marks that control gene expression by providing recognition sites for 
downstream regulatory factors (Nowak and Corces 2000; Rice and Allis 2001; 
Fischle et al. 2003; Bottomley 2004). Specific HATs are also capable of generating 
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specific local or global acetylation patterns (Hebbes et al. 1994; Elefant et al. 2000a; 
Elefant et al. 2000b; Fernandez et al. 2001; Smith et al. 2001; Ho et al. 2002; Cooke 
2004) that influence gene expression profiles. The ability of certain HATs to acetylate 
non-histone regulatory proteins adds an additional layer of complexity to their many 
functions (Sterner and Berger 2000). Finally, histone acetylation is a reversible 
process that is achieved by histone deacetylase enzymes (HDACs), generally 
resulting in gene silencing (Alland et al. 1997). Thus, histone acetylation directly 
influences gene programming during development as it permits only certain portions 
of the genome to be activated in any given developmental stage, cell, or tissue-type 
(Wolffe and Dimitrov 1993; Patterton and Wolffe 1996). Understanding how these 
differentially folded chromatin domains are created and maintained in specific cell 
types is of central importance to the study of biological regulation during 
development.  
Previous reports have shown that Drosophila contains a number of human 
HAT homologs that belong to each of the three major HAT superfamilies: GNAT 
(Smith et al. 1998), MYST (Grienenberger et al. 2002) and p300/CREB-binding 
protein (CBP) (Akimaru et al. 1997; Ludlam et al. 2002). Their genetic analysis in 
Drosophila has provided essential information on the role of acetylation in a wide 
variety of developmental cellular processes. To gain further understanding into the 
developmental roles of HATs and acetylation during development, we wished to 
identify and characterize human HAT homologs in Drosophila (Dmel\HATs), with the 
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reasoning that we could use such Dmel\HATs as “tools” to decipher human relevant 
HAT function in the multicellular Drosophila model setting (Chien et al. 2002). We 
chose to focus our studies on TIP60, as this HAT is representative of the MYST HAT 
superfamily, and carries out previously described diverse roles essential for cellular 
function. TIP60 (tat-interactive protein, 60kD) was identified as part of a multimeric 
protein complex (Allard et al. 1999; Ikura et al. 2000; Doyon and Cote 2004) that 
regulates its activity in many essential cellular processes including apoptosis (Ludlam 
et al. 2002; Legube et al. 2004) DNA repair (Ikura et al. 2000; Bird et al. 2002; 
Morrison and Shen 2005) cell cycle progression (Clarke et al. 1999), developmental 
cell signaling (Ceol and Horvitz 2004), ribosomal gene transcription (Reid et al. 2000; 
Halkidou et al. 2004) and histone variant exchange during DNA repair (Kusch et al. 
2004). However, despite the importance of TIP60 in many essential cell processes, it 
has yet to be studied extensively in a multicellular in vivo model setting, and thus its 
developmental, tissue, and cell type specific roles remain to be explored. 
Here, we report the first isolation and developmental characterization of a 
Drosophila HAT gene (Dmel\TIP60) that is the homolog of the human HAT gene 
TIP60. We present evidence that Dmel\TIP60 is differentially expressed throughout 
Drosophila development, with expression levels significantly peaking during 
embryogenesis. Using RNAi, we show that reducing endogenous Dmel\TIP60 
expression in a Drosophila embryonic cell line results in cellular defects and lethality. 
Finally, we confirm this detrimental in vitro effect in vivo by using an inducible 
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GAL4 targeted RNAi system in Drosophila, and demonstrating that early ubiquitous 
and mesoderm specific reduction of Dmel\TIP60 expression results in total lethality 
of the developing flies. Our results suggest a potential mechanism underlying HAT 
regulation involving developmental control of HAT expression profiles, and 
demonstrate an essential role for Dmel\TIP60 during multicellular development. 
 
Materials and methods 
 
Identification of D. melanogaster histone acetyltransferases, isolation of cDNA clones 
and DNA sequencing 
 
BLAST searches were carried out using the BLAST algorithm at both 
FLYBASE (1999) and NCBI with sequences corresponding to either hTIP60 
(NM_182710) or hELP3 (NM_018091). Two Drosophila EST clones were identified 
that displayed high homology to hTIP60 and hELP3. Embryonic EST cDNA clones 
were identified that matched each of these sequences (clone LD31064 for 
Dmel\TIP60 and RE35395 for Dmel\ELP3) and these clones were purchased from 
Invitrogen (Carlsbad, CA). The full ORFs for each Dmel\HAT were amplified by 
PCR using the following primer sets. For Dmel\TIP60, the forward primer, 5’-CGG 
CGA ATT CGC CAT CAT GAA AAT TAA CCA CAA ATA TGA G-3’ contained a 
EcoR1 site (italics), a KOZAK sequence (bold), and sequence corresponding to the 
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first eight codons of Dmel\TIP60. The reverse strand primer, 5’-GGT TGG ATC CTC 
ATC ATC ATT TGG AGC GCT TGG ACC AGT C-3’ contained a BamHI site 
(italics), two in frame stop codons (bold), and the last eight codons of Dmel\TIP60. 
For Dmel\ELP3, the forward primer 5’-GGC TGA ATT CGC CAT CAT GAA GGC 
AAA AAA GAA GTT GGG CG-3’ contained a EcoRI site (italics), a KOZAK 
sequence (bold), and sequence corresponding to the first twenty-five bp of 
Dmel\ELP3. The reverse strand primer, 5’-GGC CGG TCT AGA TCA TCA CTA 
GTT ATT TTC TTC TAT GCT CTT TGA C-3’ contained an XbaI site (italics), two in 
frame stop codons (bold), and the last 28 base pairs of Dmel\ELP3. PCR reactions 
were carried out using Expand™ High Fidelity PCR System (Roche) according to the 
manufacture’s instructions using 400 nM of each forward and reverse primers. The 
cycling parameters were 30 cycles of 95° for 2 min, 55° for 1 min, and 72° for 3 min, 
using Mastercycler (Eppendorf). The correct sized PCR amplification products were 
cloned into the TOPO pCR2.1 vector (Invitrogen) according to the manufacture’s 
instructions. The entire insert DNA sequence for each of these constructs was 
determined by the University of Pennsylvania DNA Core Sequencing Facility, 
Philadelphia, PA. 
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Real-time PCR analysis of staged Drosophila RNA 
 
Total RNA was isolated from staged Canton S. D. melanogaster (12-24h 
embryo, 1st instar larvae, 2nd instar larvae, 3rd instar larvae, pupae, and adult fly) 
using TRIzol (Invitrogen) and treated twice with DNA-freeTM (Ambion) to remove 
DNA. First strand cDNA was prepared using the SuperScriptTM II reverse 
transcriptase kit (Invitrogen) according to the manufacture’s instructions with 1μg 
total RNA and 15 ng/μL of random hexamer primers (Roche).  Primer sets for 
Dmel\ELP3 (forward primer: 5’-TCC CCA TGC CGC TTG TTA GT-3’; reverse 
primer: 5’-CCG CCA TTG GCC ACA TAG TC-3’) amplified a 190 bp fragment. 
Primer sets for Dmel\TIP60 (forward: 5’-CAC AGC GCC ACC ATT CCC TA-3’; 
reverse: 5’-CCA GAT TGT TGC CAT TCA C-3’) amplified a 202 bp fragment. All 
PCR reactions were carried out in triplicate in 20 μl total reaction volumes containing: 
0.5 U Taq (Qiagen), 1 μl cDNA (from the RT reaction described above), 250 μM 
dNTPs (Amersham Pharmacia Biotech), 500 nM for each forward and reverse primer, 
and 0.25X SYBR® Green I dye (Molecular Probes, Invitrogen). The PCR was carried 
out in 96 well microtiter plates and the cycling conditions were: 40 cycles at 95° for 
45s, 55° for 45s, and 72° for 1 min with plate readings recorded after each cycle. All 
results were converted to real cDNA quantities by comparison to a standard curve 
generated with serial dilutions of either Dmel\TIP60 or Dmel\ELP3 cDNA TOPO 
pCR2.1 clones. All data analysis was performed using OpticonTM2 system software, 
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MJ Research. 
 
RNAi and control Dmel\TIP60 constructs 
 
To create the inverted repeat Dmel\TIP60/RNAi pUAST construct, a 613 bp 
target RNAi sequence was amplified by PCR using primer sets specific for the 
Dmel\TIP60 cDNA sequence and the Dmel\TIP60 cDNA TOPO pCR2.1 clone as 
template. The forward primer 5’-GGA GAA TTC GCA CTG GAG TGA CCA CGC 
CAC AGC GCC-3’ contained an EcoRI site (italics). The reverse primer 5’-GCA 
TAA GAG CGG CCG CAT CTA CTG TAC TTC AGG CAG AAC TCG CAG 
ATG-3’ contained a NotI site (italics), and a 5 bp polylinker sequence (bold). PCR 
reactions were performed as described above for Dmel\HAT cloning. The correct size 
PCR generated fragment was cloned in the sense direction into EcoRI/NotI sites in 
the pUAST vector under the control of the UAS promoter. This construct was 
designated Dmel\TIP60/pUAST.1. The same target fragment described above was 
next PCR amplified using the Dmel\TIP60 cDNA TOPO pCR2.1 clone as template. 
The forward primer 5’-GGA TCT AGA GCA CTG GAG TGA CCA CGC CAC AGC 
GCC-3’ contained an XbaI site (italics) and the reverse primer 5’-GCA TAA GAG 
CGG CCG CCT GTA CTT CAG GCA GAA CTC GCA GAT G-3’ contained a NotI 
site (italic). The PCR generated fragment was cloned in an anti-sense orientiation into 
NotI and XbaI sites of the Dmel\TIP60/pUAST.1, thereby creating the inverted repeat 
 66
Dmel\TIP60/RNAi/pUAST construct. To create the sense-sense Dmel\TIP60/control 
construct, the same target RNAi sequence was PCR amplified with the following 
primers: the forward primer 5’-GCA TAA GAG CGG CCG CGC ACT GGA GTG 
ACC ACG CCA CAG CGC C-3’ contained a NotI site (italics) and the reverse primer 
5’-GCA TCT AGA CTG TAC TTC AGG CAG AAC TCG CAG ATG-3’ contained a 
XbaI site (italics). The PCR generated fragment was cloned in a sense orientiation 
into the NotI and XbaI sites of Dmel\TIP60/pUAST.1, creating a sense-sense 
Dmel\TIP60/control/pUAST construct. The PCR generated polylinker and the 
common NotI restriction site that joined the two target Dmel\TIP60 repeat fragments 
served as the “hinge” region of the hairpin in both Dmel\TIP60/RNAi/pUAST and 
Dmel\TIP60/control/pUAST constructs. All cloning was carried out using standard 
procedures except that SURE 2 competent bacterial cells (Stratagene) were used for 
all bacterial transformations to prevent recombination from occurring. 
Dmel\TIP60/RNAi and control constructs for transient cell transfection were 
created by digesting the Dmel\TIP60/RNAi/pUAST and Dmel\TIP60/control/pUAST 
constructs with EcoRI and XbaI restriction enzymes, gel-purifying (Qiagen) the 
released fragments, and sub-cloning each fragment into EcoRI and XbaI restriction 
sites within the pAc5.1/V5-HisA vector (Invitrogen). These constructs were 
designated Dmel\TIP60/RNAi/pAc5.1 and Dmel\TIP60/control/pAc5.1. 
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Cell culture and transfection 
 
D. Mel-2 Cells (Gibco, Invitrogen) were grown in Drosophila-SFM media 
(Invitrogen) supplemented with 90 mL/L of 200 mM L-Glutamine (Gibco, 
Invitrogen). The cells were grown in a 28°, non-humidified, ambient air-regulated 
incubator (Torrey Pines Scientific), and subcultured every three to four days to 
maintain exponential growth.  On day three post-subculture, the cells were seeded to 
50-60% confluence into 35 mm plates in 2.0 ml Drosophila-SFM with L-Glutamine. 
After an overnight incubation at 28°, the cells were incubated with the transfection 
mixture containing 2 μg plasmid DNA, 8 μL Cellfectin (Invitrogen) and 500 μl 
Drosophila-SFM without L-Glutamine for 3 hours. After removal of transfection 
mixture, and addition of 2 mL of Drosophila-SFM with L-Glutamine, each plate was 
incubated at 28° and observed after 24, 48, and 72 hours. As a transfection efficiency 
control, separate plates of cells were transfected with pAC5.1/V5-His/lacZ 
(Invitrogen), cells were stained using the β-Gal staining kit (Invitrogen) according to 
the manufacture’s instructions and blue cells were counted to determine the 
transfection efficiency. All transient transfections were performed in triplicate. 
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Semi-quantitative RT-PCR 
 
Total RNA from either a plate of transfected cells or three third instar larvae 
progeny from a homozygous Dmel\TIP60/RNAi or control x GAL4 337 cross was 
isolated using TRIzol (Invitrogen) and twice treated with DNA-freeTM (Ambion) to 
remove DNA. First strand cDNA was prepared using the SuperScriptTM II reverse 
transcriptase kit (Invitrogen) according to the manufacture’s instructions with 1μg 
total RNA and 15 ng/μL of random hexamer primers (Roche). PCR reactions were 
performed in a 40 ul total volume containing 1 U Taq (Qiagen), 1 μl cDNA template, 
250 μM dNTPs (Amersham Pharmacia Biotech) and 500 nM of each forward and 
reverse primer. The cycling conditions were 36 cycles of 95° for 45s, 55° for 45s, and 
72° for 1 min. The forward primer (5’-TGG TAT TTC TCA CCC TAT CC-3’) and the 
reverse primer (5’-CAA TGA GCA GCT TGC CGT AG-3’) amplified a 427 bp 
fragment that corresponded to position 1407 to 1833 within the cDNA Dmel\TIP60 
sequence.  
 
Creation of P-element-transformed fly lines 
 
P-element germ-line transformations with pUAST constructs were performed 
as previously described (Elefant and Palter 1999), to create fly lines containing 
Dmel\TIP60/RNAi or Dmel\TIP60/control pUAST constructs. To determine on which 
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chromosome the P-element inserted, lines heterozygous for the TM3 and TM6 
balancer were mated to w1118 flies, and segregation of the w+ marker was scored: if 
segregation of w+ was neither with the third chromosome balancer or a sex 
chromosome, it was inferred to segregate with the second chromosome. Balancer 
chromosomes were subsequently crossed away by successive mating to w1118. 
Multiple, independent fly lines were created for each construct as the level of gene 
expression is dependent upon the chromosomal location of the P-element, which 
occurs randomly. 
 
Drosophila stocks and RNAi crosses 
 
Flies used in this study were as follows: P{pUAST}/P{pUAST} flies 
containing either Dmel\TIP60/RNAi or control constructs were created as described 
above, y1 w*; P{Act5C-GAL4}25FO1/CyO, (donated by Bloomington stock center, 
stock# 4414; Y. Hiromi), w*;P{GawB}how24B (Brand and Perrimon 1993), and GAL4 
line 337 (Elefant and Palter 1999). All crosses were performed using three males and 
three newly eclosed virgin females in narrow plastic vials (Applied Scientific) with 
yeasted Drosophila media (Jazz-Mix, Fisher Scientific) at 25 º. 
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Results 
 
Identification and characterization of two Drosophila HAT (Dmel\HAT) genes that 
are homologous to human HAT genes TIP60 and ELP3 
 
We first wished to identify the human HAT homolog of MYST family 
member TIP60. Additionally, we also set out to identify the human HAT homolog of 
GNAT family member ELP3 in Drosophila so that we could compare the 
developmental expression profiles of two different HAT family members. Conserved 
sequences within the human TIP60 (hTIP60) and ELP3 (hELP3) genes were used to 
query the Drosophila Genome database for genomic DNA encoding homologous 
sequences. A single genomic clone mapping to band 4A6-B1 on the X chromosome 
showed significant homology to hTIP60 while a single genomic clone mapping to 
band 24F2 on the 2L chromosome demonstrated significant homology to hELP3. 
Sequences corresponding to these regions were used to conduct a BLAST search of 
the Drosophila expressed sequence tag (EST) library at Flybase and cDNA sequences 
were identified that diplayed high homology to the hTIP60 sequence (listed as 
CG6121) and hELP3 sequence (listed as CG15433). Embryonic EST cDNA clones 
were identified for each Dmel\HAT (clone LD31064 for Dmel\TIP60 and RE35395 
for Dmel\ELP3) and these clones were purchased and sequenced. The full sequence 
was determined for the open reading frame (ORF) of each cDNA Dmel\HAT clone, 
designated Dmel\TIP60 and Dmel\ELP3, and aligned to its respective cDNA 
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sequence identified in Flybase, confirming a full ORF and correct sequence identity 
for each Dmel\HAT construct. 
Analysis of the conceptual translation products for both Dmel\TIP60 and 
Dmel\ELP3 provided evidence that these Drosophila genes are homologs of human 
HATs TIP60 and ELP3. First, alignments between each Dmel\HAT and its human 
HAT counterpart demonstrated significant homology over their entire coding 
sequences: Dmel\TIP60 is 58% identical/67% similar and Dmel\Elp3 is 82% 
identical/91% similar (Figure 1 A and B; Figure 2 A and B). Additionally, the 
Dmel\TIP60 transcript was found to contain an open reading frame of 1,626 bp, 
encoding a protein of 541 a.a. with a predicted molecular mass of 61.2 kD, in good 
agreement with the apparent molecular mass of human TIP60 (Ikura et al. 2000). The 
ELP3 transcript contained an ORF of 1,659 bp, producing a protein of 552 a.a. with a 
predicted molecular mass of 62.8 kD, shown to be the approximate molecular mass 
for the human Elp3 protein (Hawkes et al. 2002). Finally, structural protein data 
obtained using the conserved domain architecture retrieval tool (CDART) at NCBI 
revealed that the predicted protein domains specific for Dmel\TIP60 and Dmel\Elp3 
and their location within each Dmel\HAT protein are highly conserved between 
human and Dmel\HAT counterparts (Figure 1 A and B; Figure 2 A and B).  Both 
Drosophila and human MYST family member TIP60 contain an N-terminal 
chromodomain and a C-terminal MYST domain, while both Drosophila and human 
GNAT family member Elp3 contain an N-terminal putative histone demethylation 
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domain and a C-terminal HAT domain. As expected, each of these conserved domains 
showed significant homology to one another: for dTIP60 the chromodomain is 70% 
identical/87% similar and the MYST domain is 80% identical/89% similar, and for 
Dmel\Elp3 the HAT domain is 85% identical/93% similar while the putative histone 
demethylase domain is 88% identical/94% similar to their human homolog 
counterparts. Protein sequence analysis of a number of Dmel\TIP60 and Dmel\Elp3 
homologs in a variety of different species in addition to humans, including Mus 
musculus, Danio rerio, Caenorhabditis elegans, Arabidopsis thaliana and 
Saccharomyces cerevisiae demonstrated that such HAT conservation for both 
Dmel\TIP60 and Dmel\Elp3 is evolutionarily well conserved (Figure 2 A and B). The 
significant sequence and structural similarity between each Dmel\HAT with its human 
HAT counterpart strongly indicates that these newly isolated Drosophila genes are 
homologs of human TIP60 and ELP3. 
 
Dmel\TIP60 and Dmel\ELP3 are differentially expressed during Drosophila 
development 
 
The mechanism underlying the regulation of HAT activity remains unclear. 
Although detailed analysis of HAT expression throughout development is limited, 
studies analyzing HAT expression profiles suggest that a number of HATs including 
HBO1, TIP60, CBP, P/CAF and GCN5 are controlled, at least in part, through their 
differential regulation in certain tissues (Xu et al. 1998; Iizuka and Stillman 1999; 
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Stromberg et al. 1999; Xu et al. 2000; Lough 2002; McAllister et al. 2002). To 
determine whether different families of HATs might also be regulated throughout 
development, we examined the expression profiles of MYST family member 
Dmel\TIP60 and GNAT family member Dmel\ELP3 genes in all stages of Drosophila 
development using a real-time RT-PCR assay. RNA was isolated from staged 
Drosophila melanogaster (12-24 h staged embryos, first, second and third instar 
larvae, pupae, adult flies) and DNaseI treated. cDNAs were generated from equal 
amounts of RNA for each developmental stage by RT priming with random hexamers. 
The RT products were then amplified in a real-time PCR assay using primer pairs 
corresponding to a region specific for each Dmel\HAT and expression levels were 
displayed in absolute values. We found that transcript levels of both HATs 
significantly peaked in the embryo, sharply decreased to almost undetectable levels 
by the second instar larvae stage, then gradually increased as development proceeded, 
reaching a second, albeit lower, peak of expression in the adult fly (Figure 3). 
Interestingly, although exact levels of Dmel\TIP60 and Dmel\ELP3 expression 
differed at each Drosophila stage tested, the trend of these levels throughout 
development was similar for both HATs. These data demonstrate that Dmel\TIP60 
and Dmel\ELP3 are each differentially expressed throughout Drosophila 
development. 
 
 74
Plasmid mediated Dmel\TIP60 dsRNA production in a Drosophila embryonic cell 
line reduces cell viability and Dmel\TIP60 mRNA levels 
 
We found that levels of Dmel\TIP60 and Dmel\ELP3 expression dramatically 
peaked in the Drosophila embryo, supporting an important role for these Dmel\HATs 
during embryogenesis. Therefore, we wished to decipher their function during early 
development. As no characterized Dmel\TIP60 and Dmel\ELP3 mutant alleles exist 
to date, we chose to silence specific endogenous HAT expression in a variety of 
tissues, cell types, and stages of development of choice by using an inducible GAL4 
targeted RNAi based system in Drosophila. In this RNAi/GAL4 system, expression 
of an inverted repeat transgene of choice triggers double-stranded RNA mediated 
postranscriptional gene silencing (Fortier and Belote 2000; Kennerdell and Carthew 
2000). This method is used in conjunction with the targeted GAL4/UAS binary 
system (Brand and Perrimon 1993) to control expression of the inverted repeat 
transgene in both a developmental and cell type restricted fashion. 
We chose to initially focus our studies on TIP60, as this HAT has been 
previously reported to play wide range of biological roles essential for numerous 
cellular processes (Clarke et al. 1999; Ikura et al. 2000; Reid et al. 2000; Bird et al. 
2002; Ceol and Horvitz 2004; Halkidou et al. 2004; Kusch et al. 2004; Legube et al. 
2004). To create the Dmel\TIP60/RNAi construct, we selected a 613 bp RNAi 
non-conserved target sequence specific for Dmel\TIP60 (Figure 4 A). BLAST 
searches using this sequence ensured non-redundancy within the genome. The chosen 
 75
Dmel\TIP60 cDNA fragment was cloned into the inducible expression vector 
(pUAST) under the control of GAL4-UAS binding sites in a sense-antisense inverted 
gene arrangement predicted to form a double-stranded RNA hairpin that would 
induce an RNAi response. This plasmid was designated the Dmel\TIP60/RNAi 
construct (Figure 4B). A control construct was created in which the same RNAi target 
sequences were cloned into a sense-sense orientation so that it would not induce 
RNAi. This plasmid was designated the Dmel\TIP60/control construct (Figure 4C). 
Both the sense-antisense and sense-sense sequences in each of the constructs were 
separated by a short polylinker that served as the “hinge” region of the hairpin 
arrangement. 
To initially test whether our Dmel\TIP60/RNAi construct would potently 
down-regulate endogenous Dmel\TIP60 expression and result in phenotypic defects, 
we utilized the Drosophila embryonic D.mel-2 cell culture based system (Figure 5 A 
and B). The Dmel\TIP60/RNAi sense-antisense repeat and Dmel\TIP60/control 
sense-sense sequences were each subcloned into the pAc5.1/HisA vector under the 
control of an active actin promoter. Both the Dmel\TIP60/RNAi and control 
constructs were each transiently transfected into D.mel-2 cells and visualized using 
phase/contrast optics 24 hours post transfection. We observed morphological defects 
in cells transfected with the Dmel\TIP60/RNAi construct. These cells were found to 
grow poorly, suffering approximately 50-70% lethality 24 hours post-transfection 
(Figure 5D). Additionally, Dmel\TIP60/RNAi induction appeared to disrupt mitotic 
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cell cycle progression, as those cells that did survive were larger than the wild-type 
and control cells and appeared to be arrested during cytokinesis. None of these 
defects were observed in cells transfected with the Dmel\TIP60/control construct 
(Figure 5C). These results demonstrate that Dmel\TIP60 /RNAi production in a 
Drosophila embryonic cell line results in cellular defects and lethality, supporting an 
essential role for Dmel\TIP60 in early development.  
To determine whether the Dmel\TIP60/RNAi construct was down-regulating 
endogenous Dmel\TIP60, RNA was isolated from cells transfected with either the 
Dmel\TIP60/RNAi or Dmel\TIP60/control construct 24 hours post-transfection, and 
DNaseI treated. Interestingly, RNA isolated from cell plates transfected with the 
Dmel\TIP60/RNAi construct was found to be consistently and significantly lower in 
concentration than RNA isolated from cells transfected with the Dmel\TIP60/control 
construct (data not shown). This result is likely due to cell lethality occurring in the 
Dmel\TIP60/RNAi test cell lines (Figure 5D). cDNAs were generated from equal 
amounts of RNA for each transfection sample by RT priming with random hexamers. 
The RT products were amplified in a semi-quantitative RT-PCR assay using primer 
pairs specific for each Dmel\TIP60 that did not amplify dsRNA species. The gene for 
the RP49 ribosomal protein was also amplified from each sample and served as an 
internal control. Our results revealed that endogenous Dmel\TIP60 is reduced in 
RNAi samples when compared to control samples, whereas RP49 expression 
remained unaffected. These observations indicated that our Dmel\TIP60/RNAi 
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construct is effectively and specifically inhibiting endogenous Dmel\TIP60 RNA 
production. 
 
Dmel\TIP60 is essential for Drosophila development 
 
To confirm and further explore our finding that Dmel\TIP60 is required for 
cell viability, we used a GAL4 targeted RNAi knockdown system to induce silencing 
of endogenous Dmel\TIP60 expression in the Drosophila multicellular model setting. 
Flies were transformed with our Dmel\TIP60/RNAi and control GAL4 inducible 
pUAST constructs, and three independently derived transgenic fly lines with 
insertions for each of the constructs were chosen for use. The insertions were 
homozygous viable, and did not cause any observable mutant phenotypes in the 
absence of GAL4 induction. 
Based on our previous findings that the actin promoter (Act5C) induced potent 
Dmel\TIP60 RNAi knockdown in the Drosophila cell culture line, we chose to induce 
Dmel\TIP60/RNAi and control transgene expression in the fly using the Act5c-Gal4 
driver strain (Bloomington stock 4414), as this actin driver expresses robust levels of 
GAL4 constitutively and ubiquitously early in embryogenesis (Chavous et al. 2001; 
Rollins et al. 2004). We found that when the Act5c-Gal4 driver was used to induce 
transgene expression at 25o, each of the three Dmel\TIP60/RNAi insertion lines 
reduced survival to 0% that of all three Dmel\TIP60/control insertion lines (Table 1). In 
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each case, lethality for the majority of flies occurred during pupal development, which 
was the latest stage that flies were able to survive. Those flies that did survive until this 
stage showed essentially wild-type development. As an internal control, Act5c flies are 
hemizygous for the GAL4 driver over a CyO balancer chromosome 
(P{Act5c-Gal4}y/CyO y+) and thus approximately 50% of flies are expected to eclose 
due to no GAL4 production in half of the progeny in any given cross. Thus, to 
determine whether a significant percentage of flies died earlier than the pupal stage, the 
total number of dead, non-eclosed GAL4+ (y;Cy+) pupae was compared to the total 
number of non-RNAi induced GAL4- (y+;Cy) flies that eclosed over a ten day period. 
We found that although no Dmel\TIP60 RNAi induced GAL4+ (y;Cy+) flies were found 
to eclose, the number of dead pupae was significantly lower than the number of viable 
GAL4- (y+;Cy) flies for one of the Dmel\TIP60/RNAi insertion lines tested. An analysis 
of the number of such “missing” dead pupae to the total number of eclosed GAL4- 
(y+;Cy) flies demonstrated that for Dmel\TIP60/RNAi/A, 24% of the 
Dmel\TIP60/RNAi induced flies must have died sometime earlier than pupal 
development (data not shown). The variation in lethality observed between fly lines is 
likely due to position effects on transgene expression. Our results demonstrate that 
early and ubiquitous induction of Dmel\TIP60/RNAi in the fly using an actin specific 
GAL4 driver results in total lethality for each of the three Dmel\TIP60/RNAi insertions 
tested, supporting an essential role for Dmel\TIP60 in multicellular development and 
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the feasibility of our inducible GAL4 targeted HAT/RNAi knockdown system in 
Drosophila. 
We next wished to determine whether GAL4 induced expression of 
Dmel\TIP60/RNAi reduced endogenous Dmel\TIP60 transcripts. Because Act5c flies 
are hemizygous for the GAL4 driver, only 50% of the progeny in any given cross will 
induce the Dmel\TIP60/RNAi transgene, making analysis of endogenous Dmel\TIP60 
down-regulation using this GAL4 driver problematic. We therefore chose to induce 
Dmel\TIP60/RNAi and control transgenes using the ubiquitous homozygous GAL4 
driver 337 (Elefant and Palter 1999). Progeny resulting from a cross between three 
independently derived homozygous Dmel\TIP60/RNAi or Dmel\TIP60/control fly 
lines and GAL4 line 337 were allowed to develop to the third instar larval stage, 
before lethality in the pupal stage was shown to occur (data not shown). RNA was 
isolated from three third instar larvae from each of the above crosses and DNaseI 
treated. cDNAs were prepared from equal amounts of each RNA sample by RT 
priming with random hexamers. The RT products were amplified in a 
semi-quantitative RT-PCR assay using primer pairs specific for Dmel\TIP60 that did 
not amplify dsRNA species. The gene for the RP49 ribosomal protein was also 
amplified from each sample to serve as an internal control. Our results revealed that 
endogenous Dmel\TIP60 transcript levels were significantly reduced in RNAi 
samples from each of the three independently derived Dmel\TIP60/RNAi fly lines 
when compared to samples obtained from each of the three independently derived 
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Dmel\TIP60/control fly lines (Figure 6). These observations demonstrate that GAL4 
induced Dmel\TIP60/RNAi expression is robustly inhibiting endogenous Dmel\TIP60 
RNA production. 
 
Targeted expression of Dmel\TIP60/RNAi in the mesoderm and muscle cells of 
Drosophila results in lethal muscle mutant phenotypes 
 
To further test the specificity of our newly developed GAL4 targeted 
Dmel\TIP60/RNAi knockdown system, we wished to determine whether targeting 
Dmel\TIP60/TNAi knockdown to specific tissues would result in phenotypes that 
were distinctive for a given particular tissue type. As our in situ analysis of 
Dmel\TIP60 transcripts demonstrated that Dmel\TIP60 is expressed in the muscle 
cells during embryogenesis (our unpublished results, data not shown; similar results 
in BDGP), we chose to induce Dmel\TIP60/RNAi and control transgene expression in 
the fly using the GAL4 line 24B (P{GawB}how24B), as this driver produces high 
levels of GAL4 specifically in the presumptive mesoderm and muscle cells during 
early embryogenesis (Brand and Perrimon 1993). Three independent fly lines 
containing either Dmel\TIP60/RNAi or control transgenes were crossed to the 
mesoderm/muscle GAL4 line 24B at 25o and the resulting phenotypes were assessed. 
We found that all three fly lines expressing the Dmel\TIP60 control transgene showed 
normal development and no observable defective phenotypes when their expression 
was targeted to the mesoderm/muscle cells, similar to our results for the actin specific 
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Act-5c and the ubiquitous 337 GAL4 drivers,. However, when expression of the 
Dmel\TIP60/RNAi transgene was induced in the mesoderm/muscle cells, we 
observed a reduction in viability to 0, 40 and 29% (for lines Dmel\TIP60/RNAi/ A, B 
and C, respectively) that of the Dmel\TIP60 control lines (Table 2). Significantly, the 
lethal phenotypes we observed were different from that of the Act-5c and 337 GAL4 
driver lines in that depending on the insertion line tested, the flies died at a broad 
range of developmental stages, beginning from early pupae to directly before fly 
eclosion. Importantly, the dying flies resembled those of known muscle mutants 
(Fyrberg et al. 1994) in that the apparent cause of lethality later in development was 
due to their inability to eclose from their pupal casings (data not shown). The 
variation in developmental lethality that we observed for different insertion lines is 
likely caused by position effects on transgene expression, with higher levels of 
Dmel\TIP60/RNAi transgene expression resulting in lethality earlier in development. 
Notably, fly insertion line Dmel\TIP60/RNAi/A consistently resulted in the earliest 
developmental lethality of all three Dmel\TIP60/RNAi insertion lines when tested 
with the actin Act-5c, ubiquitous 337 and mesoderm/muscle 24B GAL4 drivers, 
indicating that this is the strongest expresser of our three independent 
Dmel\TIP60/RNAi fly lines (Tables 2). These results demonstrate the feasibility of 
targeting different levels of Dmel\TIP60 knockdown specifically to certain cells and 
tissue types, and also suggest that Dmel\TIP60 is essential for proper muscle 
formation in the developing fly. 
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Discussion 
 
The importance of histone acetylation in chromatin control and gene 
regulation supports a critical role for HAT function in promoting the rapidly changing 
gene expression profiles that drive developmental processes (Roth et al. 2001). 
However, the specialized roles of certain HATs in a multicellular developmental 
setting remains to be explored. Thus, we set out to identify human HAT family 
homologs in Drosophila (Dmel\HATs) in order to elucidate their human relevant 
developmental functions in the multicellular Drosophila model setting. Using 
homology searches of the Drosophila genome, we identified human homologs of 
MYST family member TIP60 (Dmel\TIP60) and GNAT family member ELP3 
(Dmel\ELP3). Our isolation and characterization of the cDNA clones encoding these 
genes demonstrated high conservation to their human counterparts in terms of both 
their amino acid sequence identity and location of conserved protein domains. 
Importantly, while this work was in progress, Kusch et al. (Kusch et al. 2004) purified 
the dTIP60 multiprotein complex from Drosophila embryonic S2 cells and 
demonstrated by mass spectrometer and sequence analysis that this complex is 
structurally homologous to its human counterpart and that the dTIP60 protein 
component is encoded by the Dmel\TIP60 gene we report here, supporting our 
conclusion that Dmel\TIP60 is the Drosophila homolog of human TIP60. 
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Our analysis of Dmel\TIP60 and Dmel\ELP3 expression levels using real-time 
PCR demonstrated that both Dmel\HATs are differentially expressed throughout 
Drosophila development. These results suggest that in addition to being regulated by 
specific protein partners (Marmorstein and Roth 2001), HAT activity may also be 
controlled, at least in part, by their developmental regulation. In support of this idea is 
the observation that mice heterozygous for null alleles for each of the p300, CBP and 
GCN5 HATs show less severe developmental defects than do homozygous null 
alleles, demonstrating that the overall dosage of HATs is critical for developmental 
processes (Xu et al. 2000; Roth et al. 2001). We also observed that both Dmel\TIP60 
and Dmel\ELP3 expression peaked in the embryo, consistent with studies 
demonstrating the importance of chromatin control in early development (Patterton 
and Wolffe 1996). Importantly, high levels of embryonic expression is not the case 
for all HATs as shown by studies demonstrating that GCN5 is expressed at high 
levels in the mouse embryo whereas expression levels of the HAT P/CAF are 
virtually undetectable (Xu et al. 1998). This data, in conjunction with the HAT 
expression data reported here, suggest that only certain HATs may be essential for 
embryogenesis to proceed. 
Although research on HATs in multicellular systems is still limited to date, 
knockout studies of p300, CBP (Tanaka et al. 1997; Roth et al. 2003) and GCN5 (Xu 
et al. 2000) in mice and CBP (Akimaru et al. 1997), HBO1 (Grienenberger et al. 2002) 
and MOF (Smith et al. 2001) in Drosophila have revealed essential roles for these 
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HATs during development. Significantly, the phenotypic defects that arise from such 
different HAT knockouts are not identical. GCN5 is essential for mouse development 
and formation of several mesoderm tissues while PCAF is dispensable (Xu et al. 2000) 
and differential roles for CBP and p300 in heart, lung, small intestine (Shikama et al. 
2003) and muscle development (Roth et al. 2003) have been reported. Taken together, 
these studies indicate that HATs carry out specific functions required for proper 
multicellular development (Roth et al. 2001). Here, we show that reducing 
endogenous Dmel\TIP60 expression by RNAi in either all tissues or specifically in 
the mesoderm/muscles of the developing fly results in lethality. Our results extend 
prior HAT knockout studies and add Dmel\TIP60 to the growing list of HATs that 
carry out potentially specialized roles essential for multicellular development. 
Prior studies on the yeast TIP60 homolog, ESA1, demonstrated that 
temperature-sensitive yeast esa1 mutant cells were found to be arrested during cell 
division with a G2/M stage DNA content and partially depleted acetylated H4 levels, 
thereby linking Esa1 HAT function to cell cycle control via potential transcriptional 
regulatory events (Clarke et al. 1999). Consistent with these results, we observed that 
Dmel\TIP60 depletion in the Drosophila D.Mel-2 cell culture line resulted in a lethal 
phenotype reminiscent of mitotic cell cycle progression defects. Cells that did survive 
were larger than wild-type and control cells and appeared unable to complete 
cytokinesis, supporting a role for Dmel\TIP60 in metazoan embryonic cell division. 
We also found that either ubiquitous or mesoderm/muscle specific depletion of 
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Dmel\TIP60 in our GAL4 inducible HAT knockdown system resulted in lethality for 
all three independent Dmel\TIP60/RNAi insertion fly lines tested, with the majority 
of flies dying during early pupal development. Thus, as development proceeds, 
depletion of Dmel\TIP60 may result in the disruption of cell processes shown to 
require Dmel\TIP60 such as apoptosis (Ikura et al. 2000; Legube et al. 2004), DNA 
repair (Bird et al. 2002) , and cell cycle progression (Clarke et al. 1999), culminating 
in lethality caused by an accumulation of cell defects that accrue over time, all 
possibilities that we are currently exploring. 
HATs execute acetylation profiles required for target gene regulation and thus 
their misregulation is linked to numerous types of cancers and developmental defects 
(Petrij et al. 1995; Mahlknecht et al. 2000; Steffan et al. 2001; Roelfsema et al. 2005; 
Close et al. 2006). The importance of TIP60 is underscored by studies demonstrating 
its involvement in both normal cellular processes, and abnormal ones, resulting in 
oncogenesis and developmental disorders. For example, overproduction of TIP60 in 
the nucleus of prostate cells is associated with androgen–resistant prostate cancer 
(Halkidou et al. 2003; Sapountzi et al. 2006). TIP60 is also associated with numerous 
disease related proteins including the c-MYC oncoprotein (Frank et al. 2003; Patel et 
al. 2004) proteins involved in hematological malignancies (Chambers et al. 2003; 
Nordentoft and Jorgensen 2003) and Alzheimer’s associated ameloid precursor 
protein (APP-CT) (Baek et al. 2002; Kim et al. 2004). Interestingly, overproduction 
of APP-CT induces an increase in histone acetylation that significantly enhances 
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neurotoxicity, implicating TIP60 HAT mistargeting in Alzheimer’s disease (Kim et al. 
2004). Our isolation and characterization of Dmel\TIP60, in conjunction with our 
newly developed inducible and targeted HAT knockdown system in Drosophila, will 
now allow us to effectively study the roles of these and other chromatin regulators in 
both multicellular development and epigenetic-based disorders. 
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Chapter 3: Dmel\TIP60 is required for the differentiation of a variety of specific 
cell and tissue types during Drosophila development 
 
Abstract 
 
Combinatorial histone modifications control chromatin packaging which in 
turn, contributes to the precise patterning of gene expression during development. 
The histone acetyltransferase TIP60 is a histone modifying enzyme that plays 
essential roles in a wide variety of chromatin mediated cellular processes including 
gene control, DNA repair and cell cycle control, however little is known about its 
roles during multicellular development. Here, we use our Drosophila GAL4 inducible 
Dmel\TIP60 knockdown/overexpression system to explore the role of Dmel\TIP60 in 
a wide variety of specific tissues during Drosophila development. We show that loss 
of Dmel\TIP60 in the wing leads to a range of wing abnormalities, including the 
formation of wing blisters in the most severe cases. Wing surface area and cell 
count/hair density assays reveal that although the number of cells that compose the 
wing remain unaffected, their size is significantly smaller than normal and there are 
defects in wing cell planer polarity. Additionally, we find that loss of Dmel\TIP60 in 
the CNS leads to lethality and a substantial loss of differentiated neurons in the larval 
brain, while cyclin E levels and apoptosis remain unaffected. Finally, we show that 
loss of Dmel\TIP60 in the mesoderm leads to lethality, and malformation or absence 
of the muscle fibers in the developing embryo. Expression of an additional copy of 
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Dmel\TIP60 in each of these tissues has no affect on their development. Taken 
together, our results support an essential role for Dmel\TIP60 in the differentiation 
and formation of a variety of specific cell and tissue types. 
 
Introduction 
 
Metazoans are comprised of a multitude of different cell-types that each carry 
out specialized functions essential for proper development (Orphanides and Reinberg 
2002). Differentiation of such specialized cell-lineages is achieved through the 
establishment and maintenance of tightly regulated gene expression profiles distinct 
for each cell type (Orphanides and Reinberg 2002; Reik 2007) Such regulation in 
eukaryotic cells is determined in large part by the differential packaging of genes into 
chromatin (Kiefer 2007; Reik 2007). All DNA in the eukaryotic nucleus is packaged 
into nucleosomes, consisting of 146 base pairs of DNA wrapped around a histone 
octomer core, containing two subunits each of histones H2A, H2B, H3 and H4. The 
majority of these nucleosomes are further packaged into a highly organized and 
compact chromatin structure through their association with nucleosomal-linking 
histone H1 and additional non-histone proteins (Luger 2006). Certain enzymes and 
protein complexes are found to bring about changes in the state of chromatin structure 
by numerous mechanisms (Felsenfeld and Groudine 2003). Numerous types of 
covalent modification of histones are one way to remodel chromatin (Berger 2002; 
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Fischle et al. 2003). This type of epigenetic gene regulation has been termed the 
“histone code” (Strahl and Allis 2000; Jenuwein and Allis 2001). Histone 
modifications include acetylation, methylation, phosphorylation, ubiquitination, and 
sumyolation. The histone code regulates different levels of chromatin packaging and 
thus contributes to the precise pattern of gene expression during development 
(Margueron et al. 2005). 
Histone acetylation is carried out by a family of enzymes termed histone 
acetyltransferases (HATs). This particular modification is one of the most 
well-studied of the histone modifications. HATs enzymatically transfer an acetyl 
group from acetyl-coenzyme A (acetyl-CoA) to the ε-terminal group of specific and 
highly conserved lysine residues within the histone N-terminal tail (Sterner and 
Berger 2000; Roth et al. 2001). The distribution patterns of histone acetylation within 
the eukaryotic genome have been shown to be associated with specific gene 
expression profiles. For example, coactivators that display HAT activity, such as the 
p300/CREB-binding protein (CBP) and steroid receptor coactivator 1 (SRC1), are 
recruited to specific promoters through their interaction with DNA-bound 
transcriptional activators, thus providing a mechanism for promoter-specific histone 
acetylation (Bannister and Kouzarides 1996; Mizzen et al. 1996; Shiama 1997; 
Brown et al. 2000; Deckert and Struhl 2001; Nagy and Tora 2007). HAT function 
during development is strongly supported by studies demonstrating that histone 
acetylation plays critical roles in chromatin control and gene expression, which is 
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required for proper multicellular development (Roth et al. 2001). 
The tat-interactive protein, 60 KDa (TIP60) belongs to MYST histone 
acetyltransferase super family (Sterner and Berger 2000), which was identified 
through its interaction with the human immunodeficiency virus, type 1-encoded 
transactivator protein Tat (Kamine et al. 1996). Recombinant TIP60 protein was 
found to directly acetylate free histone substrates H2A, H3 and H4 in vitro via its 
C-terminal MYST domain (Yamamoto and Horikoshi 1997; Kimura and Horikoshi 
1998). The TIP60 complex can acetylate nucleosomal histones H2A and H4 even 
when the linker histones are present (Ikura et al. 2000). Recent data has also shown 
that Drosophila Dmel\TIP60 can acetylate the histone variant phospho-H2Av at Lys5 
which is essential for DNA repair (Kusch et al. 2004). Cellular TIP60 can also 
acetylate a wide variety of transcription factors which influences their function. Such 
factors include the androgen receptor (AR) (Gaughan et al. 2002), upstream binding 
transcription factor (UBF) (Halkidou et al. 2004), myelocytomatosis oncogene c 
(MYC) (Patel et al. 2004), and the kinase Ataxia Telangiectasia mutated (ATM) (Sun 
et al. 2005). 
TIP60 has been reported to play many essential roles in a wide variety of 
cellular processes based upon the different protein complexes it is associated with. 
For example, TIP60 is generally found to be associated in a TIP60 protein complex 
that contains at least18 subunits (Sapountzi et al. 2006). Two such TIP60 associated 
proteins, p400/Domino and RuvB1/2, carry out DNA remodeling ATPase activity and 
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DNA helicase activity, respectively, which are essential for the function of TIP60 in 
DNA repair and apoptosis (Ikura et al. 2000; Kusch et al. 2004). Additionally, TIP60 
can activate specific genes via its interaction with different transcriptional activators. 
For example, TIP60 was found to up-regulate class I nuclear hormone receptors 
through the interaction of its LXXLL motif with the nuclear receptors (Brady et al. 
1999; Gaughan et al. 2001). Furthermore, the ternary complex of TIP60, AICD, and 
Fe65 activates a variety of specific target genes known to play essential roles in 
processing of APP and Tau proteins in Alzheimer's disease (Cao and Sudhof 2001; 
Baek et al. 2002; Cao and Sudhof 2004; von Rotz et al. 2004). Finally, TIP60 also 
plays a role as a negative regulator of gene expression. For example, it was reported 
that overexpression of TIP60 completely blocks activation of the cAMP-response 
element-binding protein (CREB)(Gavaravarapu and Kamine 2000). Other studies 
show that TIP60 acts as corepressor of the transcriptional repressor zinc finger E 
box-binding protein (ZEB) and inhibits the CD4 enhancer/promoter activity in Jurkat 
cells (Hlubek et al. 2001). 
Despite the important role that TIP60 plays in regulating gene expression 
profiles, and the finding that it is essential for both yeast viability as well as 
Drosophila multicellular development (Clarke et al. 1999; Zhu et al. 2007), there are 
few studies that investigate the specific role that TIP60 plays during multicellular 
development. One such study examines TIP60 expression profiles in chicken heart 
development and demonstrates that TIP60 may play a critical role in regulating 
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transcriptional events essential during myocardial development (Lough 2002). In 
another study, Brody et al. carried out a genome wide screen to identify neuronal 
precursor genes in Drosophila. Intrigugly, one of the genes identified in the screen 
was Dmel\TIP60, suggesting that TIP60 may play an important role during the 
neuroblast lineage development (Brody et al. 2002). 
In this report, we utilize our Drosophila GAL4 inducible Dmel\TIP60 
knockdown/overexpression system to further explore the role of Dmel\TIP60 in a wide 
variety of specific tissues during Drosophila development. We show that loss of 
Dmel\TIP60 in the wing leads to a range of wing abnormalities, including the formation 
of wing blisters in the most severe cases. Wing surface area and cell count/hair density 
assays reveal that although the number of cells that compose the wing remain unaffected, 
their size is significantly smaller than normal and there are defects in wing cell planer 
polarity. Additionally, we find that loss of Dmel\TIP60 in the CNS leads to lethality and a 
substantial loss of differentiated neurons in the larval brain, while cyclin E levels and 
apoptosis remain unaffected. Finally, we show that loss of Dmel\TIP60 in the mesoderm 
leads to lethality, and malformation or absence of the muscle fibers in the developing 
embryo. Expression of an additional copy of Dmel\TIP60 in each of these tissues has no 
affect on their development. Taken together, our results support an essential role for 
Dmel\TIP60 in the formation and differentiation of a variety of specific cell and tissue 
types. 
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Materials and methods 
 
Drosophila stocks 
 
All stocks were maintained under standard conditions at 25 °C. 
P{pUAST}/P{pUAST} fly line containing Dmel\TIP60/OverEx was created as 
described below. P{pUAST}/P{pUAST} flies containing Dmel\TIP60/RNAi and 
control were created and maintained in our lab (Zhu et al. 2007). w*;P{GawB}how24B 
(Brand and Perrimon 1993) and GAL4 line 337 (Elefant and Palter 1999) were kindly 
provided by Dr. Karen Palter (Temple University, PA). en-GAL4 was kindly provided 
by Dr. Marenda (University of the Sciences in Philadelphia, PA). Bloomington Stock 
Center (Bloomington, IN; http://flystocks.bioindiana.edu/) provided all the other 
GAL4 drivers: y1 w*; P{Act5C-GAL4}25FO1/CyO, (stock# 4414; Y. Hiromi), 
P{GawB}60IIA (stock# 7029), P{GawB}109-30 (stock# 7023), P{GawB}109-69 
(stock# 7026), P{GawB}c179 (stock# 6450), P{GawB}69B (stock# 1774), 
P{GawB}32B (stock# 1782), P{GAL4-ninaE.GMR}12 (stock# 1104), 
P{sevEP-GAL4.B}7 (stock# 5793), P{GAL4-elav.L}2 (stock# 8765). 
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Creation of Dmel\TIP60/OverEX fly lines 
 
To create the overexpression Dmel\TIP60/OverEX pUAST construct, the open 
reading frame (ORF) of Dmel\TIP60 was amplified by PCR using primer sets specific 
for the Dmel\TIP60 cDNA sequence with Dmel\TIP60 cDNA TOPO pCR2.1 clone 
(Zhu et al. 2007) as template. The forward primer 5’-CGG CGA ATT CGC CAT CAT 
GAA AAT TAA CCA CAA ATA TGA G-3’ contained an EcoRI site (italics), a Kozak 
consensus sequence (bold), and the sequence corresponding to the first eight codons 
of Dmel\TIP60. The reverse primer 5’-GGT TGG TAC CTC ATC ATC ATT TGG 
AGC GCT TGG ACC AGT C-3’ contained a KpnI site (italics), and two stop codons 
(bold). PCR reactions were carried out using Expand™ High Fidelity PCR System 
(Roche) according to the manufacture’s instructions using 400 nM of each forward 
and reverse primers. The cycling parameters were 30 cycles of 95 °C for 2 min, 55 °C 
for 1 min, and 72 °C for 3 min, using Mastercycler (Eppendorf). The correct size PCR 
generated fragment was then cloned into EcoRI/KpnI sites in the pUAST vector 
downstream of the UAS promoter. P-element germ-line transformations with pUAST 
constructs were performed as previously described (Elefant and Palter 1999; Zhu et al. 
2007), to create fly lines containing Dmel\TIP60/OverEX construct. To determine on 
which chromosome the P-element inserted, lines heterozygous for the TM3 and TM6 
balancer were mated to w1118 flies, and segregation of the w+ marker was scored: if 
segregation of w+ was neither with the third chromosome balancer or a sex 
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chromosome, it was inferred to segregate with the second chromosome. Balancer 
chromosomes were subsequently crossed away by successive mating to w1118. Several 
independent fly lines were created as the level of gene expression is dependent upon 
the random P-element insertion. 
 
Semi-quantitative RT-PCR 
 
As described previously (Zhu et al. 2007), total RNA from three third instar 
larvae progeny from a homozygous Dmel\TIP60/OverEX or control to GAL4 337 
cross was isolated using TRIzol (Invitrogen) and twice treated with DNA-freeTM 
(Ambion) to remove DNA. First strand cDNA was prepared using the SuperScriptTM 
II reverse transcriptase kit (Invitrogen) with 1μg total RNA and 15 ng/μL of random 
hexamers (Roche). PCR reactions were performed in a 40 μl total volume containing 
1 U Taq (Qiagen), 1 μl cDNA template, 250 μM dNTPs (Amersham Pharmacia 
Biotech) and 500 nM of each forward and reverse primer. The cycling conditions 
were 36 cycles of 95 °C for 45 s, 55 °C for 45 s, and 72 °C for 1 min. The forward 
primer (5’-TGG TAT TTC TCA CCC TAT CC-3’) and the reverse primer (5’-CAA 
TGA GCA GCT TGC CGT AG-3’) amplified a 427 bp fragment of position 1407 to 
1833 within Dmel\TIP60 cDNA sequence (Zhu et al. 2007). 
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Viability and mutant phenotype analyses 
 
All crosses were performed using three males and three newly eclosed virgin 
females in narrow plastic vials (Applied Scientific) with yeasted Drosophila media 
(Jazz-Mix, Fisher Scientific) at 25 ºC. Old flies were removed after 10 days and the 
number of newly eclosed progeny was scored every 48 h for total 10 days to 
determine the percent viability per genotype. 
As described in the previous protocol (Marenda et al. 2003), ImageJ 1.38X 
was used to determine wing size of 10 wings per genotype, whose pictures were taken 
under 10X magnification, by measuring the number of pixels corresponding to 
anterior and posterior of each wing. The relative wing size was calculated by dividing 
the number of pixels corresponding to posterior of a wing by that of anterior. To count 
the hair number, the images of anterior and posterior of each of the 10 wings were 
taken under 40X magnification. Given a 200 X 200 dpi squire which is measured by 
the software Pixel Ruler, the number of hairs in anterior and posterior of each wing 
was counted to determine cell number (Meyer et al. 2000). The relative hair number 
was calculated by dividing the number of hairs corresponding to posterior of a wing 
by that of anterior. 
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Immunohistochemical staining of embryos 
 
The antibodies used in immunohistochemical staining of embryos were as 
follows: mouse anti-ELAV (Developmental Studies Hybridoma Bank, University of 
Iowa); mouse anti-REPO (Developmental Studies Hybridoma Bank, University of 
Iowa); mouse 22C10 (Developmental Studies Hybridoma Bank, University of Iowa); 
rat anti-filamin (Sokol and Cooley 2003) (Dr. Cooley, Yale University; Gift from Dr. 
DiNardo, University of Pennsylvania); biotin-conjugated anti-mouse secondary 
antibody (Vectastain ABC Elite kit; Vector Laboratories); biotin-conjugated anti-rat 
secondary antibody (Vector Laboratories). Embryos collected from grape-agar plates 
(Flystuff) were dechorionated in 50% Clorox for 5 min and washed thoroughly with 
water and 0.1% Triton X-100. Embryos were shaken in 500 μl 4% paraformaldehyde 
and equal amount of heptane for 2 min. The bottom layer of paraformaldehyde was 
then removed. The remaining heptane layer with embryos was mixed with 700 μl 
methanol and shaken vigorously for 15 s. The top heptane layer was removed and the 
devitellinized embryos that settled to the bottom were washed with methanol twice 
and stored at 4°C until staining. 
Antibody staining was performed by first washing the embryos in 
phosphate-buffered saline (PBS) with 0.1% Tween (PBT) every 30 min for 3 h at 
room temperature. Embryos were treated with primary antibody (diluted 1:500 in 
PBT) overnight at 4°C. Embryos were washed with PBT every 30 min for 3 h at room 
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temperature. Biotinylated anti-mouse secondary antibody from Vectastain ABC Elite 
kit (Vector Laboratories; diluted 1:400 in PBT) was added to the embryos for 
overnight incubation at 4°C. Embryos were washed with PBT every 30 min for 3 h at 
room temperature. Embryos were incubated in biotin–streptavidin–horseradish 
peroxidase complex (Vectastain ABC Elite kit; Vector Laboratories) at room 
temperature for 1.5 h. Embryos were then washed eight times in PBT for 2 h. The 
signal was developed by incubation with 500 μl ImmPACT DAB (Vector 
Laboratories) in the presence of 1 μl of 10% H2O2. The reaction was terminated by 
washing the embryos with PBT and then with ethanol. The embryos were stored and 
mounted in methyl salicylate for microscopy with Zeiss Axioplan2 optics. 
 
Immunohistochemical staining of larval tissues 
 
Imaginal discs and brains were fixed and stained according to standard 
protocols. The following antibodies with specific dilutions were used: mouse 
anti-ELAV (1:200; Developmental Studies Hybridoma Bank, University of Iowa); 
mouse anti-REPO (1:100; Developmental Studies Hybridoma Bank, University of 
Iowa); mouse anti-cyclin E (1:5; Dr. Marenda, University of the Sciences in 
Philadelphia); mouse anti-integrin αPS1 (1:200; Developmental Studies Hybridoma 
Bank, University of Iowa); mouse anti-integrin αPS2 (1:200; Developmental Studies 
Hybridoma Bank, University of Iowa); biotin-conjugated anti-mouse secondary 
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antibody (1:100; Vectastain ABC Elite kit; Vector Laboratories); rhodamine 
(TRITC)-conjugated anti-mouse secondary antibody (1:100; Jackson 
Immunoresearch). The tissues were fixed in the fixation buffer (PBS with 2% 
paraformaldehyde, 1% lysine, and 0.25% sodium m-periodate). After being washed 
with PBT (PBS with 0.1% Triton) 15 min each time for 3 times, the tissues were 
incubated in block buffer (10% horse or goat serum depending on the secondary 
antibody) for 15 min. Then the tissues were transferred into the appropriate primary 
antibody and incubated at 4 ºC overnight. After being washed with PBT for 3 times, 
the tissues were transferred into the appropriate secondary antibody and incubated at 
4 ºC overnight. The tissues were washed with PBT for 3 times. If fluorescence 
secondary antibody were used, the tissues would be directly mounted in Vectashield 
mount media (Vector Laboratories) for microscopy using Olympus IX81. If 
ImmPACT DAB (Vector Laboratories) were used, the color development protocol 
and reagent concentration were the same as previously described in the 
immunohistochemical staining of embryos. And the tissues were mounted on the 
slides and visualized by Zeiss Axioplan2 optics. 
 
TUNEL Assay 
 
TUNEL assays were performed by following the protocol of the in situ 
fluorescein cell death detection kit (Roche) with some modifications (Kim et al. 
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2007). The imaginal discs and brains from the third instar larvae were fixed the same 
as stated above in immunohistochemistry. The tissues were washed with 5X PBT 
(PBS with 0.5% Triton) 10 min each time for three times. Then the tissues were 
transferred into the reaction buffer at 37 ºC for 10 min before adding terminal 
deoxynucleotide transferase (TdT) and incubating at 37 ºC for 2 h. The tissues were 
rinsed with 5X PBT three times and mounted by Vectashield mount media (Vector 
Laboratories) for microscopy using Zeiss Axioplan2 optics. 
 
Results 
 
An additional copy of Dmel\TIP60 rescues Dmel\TIP60/RNAi induced lethality 
 
We had previously generated transgenic flies carrying either 
Dmel\TIP60/RNAi or control GAL4 inducible pUAST constructs. (Zhu et al. 2007). 
Using this system, we demonstrated that loss of Dmel\TIP60 using ubiquitous GAL4 
drivers Act5c-GAL4 and 337 resulted in lethality. We also observed that our 
Dmel\TIP60/RNAi A line with the P-element located on the X chromosome is our 
strongest RNAi line, likely due to the position effects on transgene expression. 
To confirm that Dmel\TIP60/RNAi induced lethality was specifically caused 
by the reduction of endogenous Dmel\TIP60, experiments were carried out to 
determine whether additional Dmel\TIP60 would rescue the lethality resulting from 
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Dmel\TIP60/RNAi induction. To generate transgenic flies carrying a GAL4 inducible 
Dmel\TIP60 overexpression construct (Figure 1A), we first subcloned the ORF 
region of Dmel\TIP60 into the pUAST vector. To facilitate the expression of 
Dmel\TIP60, we introduced the Kozak consensus sequence (Kozak 1987) at the 5’ 
end and two stop codons at the 3’ end by PCR. We then generated 
Dmel\TIP60/OverEx transgenic fly lines by microinjection of embryos with the 
Dmel\TIP60/OverEx construct. To ensure that the constructs were indeed 
overexpressing Dmel\TIP60, we first induced their expression using GAL4 drivers 
Act5c-GAL4 or 337 at 25 °C (data not shown). Interestingly, no apparent phenotypes 
in the progeny were observed. We next assessed the expression level of Dmel\TIP60 
in 3rd instar larva progeny from the ubiquitous 337 GAL4 driver cross using RT-PCR 
with specific primers for Dmel\TIP60 (Zhu et al. 2007) and RP49 as an internal 
control. We observed increased levels of Dmel\TIP60 mRNA in the three different fly 
lines carrying Dmel\TIP60/OverEX construct we generated (Figure 1B). Of note, 
Dmel\TIP60 expression level was relatively low when compared to the internal 
control RP49, which was in accordance with my previous real-time RT-PCR results 
(Zhu et al. 2007).  
We next conducted rescue experiments to determine whether an additional 
copy of Dmel\TIP60 would rescue the lethal phenotype caused by induction of 
Dmel\TIP60\RNAi. To perform the rescue crosses, I chose to use the 
Dmel\TIP60/RNAi A line to provide the RNAi construct on X chromosome as it 
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displays the strongest RNAi expression level. Three separate fly strains were 
produced that each carried the P-element transposed GAL4 inducible 
Dmel\TIP60/RNAi construct on the X chromosome as well as an additional 
P-element transposed GAL4 inducible Dmel\TIP60 overexpression construct derived 
from each of my three independent overexpression Dmel\TIP60 lines on the third 
chromosome balancer (TM3). These three rescue fly lines were designated 
Dmel\TIP60/Rescue/A, B and C. Each of the three fly lines were then crossed to the 
ubiquitous GAL4 driver 337 and the viability of the progeny was scored. The results 
showed that when the Dmel\TIP60 overexpression construct was present in flies also 
expressing the Dmel\TIP60/RNAi construct, a significant number of flies were 
rescued (an average of 54% flies surviving). Of note, the survival rates were different 
among the three different rescue fly constructs likely due to the different levels of 
wild-type Dmel\TIP60 protein produced from each of the three Dmel\TIP60 
independent constructs used. Intriguingly, although the majority of such rescued flies 
displayed a normal phenotype, a number of these flies (an average of 23%) were 
found to exhibit a wing blister phenotype (Figure 2B) that is typically characteristic 
of defects in cell adhesion and signaling molecules termed integrins (Li et al. 1998) 
(discussed further in next section). 
Our results demonstrate that Dmel\TIP60 induced lethality is specifically 
caused by the reduction of endogenous Dmel\TIP60 as it can be partially rescued by 
increasing the level of wild-type Dmel\TIP60. Additionally, our results suggest that a 
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critical threshold expression level of Dmel\TIP60 is required for the appropriate 
Drosophila development. 
 
Dmel\TIP60 is required for the cell growth and differentiation during wing 
development 
 
We found that 23% of the flies that were rescued from Dmel\TIP60/RNAi 
induced lethality by increasing levels of wild-type Dmel\TIP60 exhibited a distinct 
wing blister phenotype. This well characterized phenotype reflects the inability of the 
dorsal and ventral wing epithelial layers to become permanently fused and often 
results from misexpression of the integrin genes (Brown 1993). As the integrin 
protein family carries out essential functions in both cell adhesion and cell signaling 
(Hynes 1992; Li et al. 1998), we wished to further explore the role of Dmel\TIP60 in 
these cell processes. Thus, Dmel\TIP60/RNAi, overexpression and control transgene 
expression were each induced specifically in the wing discs of the fly using GAL4 
drivers 69B and 32B. Three independent fly lines containing either 
Dmel\TIP60/RNAi or control transgenes were crossed to flies homozygous for either 
GAL4 69B or 32B driver at 25oC and the resulting phenotypes were assessed. All 
three fly lines expressing the Dmel\TIP60 overexpression and control transgenes 
showed normal development and no observable defective phenotypes. However, 
when expression of the Dmel\TIP60/RNAi transgene was induced in the wing disc, a 
range of wing defective phenotypes were observed , including wing blisters in the 
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most severe cases when the 69B GAL4 driver was used (Figure 3 and Figure 4). Of 
note, I also observed lethality when Dmel\TIP60/RNAi was induced using these 
drivers, likely due to expression of GAL4 in tissues other than the wing discs in both 
of these drivers (our laboratories unpublished results). These results suggested that 
TIP60 plays a role in integrin-mediated cell adhesion and cell signaling pathways. 
To further explore the wing blister integrin related phenotype in a more 
controlled fashion, we targeted expression of Dmel\TIP60/RNAi specifically to the 
posterior portion of the wing disc using the engrailed GAL4 driver (en-GAL4), 
enabling us to use the anterior portion as an internal control for these and subsequent 
studies. Use of this driver led to wing defects, including blisters, which were 
specifically confined to the posterior portion of the wing, confirming that reduction of 
Dmel\TIP60 was indeed responsible for causing such wing defects (Figure 5B). 
Further study of the wing hairs revealed that the hair orientation was disordered, 
indicative of defects in the planar cell polarity (PCP; Figure 5C to F). Of note, all of 
these defects were again confined to the posterior region (Figure 5F), while the 
anterior was not affected by RNAi (Figure 5D), further indicating that loss of 
Dmel\TIP60 was responsible in causing such defects. 
To explore the mechanisms of DmelTIP60 in regulations of wing development, 
we collected ten wings from each of the male and female progeny of 
Dmel\TIP60/RNAi A and Dmel\TIP60/Control C crossed to en-GAL4. After 
measuring the sizes of the posterior and anterior of the wings, we found that the wing 
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area in the posterior of both male and female wings was significantly reduced 
(p<0.0001) when RNAi was induced in the posterior compartment of the wing when 
compared to controls (Figure 6A). The reduction on wing area could have resulted 
from either cell death or a change of cell size (or shape) due to loss of Dmel\Tip60. 
To distinguish which of these two mechanisms is responsible for the phenotypes we 
observed, cell count\hair density assays were performed. As each of the cells of the 
wing contain one hair, we counted the hair number (which represents cell number) in 
a certain area located in either the posterior or anterior regions to determine whether 
the number of cells was affected by loss of Dmel\TIP60 in the posterior portion of the 
wing compared to the anterior portion(Meyer et al. 2000). By examining ten wings 
from both males and females, we found that the number of cells was not changed in 
the posterior of the wing in both males and females when Dmel\TIP60/RNAi was 
expressed in the posterior of the wing (Figure 6B). This result suggested that the 
reduced size of the posterior wing is caused by a decrease of the size of cells likely 
due to defects in cell growth and differentiation. We also used the TUNEL assay on 
wing discs dissected from these animals to determine whether apoptosis levels were 
affected. No significant differences of apoptosis signals were observed between the 
posterior and anterior portions of the wing (Supplement Figure 1), further indicating 
that the reduced size of the posterior wing was caused by a decrease in actual cell size 
and not cell number caused by apoptotic cell death. As wing blister phenotypes have 
been shown to be associated with the molecule integrin, we next examined whether 
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the integrin expression pattern in the wing disc of these animals was altered. 
Immunohistochemical staining with anti-PS1 and anti-PS2 antibodies revealed no 
significant changes in stain between the posterior and anterior portions of the wing 
disc (Supplement Figure 2). These defects in cell size and their planar organization in 
the wing resulting from Dmel\TIP60 loss suggests that Dmel\TIP60 is required 
specifically for cell growth and differentiation, and not cell proliferation, in this 
particular tissue type. 
 
Dmel\TIP60 is required for the development of central nervous system 
 
Our in-situ analysis of Dmel\TIP60 transcripts demonstrated that Dmel\TIP60 
seems to be expressed in the nervous system during embryogenesis (data not shown). 
Additionally, our Dmel\TIP60 was identified as an uncharacterized gene in a screen 
for neural precursor genes in Drosophila (Brody et al. 2002). These findings 
suggested that Dmel\TIP60 may be involved in neural development. To determine 
whether Dmel\Tip60 is required for the development of the nervous system, we 
crossed our Dmel\TIP60/RNAi and /Control flies to each of three different nervous 
system GAL4 driver lines, i.e. 60IIA, 109-30 and 109-69 at 25 ºC. GAL4 driver 60IIA 
drives GAL4 expression in the both central and peripheral nervous system (CNS and 
PNS; Figure 7A); while both 109-30 and 109-69 drive GAL4 expression in certain 
subset of PNS tissues. Compared to the Dmel\TIP60/Control lines, we observed 
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lethality in the progeny when expressing Dmel\TIP60/RNAi in both CNS and PNS 
via GAL4 driver 60IIA (Figure 7A), and no apparent phenotypes when expressing 
Dmel\TIP60/RNAi in the subsets of PNS respectively by either 109-30 or 109-69 
(Figure 7B and C). Again, Dmel\TIP60/RNAi A was characterized as the strongest 
RNAi line with a 100% lethality of progeny. The data led to the hypothesis that 
Dmel\TIP60 may be involved in the development of nervous system, and especially 
be essential for the development of the CNS. 
To test our hypothesis, we carried out the immunohistochemistry experiments 
as follows. First, we crossed our strongest RNAi line Dmel\TIP60/RNAi A and 
control Dmel\TIP60/Control line C to 60IIA. We next collected the progeny embryos 
and stained them with the antibodies 22C10, anti-REPO and anti-ELAV respectively. 
Antibody 22C10 is used to visualize the PNS by detecting a microtubule-associated 
protein. We also used the antibodies against the well characterized neuronal marker 
protein ELAV (embryonic lethal abnormal visual system), an RNA binding protein 
present in all differentiated neurons; and REPO (reserved polarity), a homeodomain 
protein expressed specifically in glial cells. We detected no significant defects in the 
embryos that expressed Dmel\TIP60/RNAi by 60IIA when compared to controls 
using each of the three antibodies 22C10, anti-REPO and anti-ELAV (Figure 8). As 
Dmel\TIP60 induced lethality is not observed until the pupal stage (Figure 7A), we 
thought that the phenotypic defects may have not accumulated significantly enough to 
be detected in the early embryonic stages. Thus, we decided to investigate the effect 
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of RNAi knockdown in later developmental stages, i.e. the 3rd instar larval stage. We 
dissected the brains out of the 3rd instar larvae derived from a cross between 
Dmel\TIP60/RNAi A to 60IIA with Dmel\TIP60/Control C as control. We then fixed 
and stained the dissected brains with the anti-ELAV antibody. The control brains 
showed a well defined pattern of differentiated neurons particularly within the 
ganglion (Figure 9A to C). The ventral portion of the control ganglia showed the 
symmetrical condensed dots on the two edges and the neuronal “web” to link the two 
lobe portions of the brain (Figure 9A). The dorsal region of the control ganglia 
showed a middle line and symmetrical stripes on the two edges (Figure 8B). A closer 
look of the dorsal region showed that the middle line and the stripes are composed of 
symmetrical dots, indicating differentiated neurons (Figure 8C). In contrast, our 
results revealed that the wild-type ELAV staining pattern was substantially disrupted 
in the brains of all Dmel\TIP60/RNAi larvae examined when compared to control 
larvae (Figure 9 D to F). Staining was substantially reduced in the posterior portion of 
the ventral brain lobes, particularly within the region connecting the brain lobes with 
the ventral ganglion, and virtually absent within the thoracic and abdominal regions 
of the ganglion (Figure 9D to F). These ELAV staining defects indicate the absence of 
differentiated neurons specifically in these regions of the CNS. We next stained 
Dmel\TIP60/RNAi and control brains using the anti-REPO antibody and observed no 
obvious differences (Supplement Figure 3), indicating that the defects were neuron 
specific. TUNEL staining using whole mount Dmel\TIP60/RNAi and control brains 
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revealed no obvious apoptotic abnormalities (Supplement Figure 4), indicating that 
neuronal loss was not due to an increase in cell death. We next wanted to determine 
whether loss of differentiated neurons was due to defects in cell division. Since cyclin 
E is shown to be essential for the asymmetrical division of neuroblast in Drosophila 
CNS (Berger et al. 2005), we decided to test whether cyclin E expression was affected 
by loss of Dmel\TIP60. After staining the brains with the anti-cyclin E antibody, we 
did not observe any obvious differences between the Dmel\TIP60 RNAi and control 
brains (Supplement Figure 5). Taken together, our data suggest that Dmel\TIP60 is 
required for promoting differentiation of the neurons during the CNS development. 
 
Dmel\TIP60 is required for muscle formation in the developing embryo 
 
As reported in our previous paper (Zhu et al. 2007), targeted expression of 
Dmel\TIP60/RNAi in the mesoderm of Drosophila using the GAL4 line 24B results 
in a lethal muscle mutant phenotypes at 25 ºC. To extend these studies, we utilized a 
second muscle specific C179 GAL4 driver that induces higher levels of GAL4 in the 
Drosophila mesoderm and muscle system. When I crossed Dmel\TIP60/RNAi and 
Dmel\TIP60/Control fly lines to C179 at 25 ºC, I observed 0% viability for all three 
Dmel\TIP60/RNAi lines (Figure 10A) and no apparent defects for the control. 
Interestingly, I observed that the progeny died shortly after the 1st larvae stage, the 
stage directly after embryogenesis (data not shown). These data suggested that C179 
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is a stronger muscle-specific GAL4 driver compared to 24B and would be a valuable 
tool to study muscle defects caused by Dmel\TIP60 at an early developmental stage 
in Drosophila. 
To determine whether the muscle development pathway is disrupted by 
Dmel\TIP60 knockdown, we crossed Dmel\TIP60/RNAi A or Dmel\TIP60/Control to 
GAL4 driver C179, collecting the resulting progeny embryos and stained them with 
the anti-filamin antibody. Filamin is an actin associated protein (Sokol and Cooley 
2003), and thus shows an immunohistochemical muscle staining pattern where in the 
control embryos, the muscle fibers were well defined and oriented (Figure 10B). In 
contrast, I observed that this muscle pattern was significantly altered in embryos 
expressing Dmel\TIP60/RNAi (Figure 9C). First, I observed defects in the shape of 
the embryos likely due to the disordered formation of muscle fibers. Second, I 
observed that the muscle fibers were very thin when compared to that of the controls 
and that their orientations were disrupted. Taken together, our data suggested that 
Dmel\TIP60 is an important regulator during muscle development and is required for 
appropriate muscle pattern formation during embryogenesis. 
 
 
 
 
Discussion 
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HATs carry out important functions during development by their regulation of 
chromatin packaging that in turn, controls gene expression profiles both spatially and 
temporarily (Margueron et al. 2005), however little is known about specific HAT 
function in the differentiation of distinct cell types. In this paper, we utilize our GAL4 
inducible Dmel\TIP60 knockdown/overexpression system to demonstrate that 
Dmel\TIP60 plays an essential role in the differentiation of a wide variety of cell and tissue 
types during Drosophila development. We show that loss of Dmel\TIP60 in the wing 
leads to a range of wing abnormalities, including the formation of wing blisters in the 
most severe cases. Wing surface area and cell count/hair density assays reveal that 
although the number of cells that compose the wing remain unaffected, their size is 
significantly smaller than normal and there are defects in wing cell planer polarity. 
Additionally, we find that loss of Dmel\TIP60 in the CNS leads to lethality and a 
substantial loss of differentiated neurons in the larval brain, while cyclin E levels and 
apoptosis remain unaffected. Finally, we show that loss of Dmel\TIP60 in the 
mesoderm leads to lethality, and malformation or absence of the muscle fibers in the 
developing embryo. An additional copy of Dmel\TIP60 in each of these tissues has no 
affect on their development. Taken together, our results support an essential role for 
Dmel\TIP60 in promoting the differentiation of a wide variety of specific cell and 
tissue types, thus shedding light on the importance of HATs in the development of 
amulticellular organisms. 
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First, our data suggest that endogenous Dmel\TIP60 levels are precisely 
regulated during development. In support of this concept, the Dmel\TIP60/RNAi A 
line exhibited more severe phenotypes earlier in development than those of the other 
two RNAi lines, likely due to the fact that it displays the highest RNAi expression 
level due to the position effects on transgene expression. Additionally, we do not 
observe any apparent phenotype of in flies carrying an additional copy of 
Dmel\TIP60 driven by either ubiquitous or tissue/cell specific GAL4 drivers (data not 
shown), even though overexpression was confirmed by our RT-PCR results. Based on 
these observations, we conclude that knockdown or an additional copy of 
Dmel\TIP60 does not show a distinctive phenotype until the perturbation of 
Dmel\TIP60 protein level reaches a certain threshold. Similar results have been 
shown for the mouse homolog of Tip60 in that a critical level of TIP60 is found to be 
required for its tumor suppressor activity in the mouse model system (Gorrini et al. 
2007). 
Our results are the first to demonstrate that Dmel\TIP60 is required for the 
appropriate development and formation of the wing in Drosophila. As TIP60 is 
involved in many different protein complexes and carries out a variety of different 
functions, the roles Dmel\TIP60 plays during wing development may be related to its 
association with other subunits within the Dmel\TIP60 multi-protein complex and/or 
other factors that interact with Dme\TIP60. One of the TIP60 associated molecules is 
most likely to be involved in wing development is TRRAP. As shown by others, 
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TRRAP has been found in many HAT complexes that have important cellular 
regulatory functions (Carrozza et al. 2003). These studies demonstrate that TRRAP in 
both yeast and mouse is essential for cell viability (Saleh et al. 1998; Herceg et al. 
2001). When associated with the NuA4 (TIP60) complex, TRRAP was found to be 
involved in the regulation of double-strand break (DSB) repair (Murr et al. 2006) and 
mitotic checkpoint (Li et al. 2004; Deran et al. 2007). It is important to note that 
Nipped-A (Drosophila TRRAP) was found to be involved in the wing development 
by screening the genes that regulate cut and Notch pathways (Rollins et al. 1999). In 
addition, Nipped-A and Domino (another subunit of TIP60 complex) were both found 
to be required for wing development by regulating the mastermind and Notch 
signaling pathway (Gause et al. 2006). Myelomonocytic leukemia (MYC) may be 
another molecule that is associated with the function of Dmel\Tip60 during wing 
development. MYC recruits TIP60, and other HATs including p300/CBP and 
mammalian mGCN5, to the promoters of specific target genes to activate their 
experssion (McMahon et al. 2000; Frank et al. 2001; Frank et al. 2003; Adhikary and 
Eilers 2005). It has been shown that such MYC recruited HATs (TIP60 included) 
regulate MYC target gene expression by their ability to acetylate both nucleosomal 
histones at the promoter regions as well as the specific lysine residues on MYC 
(Vervoorts et al. 2003; Patel et al. 2004; Faiola et al. 2005; Zhang et al. 2005). Of note, 
Dmel\MYC, the single MYC homolog in Drosophila, is a key molecule to regulate 
cell growth and organ size (Secombe et al. 2004). While the Dmel\MYC null 
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mutation is lethal, the viable hypomorphic mutants show smaller body size due to 
smaller cells and the ectopic expression of Dmel\MYC leads to larger cells (Johnston 
et al. 1999; Maines et al. 2004; Pierce et al. 2004). These findings are consistent with 
our results demonstrating that loss of function of Dmel\TIP60 results in the reduction 
of wing size due to defects in cell growth and not cell number. Although Dmel\MYC 
regulation of cell growth is also linked to apoptosis, we did not observe a significant 
increase in cell death in response to Dmel\TIP60 loss in the wing discs of the fly. 
However, we can not rule out the fact that we did not detect apoptosis perhaps due to 
not obtaining the appropriate expression threshold of Dmel\TIP60/RNAi loss as we 
discussed previously. Interestingly, we also observed that the planar cell polarity (PCP) 
of the cells that compose the fly wings was disordered due to Dmel\TIP60 loss. Since 
it is well characterized that PCP is maintained and regulated by Fz/PCP pathway 
(Seifert and Mlodzik 2007; Zallen 2007), this finding leads us to believe that 
Dmel\TIP60 may be involved in Frizzeld (Fz)/PCP signaling pathways. Further 
supporting a role for Dmel\TIP60 in the control of cell size are studies demonstrating 
that the PCP related gene Dmel\ft (fat) affects cell growth by modulating the 
Hippo/Warts pathway (Silva et al. 2006; Willecke et al. 2006). Collectively, we show 
that Dmel\TIP60 is required for regulating the size and shape of the cells composing 
the fly wing likely through its association with specific protein factors. Additionally, 
we observed that driving Dmel\TIP60/RNAi in the wing using GAL4 drivers 69B and 
32B results in wing defective phenotypes that range severity as well as lethality. The 
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lethality is likely due to the fact that GAL4 expression using these GAL4 drivers are 
not limited in the wing tissues but also occurs in other tissues in the embryo (our 
unpublished results) as lethality was not observed when the expression of 
Dmel\TIP60/RNAi was confined to the posterior of the wing using GAL4 driver 
en-GAL4. Such easily observable wing defective phenotypes will be offer a powerful 
tool for therapeutic screening of either enhancers or inhibitors of TIP60. 
Epigenetic gene regulation plays an essential and distinct role in neural stem 
cell fate specification, neural plasticity, learning and memory (Hsieh and Gage 2005; 
Kiefer 2007). For example, the HAT activity of CBP in mouse Rubinstein-Taybi 
syndrome (RTS) model was found to be essential for neuronal plasticity and learning 
(Alarcon et al. 2004; Korzus et al. 2004). TIP60 has been found to be involved in the 
neural degenerative disease Alzheimer’s disease (AD) through its association with the 
intracellular domain of amyloid precursor protein (AICD). Yeast two-hybrid assays 
and coimmunoprecipitation experiments demonstrate that a ternary complex of AICD, 
TIP60 and adaptor protein Fe65 stimulates transcription in a cell culture model (Cao 
and Sudhof 2001). This complex was found at the promoter region of the KAI1 gene, 
a putative target of APP-mediated transcription (Baek et al. 2002). Subsequently, it 
was shown that activation of transcription of the KAI1 gene requires both the 
AICD/Fe65/TIP60 complex and the nucleosome assembly protein SET (Telese et al. 
2005). In addition, the TIP60/AICD/FE65 ternary complex was found to localize in 
nucleus with different morphology depending on the APP adapter proteins (i.e., Fe65 
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and Jun-interacting protein Jip1γ) and upregulate several APP-effector genes (von 
Rotz et al. 2004). AICD has been suggested to cause neurotoxicity via misregulation 
of the downstream transcription events associated with histone acetylation. In support 
of this premise, introduction of the histone deacetylase (HDAC) inhibitor, sodium 
butyrate, in neuronal cells enhances the cytotoxicity induced by AICD (Kim et al. 
2004). Furthermore, TIP60 may also play a role in apoptotic cell death in AD 
(Kinoshita et al. 2002).  
We show here that Dmel\TIP60 is required for the development of central 
nervous system (CNS), establishing yet another example of epigenetic gene 
regulation during neural development. Consistent with our finding, Dmel\Tip60 was 
identified as a neural precursor gene in Drosophila (Brody et al. 2002), though its 
function remained uncharacterized at that time. Thus, our work is the first to identify 
TIP60 as an essential regulator for neural development. We find that Dmel\TIP60 
may be specifically required for CNS, as loss of function in subsets of PNS did not 
result in any significant defects in flies. However, we do not rule out the possibility 
that these PNS GAL4 drivers may not be strong enough to drive sufficient 
Dmel\TIP60 knockdown to achieve and observable defect in these cell types. We 
observed that the loss of differentiated neurons in the brains did not occur until the 
3rd instar larvae stage, as we did not detect any abnormalities in embryos. This 
observation is likely due to the fact that this nervous GAL4 line drives GAL4 
expression later during embryonic development. Interestingly, we did not find any 
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defects in our immunohistological examination of the glial cells in both embryos and 
third instar larval brains, suggesting that Dmel\TIP60 is a specific regulator for the 
differentiation of neuronal and not glial cells and that the loss of neurons is not due to 
the deprivation of nutrients. Additionally, we did not observe cell division defects and 
apoptotic abnormality as indicated by our anti-cyclin E and TUNEL assays 
respectively. This finding suggest that Dmel\TIP60 is specifically required promotion 
and/or maintenance of differentiated neurons which is independent of cell lethality via 
cell cycle defects and apoptosis. TIP60 has been shown to play an essential role in a 
variety of cell processes and gene conrol via its interaction with a variety of different 
cell-specific transcription factors (Sapountzi et al. 2006; Squatrito et al. 2006). Thus, 
our finding that Dmel\TIP60 is specifically required for promoting the differentiation 
of neuronal cells extends the well established role of TIP60 in cell progression and 
apoptosis by adding yet another layer of complexity to the important role that TIP60 
plays during the development of multicellular organisms. 
Our previous report suggests that Dmel\TIP60 is essential for the appropriate 
development of muscle tissue (Zhu et al. 2007). To extend these studies, we show 
here that knockdown of endogenous Dmel\TIP60 results in defects in embryo shape 
as well as defects in the muscle fibers themselves, as visualized by the 
actin-associated filamin antibody. Our finding is consistent with the important roles 
that different HATs and HDACs play in regulating the complicated events that 
promote muscle differentiation (McKinsey et al. 2001; McKinsey et al. 2002; 
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Palacios and Puri 2006; Kiefer 2007). In proliferating myoblasts, the premature 
muscle-gene expression is inhibited by several histone modifiers, such as histone 
deacetylases (HDACs), YY1 and Polycomb proteins. Class I HDACs is found to be 
associated with MyoD in undifferentiated myoblasts (Mal et al. 2001); (Puri et al. 
2001), while Class II HDACs specifically bind and repress MEF2 protein (Lu et al. 
2000b; Lu et al. 2000c; McKinsey et al. 2000a; McKinsey et al. 2000b; McKinsey et 
al. 2002; Zhang et al. 2002). Upon induction of differentiation, the HDACs and their 
associated co-repressors dissociate from the MRFs and MEF2 factors, allowing for 
the recruitment of chromatin modifying complexes to the chromatin surrounding the 
regulatory elements of muscle specific genes. These complexes include HATs 
CBP/p300, PCAF, p/CIP, SRC1 and glucocorticoid receptor interacting protein 
(GRIP), the co-activator-associated arginine methyltransferase 1 (CARM-1) and the 
ATP-dependent switching/sucrose non-fermenting (SWI/SNF) chromatin remodelling 
complexes (Eckner et al. 1996; Yuan et al. 1996; Puri et al. 1997a; Puri et al. 1997b; 
Sartorelli et al. 1997; Chen et al. 2000; de la Serna et al. 2001; Chen et al. 2002; Wu 
et al. 2005). Acetylation of the histone tails by p300 and PCAF results in a relaxed 
chromatin structure permissive for transcription, while acetylation of MyoD by the 
same acetyltransferases increases the affinity for its recognition site in the DNA (Puri 
et al. 1997b; Sartorelli et al. 1999; Polesskaya et al. 2000; Polesskaya and 
Harel-Bellan 2001; Polesskaya et al. 2001a; Polesskaya et al. 2001b; Dilworth et al. 
2004). Similarly, p300-mediated acetylation of multiple lysines is essential for MEF2 
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function (Ma et al. 2005). It is worthwhile to note that TIP60 can interact with both 
class I (HDAC 1) and class II (HDAC 7) HDACs in different pathways associated 
with androgen receptor (AR), endothelin receptor A (ETA), signal transducer and 
activator of transcription 3 (STAT3) respectively (Lee et al. 2001; Gaughan et al. 
2002; Xiao et al. 2003). Taken together, our data have linked Dmel\TIP60 to the 
muscle development in Drosophila. Future studies can now entail further dissection 
of the particular pathways which Dmel\TIP60 is involved in and the detailed 
regulatory mechanisms on how Dmel\TIP60 contributes to each pathways. 
In summary, the results presented here support an essential role for 
Dmel\TIP60 in the differentiation of different cell and tissue types during Drosophila 
development. We show that the roles Dmel\TIP60 plays in the development of 
different tissues are diverse. These important findings will allow us and the other 
researchers to further investigate such TIP60 cell type specific roles in particular 
pathways in more detail. Furthermore, our Dmel\TIP60/RNAi, overexpression and 
rescue system will offer a powerful and unique tool to study epigenetic modes of gene 
regulation during development as well as serve as a multicellular drug screening tool 
to identify therapeutics for TIP60 associated disorders. 
 
 120
Chapter 4: Conclusion and Future Direction 
 
The work eminating from my Ph.D. project has made a significant 
contribution to deciphering the roles of epigenetic regulation during multicellular 
multicellular development. I am the first to have cloned and characterized the TIP60 
human homolog in Drosophila. Using this information, I have created a GAL4-UAS 
inducible Dmel\TIP60 transgenic fly system. This system is the first to allow for the 
induction of overexpression and knockdown of Dmel/TIP60 in a variety of specific 
tissues, cell types and developmental stages of choice, thus enabling me to explore 
the role of TIP60 in multicellular development (Zhu et al. 2007). Using this system, I 
am the first to demonstrate that Dmel\TIP60 is required for the differentiation of a 
variety of tissues that include wing, CNS and muscle during Drosophila development 
(unpublished data, Chapter 3). Thus, my studies on Dmel\TIP60 have shed new light 
on the important epigenetic regulatory roles that TIP60 plays in the development of a 
multicellular organism. 
As the last is not the least, the first does not always mean the best. Although 
my Ph.D. work has opened a door to the new world of epigenetic study, further work 
is still needed to enhance our understanding of epigenetic regulation during 
development. Thus, I feel that future directions should entail research that reveals the 
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molecular mechanisms underlying the genetic phenotypes that I observed during my 
Ph.D. research. I feel that the most important and urgent questions to be answered in 
the future is identifying the specific target genes that are regulated by Dmel\TIP60 
and how the proteins they encode interact with each other. Since our lab has been 
focusing on the study of relationships between epigenetic regulation and development, 
I would focus this question to understanding the mechanism(s) by which the HAT 
activity of Dmel\TIP60 regulates such genes during development. By using the 
GAL4-UAS inducible Dmel\TIP60 system that I have created, my strategies to 
address the above questions would be to utilize DNA microarrays and chromatin 
immunoprecipitation (Chip) assays for the genome-wide screening of Dmel\TIP60 
regulated genes, and then choose several specific targets for further study. I will now 
outline my strategy to carry out these experiments. 
First, I will use DNA microarrays to explore how many and which genes are 
directly and/or indirectly affected at mRNA level by Dmel\TIP60 knockdown 
Although an additional copy of Dmel\TIP60 did not induce any phenotypes it will 
serve as a control for the knockdown system. I will extract mRNA from third instar 
larvae that are ubiquitously expressing Dmel\TIP60/control and Dmel\TIP60/RNAi 
transgenes using the ubiquitous GAL4 driver 337. I have chosen the 3rd instar larval 
stage because our previous experiments showed that my transgenes are expressed at 
the highest expression level in this stage and hence the genes controlled by 
Dmel\TIP60 should be affected the most at this stage. Then the mRNA will be labeled 
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with fluorescent dyes and hybridized on DNA microarrays composed of Drosophila 
genes. The fluorescent signals on the DNA arrays will be detected by a confocal 
scanner. Finally, image and statistical analysis will determine the differences of gene 
expression profiles between the control and RNAi knockdown. I expect that several 
clusters of genes will be downregulated or upregulated by Dmel\TIP60/RNAi. Based 
on my results that Dmel\TIP60 is required for wing, muscle and CNS development, I 
would expect that the TIP60 genes that I will identify will be involved in 
developmental pathways critical for the development of these tissues. I would also 
like to identify specific TIP60 target genes that are exclusively regulated by the HAT 
activity of Dmel\TIP60. One of the easiest ways to achieve this goal is to use a 
dominant negative (DN) version of Dmel\TIP60 defective only in its HAT activity. 
Meredith Toth, a member of our laboratory, has recently generated such a TIP60 DN 
protein and her unpublished data demonstrates that expressing TIP60/DN protein 
using the ubiquitous Act5-GAL4 driver leads to total lethity of the progeny during 
early stages of their development. Since the DN mutants carry a specific amino acid 
substituition in the catalytic region of the MYST HAT domain, her results suggest 
that the HAT activity of TIP60 is required for multicellular development. Thus, the 
same DNA microarray procedures as described above would be carried out using 
mRNA extracted from larvae expressing TIP60/DN proteins. Such experiments would 
enable me to identify Tip60 target genes exclusively affected by the HAT activity of 
Dmel\TIP60. 
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Several chromatin immunoprecipitation (ChIP) assays will next be applied to 
further narrow down the genes that are regulated by Dmel\TIP60. Instead of using the 
conventional Chip assays, I propose to use the state-of-art Chip-Seq (Sequence) assay, 
which combines high-throughput DNA sequencing and Chip. The advantage of 
Chip-Seq is that the data are read in absolute counts so that no normalization is 
necessary (Bock and Lengauer 2007; Euskirchen et al. 2007). Chip-Seq is also 
cost-efficient because of the new sequencing-by synthesis methods (e.g. Roche/454 
(Margulies et al. 2005) and Illumina/Solexa (Barski et al. 2007)). The general 
procedure is as follows. Cell samples are treated with formaldehyde to cross-link 
DNA-bound proteins to DNA. The chromatin extract is then prepared and sheared 
into fragments (approximately 500 bp in length). The targeted fragments are enriched 
by incubating them with an antibody of choice. The DNA released from the 
immunoprecipitated protein-DNA complex is then purified and ready for sequencing 
and analysis. 
As previously demonstrated, TIP60 can acetylate H2A, H3 and H4 
(Yamamoto and Horikoshi 1997; Kimura and Horikoshi 1998; Ikura et al. 2000). To 
investigate the specificity of histone acetylation profiles created by TIP60 during 
development, I propose to use the antibodies that specifically recognize histone 
acetylation on H2A, H3 and H4 respectively for Chip-Seq. The chromatin will be 
extracted from the 3rd instar larvae of DmelTIP60/control and RNAi respectively. 
Compared to those of the controls, the data of RNAi samples will reveal most of gene 
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regions where the histone acetylation is reduced due to Dmel\TIP60 knockdown. As 
histone acetylation is generally related to the transcriptional activation, the genes 
identified by the Chip-Seq described above should overlap with the genes found in 
DNA microarrays using dominant negative mutants. However, the data generated by 
the Chip-Seq assay described above will be more specific because of the usage of 
antibodies against specific histone acetylation sites. It is worthwhile to note that a 
rough acetylation map could be relatively easy to obtain by immunochemical staining 
of the polytene chromatin in the 3rd instar larvae of DmelTIP60/control and RNAi 
respectively. This would be a backup or pilot experiment because the resolution 
obtained by such experiments would not be as high as through Chip-Seq. 
Another Chip-Seq assay I would propose to carry out is one that would 
investigate how Dmel\TIP60 directly binds the regulatory regions of certain genes 
and controls their expressions during the development of specific tissue or cell types. 
For such experiments, I would use wild type flies (e.g. Canton S) and an antibody that 
directly recognizes Dmel\TIP60 (Kusch et al. 2004). My unpublished data revealed 
that Dmel\TIP60 is required for the development of wing, CNS and muscle. To 
identify the TIP60 regulated target genes that are required for these specific tissues, I 
will utilize new techniques that enable the isolation of chromatin from specific cell 
types. These techniches originated from the laboratory of Dr. Michelson at NIH 
(Estrada et al. 2006).  To isolate chromatin from muscles cells, I will utilize the 
twi-Gal4 to drive UAS-GFP specifically in the mesoderm. These embryos will be 
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gently disassociated to form a single cell suspension. The GFP expressing mesoderm 
cells will be separated and isolated by fluorescence activated cell sorting (FACS). I 
will then isolate chromatin from these mesoderm specific cells and utilize the 
Chip-Seq assay as described above. I anticipate that by using these methods, I will 
identify muscle specific target genes that are directly controlled by Dmel\TIP60 in 
muscle developmental pathway. 
After the genome-wide screening, I would next carry out several conventional 
experiments to validate the data and further explore the function of such Dmel\TIP60 
target genes. For example, real-time RT PCR, Western blots will be used to examine 
the expression levels of the genes. Immunochemistry assays in Drosophila embryos 
using Abs specific for the proteins that the Dmel\TIP60 target genes encode will 
provide the information on the localization of such proteins in the embryo. Finally, I 
expect to identify genes with both known and unknown functions. For the genes 
whose functions have been previously identifies, I would suggest to explore their 
positions in particular developmental pathways. I would then dissect the pathways 
genetically and biochemically to determine the detailed interactions between 
Dmel\TIP60 and the target genes they regulate. I believe that the most exciting 
findings would be discovering novel genes regulated by Dmel\TIP60, thus leading to 
new exciting future studies on their function. Thus, the perfect end of science is no 
end. 
I believe that the significance of my studies on Dmel\TIP60 will not be 
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limited to expanding our knowledge on epigenetic regulation during development. I 
can foresee that the information obtained from my work could ultimately benefit the 
entire scientific society. For example, genetic variation in environmental studies is 
greatly influenced by epigenetic regulation (Fraga et al. 2005; Heijmans et al. 2007). 
Additionally, epigentics is believed to regulate the orthologous regions of different 
mammals that arise during evolution (Enard et al. 2004; Bernstein et al. 2005). Thus, 
there are many potential collaborations we can create to aid in understanding the role 
of epigenetic regulation in a variety of broad fields that include nutrition, ecology and 
evolution. Finally, epigenetic disorders have been associated with causing many 
different cancers, mental disorders, autoimmune diseases and other complex diseases 
(Bjornsson et al. 2004; Feinberg 2007). Thus, our studies on Dmel\TIP60 should 
ultimately lead to finding the innovative therapeutics for human diseases caused by 
misregulation of TIP60. 
In summary, although I have completed my Ph.D. research project, I believe 
the important data generated by it and the ideas inspired by it will never be covered 
by the dust in history. My hope is that my doctoral research has enhanced the 
understanding of epigenetic regulation during development which in turn, will lead to 
the future discover of innovative and novel therapeutics for TIP60 associated human 
diseases as well as a better understanding of human beings themselves. 
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Table 1. Summary of known and putative HATs 
HAT Organisms 
known to 
have the HAT 
Known 
transcription-related 
functions/effects 
HAT activity 
demonstrated in 
vitro 
Histone Specificty 
of recombinant 
enzyme in vitro 
GNAT super 
family 
    
  Hat1 Various 
(yeast to 
mammals) 
None (histone 
deposition-related 
B-type HAT) 
Yes H4 
  Gcn5 Various 
(yeast to 
mammals) 
Coactivator (adaptor) Yes H3/H4 
  P/CAF Yeast to 
mammals 
Coactivator Yes H3/H4 
  Elp3 Yeast to 
mammalss 
Transcription 
elongation 
Yes ND 
  Hpa2 Yeast unknown Yes H3/H4 
MYST family     
  Sas2 Yeast Silencing ND  
  Sas3 Yeast Silencing Yes H3/H4/H2A 
Esa1/TIP60 Various 
(yeast to 
mammals) 
Cell cycle progression Yes H4/H3/H2A 
  MOF Drosophila Dosage compensation Yes H4/H3/H2A 
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Table 1 (Continued) 
  MOZ Mammals Leukemogenesis, upon 
chromosomal 
translocation 
ND  
  MORF Mammals Unknown (strong 
homology to MOZ) 
Yes H4/H3/H2A 
  HBO1 Humans, 
Drosophila 
(Chameau) 
ORC interaction Yes ND 
P300/CBP Various 
multicellular 
Global coactivator Yes H2A/H2B/H3/H4 
Nuclear receptor 
coactivators 
   
  SRC-1 Mammals Yes H3/H4 
  ACTR Mammals Yes H3/H4 
  TIF2 Mammals 
Nuclear receptor 
coactivators 
(transcriptional 
response to hormone 
signals) ND  
TAFII250 Various 
(yeast to 
Mammals) 
 Yes H3/H4 
TFIIIC     
  TFIIIC220 Mammals  Yes ND 
  TFIIIC110 Mammals  Yes ND 
  TFIIIC90 Mammals  Yes H3 
CIITA Mammals  Yes H4 
ATF2 Mammals  Yes H4/H2B 
CDY     
  CDY Humans  Yes H4 
  CDYL Mammals Histone-to-protamine 
transition during 
spermatogenesis 
Yes H4 
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Table 2. TIP60 complexes that show homology between yeast, human and Drosophila 
Adapted from (Doyon et al. 2004) (Kusch et al. 2004) 
Yeast NuA4 Subunit Human Drosophila 
Act1 Actin Act87E 
Arp4 BAF53a (BRG1-associated protein) BAP55 
Eaf1/Swr1 hDomino? (p400) Domino 
Eaf2 DMAP1 (DNMT1-associated protein) dDMA 
Eaf3 Mortality factor related genes (MORF4, MRG15/X) dMrg15 
Eaf5 ?  
Eaf6 hEaf6 (FLJ11730) dEaf6 
Esa1 TIP60/TIP60b Dmel\TIP60 
Epl1 Enhancer of Polycomb (EPC1, EPC-like) E(Pc) 
Tra1 TRRAP dTra1 
Yaf9 YEATS family (AF9, ENL, GAS41) dGas41 
Yng2 Inhibitor of growth gene family (ING 1 to 5) dIng3 
Rvb1 Pontin dPontin 
Rvb2 Peptin dPeptin 
Eaf7 MrgBP dMrgBP 
Bdf1 Brd8/TRCp12 dBrd8 
Vps72 YL-1 dYL-1 
H2A/H2A.Z H2A.X/H2A.Z H2A.V 
H2B H2B H2B 
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Chromo MYST
 
 
Figure 1. Schematic diagram of the conserved domains and their locations in TIP60. 
TIP60 is a ~60 KDa protein, containing (from left to right) an N-terminal 
chromodomain and a C-terminal MYST functional domain. 
 
 
 
 
 
 
Figure 2. Sequential mechanism of ESA1 enzyme kinetics. Glu338 in ESA1 
deprotonates the N-ε-lysine in the histone tails when the ternary complex of 
acetyl-CoA, histone substrate and ESA1 is formed. Then lysine attacks the carbonyl 
carbon on acetyl-CoA to form a tetrahedral intermediate. CoA-SH and acetylated 
histone tail are released. 
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Table 1. Ubiquitous expression of Dmel\TIP60/RNAi in three independent fly lines 
results in total lethality of developing flies. 
Fly linesa GAL4+(y; Cy+)b GAL4-(y+; Cy)b 
Dmel\TIP60/RNAi/A 0±0 49±11 
Dmel\TIP60/RNAi/B 0±0 53±12 
Dmel\TIP60/RNAi/C 0±0 57±14 
Dmel\TIP60/control/A 67±16 63±7 
Dmel\TIP60/control/B 57±0 59±8 
Dmel\TIP60/control/C 69±3 67±12 
 
 
 
a Three flies homozygous for either Dmel\TIP60/RNAi or Dmel\TIP60/control 
P-element insertions were mated to three flies homozygous for the actin GAL4 driver 
line Act5c-GAL4: (Dmel\TIP60/RNAi or control x P{Act5c-GAL4}/CyO,y+). For 
Dmel\TIP60/RNAi lines, the P element insertion is located on the X chromosome for 
line A and on the second chromosome for lines B and C. For Dmel\TIP60/control 
lines, the P-element insertion is located on the second chromosome for line A and on 
the X chromosome for lines B and C. b Adult progeny were counted over a ten day 
period and scored for either GAL4+(y;Cy+) or GAL4-(y+;Cy) phenotypes. All three 
Dmel\TIP60/RNAi lines strongly reduced viability to 0% that of the 
Dmel\TIP60/control lines. Lethality for the majority of flies occurred during pupal 
development. The results are reported as Mean ± SD (n=3). 
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Table 2. Mesoderm/muscle specific expression of Dmel\TIP60/RNAi in three 
independent fly lines results in a range of lethal effects during fly development. 
Fly linesa Adultb Dead Pupaeb 
Dmel\TIP60/RNAi/A 0±0 113±26 
Dmel\TIP60/RNAi/B 63±15 74±13 
Dmel\TIP60/RNAi/C 46±5 101±10 
Dmel\TIP60/control/A 120±19 1±1 
Dmel\TIP60/control/B 179±40 1±1 
Dmel\TIP60/control/C 173±14 2±1 
 
 
 
a Three flies homozygous for either Dmel\TIP60/RNAi or Dmel\TIP60/control 
P-element insertions (for P-element chromosomal locations, see Table 1) were mated 
to three flies homozygous for the mesoderm/muscle GAL4 driver line 24B. b Progeny 
were counted over a ten day period and scored for either viable adults or dead pupae. 
To calculate the effect of RNAi on viability, viable progeny for each of the 
Dmel\TIP60/RNAi independent lines was divided by the total combined number of 
viable progeny for the three Dmel\TIP60/control lines. Independent insertions 
Dmel\TIP60/RNAi A, B and C reduced viability to 0, 40 and 29%, respectively that 
of the Dmel\TIP60/control lines. Lethality for the flies occurred during a broad range 
of developmental stages, beginning from early pupae to directly before fly eclosion. 
The results are reported as Mean ± SD (n=3). 
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Figures 
 
 
 
 
 
 
 
Figure 1. MYST family member Dmel\Tip60 and GNAT family member Dmel\Elp3 
proteins are highly conserved with their human homolog counterparts. (A) Shown is 
a schematic representation (drawn to scale) of the conserved domains and their 
location within the Dmel\Tip60 and hTip60 proteins. Both proteins contain (from left 
to right): an N-terminal chromodomain and a C-terminal MYST functional domain. 
For Dmel\Tip60, the chromodomain is 70% identical/87% similar and the MYST 
domain is 80% identical/89% similar to hTip60. (B) Schematic representation (drawn 
to scale) of the conserved domains and their location within Dmel\Elp3 and hElp3 
proteins. Both proteins contain an N-terminal putative histone demethylation domain 
and a C terminal HAT domain. For Dmel\Elp3, the putative histone demethylation 
domain is 88%identical/94%similar and the HAT domain is 85% identical/93% 
similar to hElp3. (Structural domains were obtained by CDART, NCBI). 
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Figure 2. Dmel\Tip60 and Dmel\Elp3 are evolutionarily conserved among different 
species. Shown is the predicted amino acid sequences for the proteins encoded by (A) 
Dmel\Tip60 and (B) Dmel\Elp3 and their alignment with sequences encoded by 
ORFs from H.s., Homo sapiens; M.m., Mus musculus; D.r., Danio rerio; C.e., 
Caenorhabditis elegans; A.t., Arabidopsis thaliana; S.c., Saccharomyces cerevisiae. 
Interspecies homology ranges from 29%-56% (D.r. to M.m.) identity/41%-68% (D.r. 
to M.m.) similarity for Dmel\Tip60 and 70%-82% identity (A.t. to H.s.)/82%-92% 
(A.t. to H.s.) similarity for Dmel\Elp3 over their entire coding region. Black boxes 
and grey boxes represent identical and similar amino acids, respectively. Alignment 
was carried out by Genedoc. 
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Figure 3. Dmel\TIP60 and Dmel\ELP3 are each differentially expressed during 
Drosophila development. Real time PCR analysis of Dmel\TIP60 and Dmel\ELP3 
transcript levels using stage specific Drosophila melanogaster cDNAs (12-24 h 
staged embryos, first, second and third instar larvae, pupae, adult flies) prepared by 
RT priming of DNase treated RNA with random hexamers and PCR primer sets 
amplifying 200bp regions specific for each dHAT. Histogram depicts RNA copy 
number (Mean + SD) in logarithmic scale of at least three independent experiments 
for both Dmel\TIP60 and Dmel\ELP3 in each stage of development. SYBR-Green kit 
and OpticonTM2 system (MJ Research) were used for real-time detection and data 
analysis. All data shown is corrected for –RT background. 
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Figure 4. Structure of the pUAST Dmel\TIP60/RNAi and control constructs. (A) 
Schematic representation of the Dmel\TIP60 ORF. Black arrow represents the 
location of the 613 bp RNAi non-conserved target sequence chosen for use in 
creating the following constructs. (B) Schematic diagram of the Dmel\TIP60/RNAi 
construct. The 613 bp RNAi target cDNA sequence was amplified by PCR using the 
cDNA Dmel\TIP60 clone reported here as template, and cloned into a sense-antisense 
inverted gene arrangement into the inducible expression vector (pUAST) under the 
control of GAL4-UAS binding sites. A PCR generated polylinker and the common 
restriction site that joins the inverted cDNA fragments separates the cloned repeats 
and serves as the “hinge” region of the hairpin. (C) Schematic diagram of the 
Dmel\TIP60/control construct. The same RNAi cDNA target sequence was cloned 
into a sense- sense orientation and separated by the same short polylinker as 
described above. 
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Figure 5. The transient transfection of D. Mel-2 cells with the Dmel\TIP60/RNAi 
construct results in deleterious effects on cell growth and reduction of endogenous 
Dmel\TIP60 transcript levels.  Shown in panels A-D are D. Mel-2 cells visualized at 
200X magnification using phase/contrast optics. (A) Cells transiently transfected with 
pAc5.1/V-5-His/LacZ (unstained). (B) Same cells as in A stained with X-Gal 
showing transfection efficiency at 77%. (C) Cells transiently transfected with 
Dmel\TIP60/control construct, shown 24 hours post-transfection. (D) Cells 
transiently transfected with Dmel\TIP60/RNAi construct, shown 24 hours 
post-transfection. Arrows point to morphologically defective cells. (E) 
Semi-quantitative RT-PCR analysis of Dmel\TIP60 and RP49 transcript levels. RNA 
was isolated from cells (shown above) 24 hours post-transfection. Equal amounts of 
RNA for each sample was subjected to cDNA preparation using RT priming with 
random hexamers and PCR using primer sets specific for Dmel\TIP60 that did not 
amplify RNAi target sequences and primer sets specific for RP49 internal control. All 
experiments shown were repeated at least 3 independent times with consistent results. 
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Figure 6. Expression of Dmel\TIP60/RNAi in three independent fly lines reduces 
endogenous Dmel\TIP60 levels. (A) Progeny resulting from a cross between 
homozygous Dmel\TIP60/RNAi (independent lines Dmel\TIP60/RNAi/A,B and C) or 
Dmel\TIP60/control (independent lines Dmel\TIP60/control/A,B and C) and 
ubiquitous GAL4 line 337 were allowed to develop to the third instar larval stage. 
RNA was isolated from three third instar larvae progeny and subjected to 
semi-quantitative RT-PCR analysis. cDNAs were obtained from equal amounts of 
RNA for each sample using RT priming with random hexamers. PCR primer sets 
were specific for either Dmel\TIP60 that did not amplify Dmel\TIP60 RNAi target 
sequences or RP49. All RT-PCR experiments included negative (-RT) controls for 
both Dmel\TIP60 and RP49 which showed no background in all samples tested (data 
not shown). All experiments were repeated at least twice with consistent results. This 
figure shows RT-PCR analysis of one representative experiment. 
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Chapter 3 
 
Tables 
 
 
 
 
Table 1. Ubiquitous expressiona of Dmel\TIP60/OverEx in three independent fly lines 
results in the rescue of lethal effects caused by Dmel\TIP60/RNAi during fly 
development. 
 Femaleb Maleb 
Fly lines Tm3 Tm6 Tm3 Tm6 
Rescue /A 20±5c 0±0 26±5c 32±9 
Rescue /B 9±5d 0±0 29±8d 31±9 
Rescue /C 16±11e 0±0 29±12e 29±13 
 
 
 
a. The expression was induced by 337 ubiquitous GAL4 drvier. 
b. Progeny were counted over a ten day period and scored for viable adults (n=3). 
The genotypes of female Tm3 and Tm6 are 337-GAL4>Tip60/RNAi/+; Tm3, 
Tip60/OverEX/+ and 337-GAL4> Tip60/RNAi/X; Tm6/+ respectively. The genotypes 
of male Tm3 and Tm6 are 337-GAL4> Tm3, Tip60/OverEX/+ and 337-GAL4>Tm6/+ 
respectively. 
c. The full rescure was observed statistically as there is no signicant difference of 
the viability (p > 0.05). 
d. The rescue was partial showing a statistical difference of the viability (p < 0.05). 
e. The full rescure was observed statistically as there is no signicant difference of 
the viability (p > 0.05). 
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Figure 1. Determination of the specificity of Dmel\TIP60/RNAi knockdown system 
by rescue experiment. (A) Schematic diagram of the Dmel\TIP60/OverEx construct. 
This overexpression construct was created by subcloning Dmel\TIP60 ORF into 
pUAST vector between EcoRI and KpnI sites. Kozak consensus sequence was added 
at the 5’ end and two stop codons were added at the 3’ end by PCR using specific 
primers. (B) Expression of Dmel\TIP60/OverEx in three independent fly lines 
increases endogenous Dmel\TIP60 expression levels. Progeny resulting from a cross 
between homozygous Dmel\TIP60/OverEx (independent lines 
Dmel\TIP60/OverEx/A, B and C) or Dmel\TIP60/control (independent lines 
Dmel\TIP60/control/A, B and C) and ubiquitous GAL4 line 337 were allowed to 
develop to the third instar larval stage. RNA was isolated from three third instar 
larvae and subjected to semi-quantitative RT-PCR analysis. PCR primer sets were 
specific for either Dmel\TIP60 that did not amplify Dmel\TIP60 RNAi target 
sequences or RP49. All RT-PCR experiments included negative (-RT) controls for 
both Dmel\TIP60 and RP49 which showed no background in all samples tested (data 
not shown). This figure shows RT-PCR analysis of one representative experiment 
from at least twice repeats of the consistent results. (C) Scheme to make 
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Dmel\TIP60/Resue lines. The ebony homozygous Dmel\TIP60/RNAi fly line 
(Tip60/RNAi / Tip60/RNAi; Tm3/Tm6) was generated by crossing Dmel\TIP60/RNAi 
A to the fly line Tm3/Tm6. Meanwhile, Dmel\TIP60/RNAi A was crossed to three 
independent fly lines with Dmel\TIP60/OverEx on Tm3 so that to obtain three 
independent fly lines (males with Tip60/RNAi / +; Tm3, Tip60/OverEX / +) which is 
screened by the stubble phenotype (Tm3). The fly line Tip60/RNAi / Tip60/RNAi; 
Tm3/Tm6 females was crossed to three independent Tip60/RNAi / +; Tm3, 
Tip60/OverEX / + males to create three independent rescue fly lines with 
Dmel\TIP60/RNAi construct on X chromosome and Dmel\TIP60/OverEx construct 
on the 3rd chromosome (Tm3) which is screened by the dosage-dependent eye color 
due to w+ gene. 
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Figure 2. The survivors (23±9%) from the rescue experiment carry the blister 
phenotype. (A) and (B) are the wings of the Tm3 female progeny from the cross of 
337 to the rescue C line. Thus their genotypes are both 337-GAL4>Tip60/RNAi / +; 
Tm3, Tip60/OverEX /+. (A) appears to be normal, while (B) carries the blister as the 
arrow points out. 
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Figure 3. Induction of Dmel\TIP60/RNAi expression by GAL4 driver 69B at 25 ºC 
results in lethality and a variety of wing phenotypes. (A) Three flies homozygous for 
either Dmel\TIP60/RNAi or Dmel\TIP60/control P-element insertions (for P-element 
chromosomal locations, see (Zhu et al. 2007)) were mated to three of GAL4 driver 
line 69B. Progeny were counted over a ten day period and scored for either viable 
adults or dead pupae. To calculate the effect of RNAi on viability, viable progeny for 
each of the Dmel\TIP60/RNAi independent lines was divided by the total combined 
number of viable progeny for the three Dmel\TIP60/control lines. Independent 
insertions Dmel\TIP60/RNAi A, B and C reduced viability to 0, 48 and 61%, 
respectively that of the Dmel\TIP60/control lines. (B) shows the wing phenotypes in a 
descendent order of the severity of the phenotype. From the left, the first two flies are 
females 69B>Dmel\TIP60/RNAi A; the third is female 69B>Dmel\TIP60/RNAi B; The 
fourth is female from 69B>Dmel\TIP60/RNAi C. 
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Figure 4. Induction of Dmel\TIP60/RNAi expression by GAL4 driver 32B at 25 ºC 
results in lethality and a variety of wing phenotypes. (A) Three flies homozygous for 
either Dmel\TIP60/RNAi or Dmel\TIP60/control P-element insertions were mated to 
three of GAL4 driver line 32B. Progeny were counted over a ten day period and 
scored for either viable adults or dead pupae. The viability was calculated as 
described in Figure 2. Independent insertions Dmel\TIP60/RNAi A, B and C reduced 
viability to 0, 76 and 61%, respectively that of the Dmel\TIP60/control lines. (B) 
shows the wing phenotypes in a descendent order of the severity of the phenotype. 
From the left, the first fly is male and the second is female, both from 
32B>Dmel\TIP60/RNAi A; the third is female 32B>Dmel\TIP60/RNAi B; the fourth is 
male 32B>Dmel\TIP60/RNAi C. 
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Figure 5. Wing phenotypes in the posterior compartment of the wing result from 
induction of Dmel\TIP60/RNAi in the posterior of the wing by GAL4 driver en-GAL4. 
The wings are from the progeny of crosses at 25 ºC of UAS P-element lines 
Dmel\TIP60/RNAi A or Dmel\TIP60/control C to GAL4 driver en-GAL4. Compared 
to Control (A), the blister phenotype (B, as the arrow points out) was only observed 
in the posterior of the wing in 49±20% of the en-GAL4>Dmel\TIP60/RNAi A. The 
planar cell polarity (PCP) was not affected in the anterior of the wing in both control 
and RNAi (C and D). But PCP was changed in the posterior of the wing in RNAi (F) 
compared to that of the control. 
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Figure 6. Induction of Dmel\TIP60/RNAi in the posterior of the wing by GAL4 driver 
en-GAL4 reduces the wing area due to the decrease of the cell size. (A) The wing area 
in the posterior of both male and female wings was significantly reduced when 
Dmel\TIP60/RNAi A was induced in the posterior compartment of the wing by using 
en-GAL4 compared to the control Dmel\TIP60/Control C. The pixels of anterior and 
posterior in each of 10 wings per genotype were measured by ImageJ 1.38X. The 
relative wing size was calculated by dividing the number of pixels corresponding to 
posterior of a wing by that of anterior. (B) The cell number in the posterior of both 
male and female wings remained unchanged when Dmel\TIP60/RNAi A was induced 
in the posterior compartment of the wing by using en-GAL4 compared to the control 
Dmel\TIP60/Control C., suggesting that the reduction on wing area in RNAi is 
resulted from the reduction of cell size. The hair number of a 200 X 200 dpi squire 
(measured by Pixel Ruler) was counted in both anterior and posterior, since one cell 
of the wing has one hair (Meyer et al. 2000). Using 10 wings from each control and 
RNAi, the relative hair number was calculated by dividing the number of hairs 
corresponding to posterior of a wing by that of anterior. 
 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
Control RNAi Control RNAi 
Males Females 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
Control RNAi Control RNAi
Males Females
R
el
at
iv
e 
C
el
l N
um
be
r 
(P
os
te
ri
or
/A
nt
er
io
r)
n = 10
R
el
at
iv
e 
W
in
g 
A
re
a 
(P
os
te
ri
or
/A
nt
er
io
r)
*
*
*   p<0.0001
n = 10
A B
 147
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Expression of Dmel\TIP60/RNAi in central nervous system (CNS) at 25 ºC 
results in lethality. Three flies homozygous for either Dmel\TIP60/RNAi or 
Dmel\TIP60/control P-element insertions were mated to three of GAL4 driver 32B. 
Progeny were counted over a ten day period and scored for either viable adults or 
dead pupae. The viability was calculated as described in Figure 2. (A) Induction of 
Dmel\TIP60/RNAi in CNS by GAL4 driver 60IIA causes lethality. The top panel 
shows GAL4 expression in the nervous system driven by 60IIA using X-Gal staining. 
Independent insertions Dmel\TIP60/RNAi A, B and C reduced viability to 0, 111 and 
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63%, respectively that of the Dmel\TIP60/control lines. (B) and (C) Viability was not 
affected by Dmel\TIP60/RNAi compared to the controls, when Dmel\TIP60/RNAi 
was induced by GAL4 drivers 109-30 and 109-69 respectively, which drive GAL4 
expression in the subsets of peripheral nervous system. 
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Figure 8. Expression of Dmel\TIP60/RNAi in the brains at the 15th embryonic stage 
by GAL4 driver 60IIA at 25 ºC shows no apparent defect phenotypes. The embryos 
were collected from 60IIA>Dmel\TIP60/RNAi A and 60IIA>Dmel\TIP60/Control C 
respectively and then stained by using the primary antibody mouse 22C10, anti-Repo, 
and anti-Elav respectively. 
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Figure 9. Expression of Dmel\TIP60/RNAi in the brains at the 3rd instar larva stage 
by GAL4 driver 60IIA at 25 ºC causes loss of differentiated neurons in the ganglion. 
The 3rd instar larvae brains were collected from 60IIA>Dmel\TIP60/RNAi A and 
60IIA>Dmel\TIP60/Control C respectively and then stained by using the primary 
antibody mouse anti-Elav. (A) Ventral view of 60IIA>Dmel\TIP60/Control C brain, 
which showed the symmetrical signals and linkage between two sides. (B) Dorsal 
view of 60IIA>Dmel\TIP60/Control C brain, which showed the symmetrical signals 
made of stripes of dots representative of differentiated neurons in the ganglion 
(magnified in C). (D) and (E) Ventral and Dorsal view of 60IIA>Dmel\TIP60/RNAi A 
brain respectively, showing the absence of the signals compared to the control (A and 
B), which is magnified in (F). 
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Figure 10. Induction of Dmel\TIP60/RNAi expression by muscle GAL4 driver c179 
at 25 ºC results in lethality and muscle disorder. Three flies homozygous for either 
Dmel\TIP60/RNAi or Dmel\TIP60/control P-element insertions were mated to three 
of GAL4 driver line c179 at 25 ºC. Progeny were counted over a ten day period and 
scored for either viable adults or dead pupae. The viability was calculated as 
described in Figure 2. (A) 0% viability was observed in all three independent 
Dmel\TIP60/RNAi lines. Compared to that of C179>Dmel\TIP60/Control C as 
shown in (B), the embryo shape of C179>Dmel\TIP60/RNAi A was affected and the 
muscle fibers in the embryo of C179>Dmel\TIP60/RNAi A became thinner as shown 
in (C). 
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Supplement Figure 1. Induction of Dmel\TIP60/RNAi in the posterior of the wing by 
GAL4 driver en-GAL4 does not affect apoptosis. The 3rd instar larvae wing discs 
were dissected from the progeny of crosses at 25 ºC of UAS P-element lines 
Dmel\TIP60/RNAi A or Dmel\TIP60/control C to GAL4 driver en-GAL4. The 
TUNEL assay was applied to the wing discs after fixation. 
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Supplement Figure 2. Induction of Dmel\TIP60/RNAi in the posterior of the wing by 
GAL4 driver en-GAL4 does not affect the expression pattern of integrin PS1 and PS2. 
The 3rd instar larvae wing discs were dissected from the progeny of crosses at 25 ºC 
of UAS P-element lines Dmel\TIP60/RNAi A or Dmel\TIP60/control C to GAL4 
driver en-GAL4. Then the wing discs were stained with primary antibody mouse 
anti-PS1 and anti-PS2 respectively. 
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Supplement Figure 3. Induction of Dmel\TIP60/RNAi in the brains at the 3rd instar 
larval stage does not affect the glial cells. The 3rd instar larvae brains were collected 
from 60IIA>Dmel\TIP60/RNAi A and 60IIA>Dmel\TIP60/Control C respectively and 
then stained by using the primary antibody mouse anti-Repo. 
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Supplement Figure 4. Induction of Dmel\TIP60/RNAi in the brains at the 3rd instar 
larval stage does not affect apoptosis. The 3rd instar larvae brains were dissected from 
the progeny of crosses at 25 ºC of UAS P-element lines Dmel\TIP60/RNAi A or 
Dmel\TIP60/control C to GAL4 driver 60IIA. The TUNEL assay was applied to the 
brains after fixation. 
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Supplement Figure 5. Induction of Dmel\TIP60/RNAi in the brains at the 3rd instar 
larval stage does not affect the expression pattern of cyclin E. The 3rd instar larvae 
brains were collected from 60IIA>Dmel\TIP60/RNAi A and 
60IIA>Dmel\TIP60/Control C respectively and then stained by using the primary 
antibody mouse anti-cyclin E. 
 
Control RNAi 
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